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Abstract 
 
The pre-T cell receptor (preTCR) is required for αβ T cell development and 
hence efficient adaptive immunity. Composed of a rearranged TCRβ chain 
paired with the invariant preTCR α chain (pTα), it drives immature 
thymocytes through the “β-selection” checkpoint, promoting differentiation, 
proliferation and survival. Although two functional splice isoforms of pTα 
exist, non-redundant roles for pTαa and pTαb have yet to be ascribed. 
This thesis demonstrates that pTαa and pTαb display non-identical 
expression patterns in immature thymocyte subsets. Moreover, it 
demonstrates that preTCRa and preTCRb promote divergent T cell 
development; preTCRa drives prolonged expansion of post-β-selection 
thymocytes, while preTCRb drives rapid maturation of TCRαβ(+) cells. 
Importantly, by mutating charged residues in the extracellular domain of 
pTα, it is shown that pTα oligomerization is not required for preTCR 
signalling per se, as had previously been proposed. Instead, the capacity 
for oligomerization regulates surface preTCR levels, which in turn dictates 
subsequent developmental potential.  
This thesis also presents preliminary evidence for a novel role for the 
preTCR; that preTCR signalling sensitises the extracellular signal-regulated 
kinase (ERK) mitogen-activated protein (MAP) kinase pathway that in turn 
regulates the signalling thresholds for positive and negative selection in 
CD4(+)CD8(+) double positive (DP) cells. Indeed, it is suggested that this 
process may be critical for central tolerance in the thymus. 
Finally, this thesis describes the generation and initial characterisation of 
pTαa and pTαb BAC transgenic mice that will facilitate the separate 
investigation of pTαa and pTαb in a pTα-deficient background in vivo. 
Collectively, the results presented in this thesis ascribe non-redundant roles 
for the two isoforms of pTα and necessitate a fresh examination of the 
mechanism by which the preTCR initiates signalling. The implications of 
these results for αβ T cell development and the immune system as a whole 
are discussed. 
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Chapter 1 
T cells occupy a central position in adaptive immune responses. 
 
The purpose of adaptive immunity is to protect. The body is under constant 
threat from invading pathogens such as bacteria, viruses and parasites. As 
part of the adaptive immune response, T cells function to recognise 
invaders and eliminate them. 
1.1 T cells. 
T cells originate from pluripotent hematopoietic stem cells from the bone 
marrow or foetal liver, which migrate to the thymus, the sole function of 
which is to initiate and support the T lineage developmental programme 
(Rothenberg et al., 2008). Indeed, the “T” in T cell stands for thymus in 
recognition of the fact that the vast majority of T cells differentiate in this 
organ.  
T cells are distinguished from other lymphocyte populations by their 
expression of T cell receptors (TCRs). TCRs are heterodimeric surface 
protein complexes that possess immunoglobulin extracellular domains that 
serve to recognise antigen. Antigen recognition by the TCR initiates 
intracellular signalling cascades that result in activation of T cell effector 
function. Two major subtypes of T cell exist; those that express the αβ TCR 
and those that express the γδ TCR. αβ T cells are further characterised by 
their expression of co-receptor molecules CD4 and CD8.   
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1.2 T cells recognise antigen presented by MHC. 
T cells recognise pathogens through their TCRs, which bind antigens 
presented on the surface of cells (Germain, 1994). Antigens are defined as 
parts of molecules that can be recognised by antigen receptors, i.e. the 
TCR or antibodies. In the context of disease, antigens are derived from 
viruses or intracellular bacteria that replicate within cells or from pathogens 
and their products that have been endocytosed. Antigen presentation is 
mediated by peptide-binding glycoproteins encoded in a large gene cluster 
called the major histocompatibility complex (MHC). Recognition of antigen 
peptide presented by MHC molecules is one of the distinctive features of T 
cells. MHC molecules exist as two major types; MHC class I and MHC 
class II, which differ in their structure, antigen processing function and 
expression pattern on cells and tissues of the body. The MHC loci contain 
several different class I and class II genes equipping an individual with the 
capacity to present a broad range of antigens to T cells. Importantly the 
MHC is also polymorphic; meaning there are multiple variants of each gene 
within a population. This contributes to the ability of T cells to respond to 
the vast array of pathogens that may be encountered throughout one’s life.  
1.2.1 MHC-I.  
MHC class I molecules are expressed on all nucleated cells. Their function 
is to process and present intracellular antigens to T cells expressing the 
CD8 co-receptor, i.e. cytotoxic T cells, whose principle function is to kill 
infected cells (Germain, 1994; Williams et al., 2002). Peptide loading of 
MHC-I molecules occurs in the lumen of the endoplasmic reticulum (Figure 
1.1). The proteosome is part of the ubiquitin-dependent degradation 
pathway for cytosolic proteins and is involved in processing antigenic 
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peptides for presentation by MHC-I molecules. Two ATP-dependent ABC 
transporters, TAP-1 and TAP-2, are responsible for transporting peptides 
from the cytosol into the lumen of the endoplasmic reticulum. The 
appropriate folding and formation of MHC-I bound to β2m is regulated by 
chaperones in the ER, such as calnexin and Erp57, and is dependent on 
peptide loading facilitated by TAP and Tapasin. Once the peptide is bound 
the stabilised peptide-MHC-I complexes are transported to the surface of 
the cell (Williams et al., 2002).  
Figure 1.1 
 
  
 
 
 
 
 
 
 
Figure 1.1 Antigen processing for presentation by MHC-I. Endogenous 
polypeptides are degraded by the proteosome in the cytoplasm producing peptide 
fragments that are transported into the lumen of the endoplasmic reticulum by 
TAP1 and TAP2. MHC-I molecules are formed in the endoplasmic reticulum where 
they bind chaperones (Erp57 and calreticulin) and TAP via tapasin. MHC-1 
molecules are then loaded with peptide and subsequently traffic to the surface of 
the cell.  
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1.2.2 MHC-II. 
Peptides presented by MHC-II are recognised by CD4(+) helper T cells 
which function to activate other effector cells of the immune system. 
Consequently MHC-II molecules are expressed only on “professional” 
antigen presenting cells such as dendritic cells, B cells, macrophages and 
thymic epithelial cells. MHC-II presents antigens from pathogens that reside 
in intracellular vesicles such as tuberculosis which infect macrophages, or 
those from extracellular pathogens and their products that have been 
endocytosed (Villadangos, 2001)  (Figure 1.2). 
Figure 1.2 
 
 
 
 
 
 
 
 
Figure 1.2 Antigen processing for presentation by MHC-II. Exogenous material 
is internalised by the endocytic pathway. Degradation of endosomal cargo occurs 
after fusion with lysosomes. MHC-II molecules formed in the ER are prevented 
from binding antigen by association with the invariant chain. After targeting to the 
endosomal compartments the invariant chain is cleaved and CLIP is removed and 
replaced with antigen before trafficking to the cell surface.  
20 
 
The endosomes containing antigen become increasingly acidic and after 
fusing with lysosomes allow acid proteases to become active and degrade 
the polypeptides to presentable peptides. MHC-II is formed in the 
endoplasmic reticulum bound to invariant chain. The invariant chain blocks 
the peptide binding groove, thus preventing peptide loading within the 
endoplasmic reticulum. The invariant chain targets class II molecules to 
acidic endosomes where it is cleaved by acidic proteases leaving a peptide 
fragment, CLIP, still bound to the peptide groove. Removal of CLIP and 
subsequent loading of antigen is catalysed by HLA-DM and the loaded 
class II molecule is subsequently trafficked to the cell surface (Villadangos, 
2001; Watts, 1997).  
1.3 T cell receptor rearrangement creates the diversity required for 
comprehensive immune protection. 
 In a perfect world one would produce a different T cell with a TCR that 
recognised each pathogen that exists on the face of the planet. Of course 
this is not possible; bacteria and viruses rapidly and continually evolve and 
therefore the pool of pathogens is ever expanding. Furthermore, the 
number of genes required would be unfeasible to incorporate into the 
genome. The solution, therefore is to make a limitless supply of different T 
cells by rearrangement of the immunoglobulin receptor genes that code for 
the TCR (Davis and Bjorkman, 1988; Tonegawa, 1983). TCR chains 
consist of two main regions; the variable domain (V-region) that encodes 
the extracellular Ig-loop that interacts with antigen-MHC, and the constant 
domain (or C-region) that encodes a further Ig-loop, as well as the 
transmembrane and short intracellular regions of the chain (Figure 1.3).  
Diverse antigen specificities of TCRs are determined by variation in the 
amino acid sequences of the V-regions.  
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Figure 1.3 
 
 
 
 
 
 
 
Figure 1.3 The αβ T cell receptor. A schematic of TCRαβ showing the Ig-loops 
that represent the variable (V) and constant (C) regions. Ig-loops are held together 
by disulphide bonds (s-s). The two TCR chains are also connected by a disulphide 
bond. The variable regions constitute the antigen/MHC binding sites of the TCR 
chains. 
 
TCR chains are encoded by several gene segments that need to be 
brought together to form a functional gene. The TCRα chain is encoded by 
V (variable), J (joining) and C (constant) segments, while TCRβ is encoded 
by V, D (diversity), J and C regions. The V(D)J segments are joined to form 
a complete T cell receptor by a process known as gene rearrangement, 
which happens in T cells during their development in the thymus (Figure 
1.4).  
The mouse TCRβ locus consists of 20-30 Vβ segments that lie upstream of 
two gene clusters consisting of a single Dβ gene segment, 6 Jβ segments 
and a single Cβ segment and rearrange by looping out and deletion of the 
intervening DNA. One Vβ segment lies downstream of the DβJβCβ 
elements and rearranges by inversion. In mice the TCRα locus consists of 
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~75-100 Vα segments followed by 50 Jα segments and a single Cα gene 
(Figure 1.5) (Davis and Bjorkman, 1988).    
Figure 1.4 
 
 
 
 
 
 
Figure 1.4 T cell receptor gene rearrangements. Schematic representation of 
TCRα and TCRβ gene rearrangement. Different V regions of TCR chains are 
generated by different combinations of V(D) and J segments being used by a 
single T cell. For TCRα genes rearrangement occurs in a single step to bring 
together Vα and Jα segments by removal of the intervening sequences. For TCRβ 
genes two rearrangement steps are required; the first unites D and J segments the 
second joins the DJ segment to the V segments on the gene.  
 
Figure 1.5 
 
 
 
 
 
Figure 1.5 Organisation of TCR genes in mice. Schematic representation of the 
TCRα and TCRβ genes in mice. Expression of multiple V and J segments 
increases TCR diversity for antigen recognition.  
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An elegant mechanism exists to ensure the site specific rearrangement and 
joining of V D and J segments (Tonegawa, 1983). Conserved heptamer 
(5’CACAGTG-3’) and nonamer (5’-ACAAAAACC-3’) sequences exist 
adjacent to the sites at which recombination takes place. The heptamer and 
nonamers are separated by either 12bp or 23bp “spacers”. Gene segments 
carrying a 12bp spacer can only be joined to a gene segment carrying a 
23bp spacer.  Thus in TCRβ Vβ segments can only be joined with Dβ 
segments and not Jβ segments (Figure 1.6). The products of two 
lymphocyte specific recombination-activating genes; RAG-1 and RAG-2 are 
the key enzymes that mediate V(D)J recombination through recognition and 
binding of the heptamer-spacer-nonamer recognition sequences 
(Mombaerts et al., 1992b; Shinkai et al., 1992).   
Figure 1.6 
 
 
 
 
 
 
Figure 1.6 The 12/23 rearrangement rule. Schematic representation of the TCR 
gene heptamer and nonamer sequences that are adjacent to sites at which 
recombination takes place. These are separated by 12bp and 23bp spacers. Only 
those segments that possess recognition sequences containing 23bp spacers can 
be joined to those with 12bp spacers.  
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In addition to the combinatorial diversity generated by V(D)J 
rearrangements another mechanism exists to generate variation within the 
antigen binding pocket of the TCR (Davis and Bjorkman, 1988). During the 
formation of the V(D)J junctions, nucleotides are added or excised 
randomly. In this manner, even if the same two segments are joined by 
different cells the joining region will be distinct. The V(D)J junctions 
constitute the third hyper-variable loop (CDR3) that contributes to the 
antigen binding site of the TCR. Because the complete TCR is made up of 
TCRα and TCRβ chains that have both undergone rearrangements and 
have had additional variation generated at the joining regions, the potential 
diversity of TCR specificities is vast. 
1.4 Thymic selection is essential for preventing the generation of T 
cells that recognise self. 
The potential problem of generating T cells with the capability of 
recognising an almost infinite number of antigens is that a sizable subset of 
these antigens will be “self”. Clearly an immune response to “self”-antigens 
would be detrimental. Thus, the thymus has evolved a mechanism to 
overcome this dilemma; namely, T cell selection. This process assesses 
each T cell on the ability of its TCR to recognise self proteins presented by 
MHC. Based on this, thymocytes are either deleted or maintained. The fate 
of the developing T cell is dependent on the affinity of its TCR for self-
antigen-MHC presented by thymic stromal cells (Figure 1.7) (Klein et al., 
2009). Developing T cells that express “useless” TCRs that are unable to 
interact with self-peptide-MHC as a result of low affinity binding do not 
survive; a process known as “death by neglect” (Huesmann et al., 1991; 
Kisielow et al., 1988).  
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By contrast DP cells that recognise and bind self-peptide-MHC with very 
high affinity undergo apoptosis; a process known as “negative selection”. 
This is critical for depleting self-reactive TCRs from the T cell repertoire 
(Kappler et al., 1987). 
Figure 1.7 
 
 
 
Figure 1.7 TCR affinity for self-antigen-MHC determines developing T cell 
fate: progenitor T cells in the thymus are “tested” for the self reactivity of their 
TCRs. Those that express TCRs with high affinity for self-antigen MHC die by 
apoptosis; those that recognise self-antigen-MHC with little or no affinity die by 
neglect. Only those T cells that possess intermediate affinity TCRs for self-antigen-
MHC are positively selected to survive.    
 
Negative selection thus provides “central tolerance” a term that describes 
the removal of self-reactive lymphocytes at source. As a result, only the few 
T cell progenitors that recognise self-peptide-MHC with intermediate affinity 
are “positively selected” and mature to become effector cells that leave the 
thymus to populate the periphery (Figure 1.7). As an additional tolerance 
mechanism the thymus also produces T cells that provide regulatory 
function. These cells contribute to peripheral tolerance, dampening immune 
responses to self.  
1.5 Autoimmunity: When T cell selection goes wrong. 
Self-reactive T cells that escape negative selection have the potential to 
mount immune responses to self-antigens as if they were a pathogen. Self-
reactive T cells mediate tissue damage associated with a number of 
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autoimmune diseases and immunopathologies. For example, type-1 insulin 
dependent diabetes mellitus is an organ-specific autoimmune disease 
characterised by the progressive destruction of pancreatic β-islet insulin-
producing cells (Santamaria, 2010). Although the nature of the disease is 
very complex and not fully understood, it is evident that autoreactive T cells 
play a central role in the pathogenesis of type-1 diabetes. Autoreactive CD4 
and CD8 T cell infiltrates are found in diseased pancreatic islets and β-cell 
destruction is thought to be a consequence of cytotoxic T cell function. 
Many different antigen targets of diabetes-specific T cells have been 
identified, that include insulin, GAD65, as well as islet-specific glucose-6-
phosphatase catalytic subunit-related protein IGRP (Santamaria, 2010).  
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Chapter 2 
 T cell development in the Thymus  
 
2.1 The Thymus. 
The thymus has evolved as the primary lymphoid organ to support T cell 
development, its appearance, in evolutionary terms corresponding with the 
appearance of lymphocytes expressing highly diverse antigen receptors 
(Rodewald, 2008). Consistent with this view, the stromal cells of the 
thymus, in particular the cortical and medullary epithelial cells (cTECs and 
mTECs) and thymic dendritic cells have specialised functions that serve 
particular roles during T cell development (Anderson et al., 2007; Anderson 
et al., 1996; Klein et al., 2009). cTECs express both MHC-I and MHC-II and 
are efficient mediators of both positive and negative selection (Anderson et 
al., 1994b; Goldman et al., 2005). Indeed, expression of the β5t catalytic 
subunit of the proteosome is exclusive to cTECs in the thymus and is 
essential for positive selection of CD8 thymocytes (Murata et al., 2007). 
Moreover, cTECs express a specific acid protease required for MHC-II 
loading, Cathepsin L, which is necessary for positive selection of CD4 
thymocytes (Nakagawa et al., 1998). In the context of immune responses, 
MHC-II normally presents exogenous antigens to T cells. Thus, in the 
thymus, thymic epithelial cells have had to evolve a mechanism to present 
endogenous antigens to T cells, a process known as macroautophagy. This 
involves engulfment of portions of the cytoplasm by intracellular organelles 
which then fuse with lysosomes for degradation of their cargo (Klein et al., 
2009). Macroautophagy provides a mechanism by which MHC-II molecules 
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can be loaded with and present endogenous self-antigen to developing 
CD4(+) cells. Indeed the thymus is a site of unusually high constitutive 
autophagy activity (Klein et al., 2009).    
MHC-I and MHC-II are both also expressed by mTECs (Anderson et al., 
2007). Like cTECs, mTECs can also mediate negative selection of 
thymocytes and possibly positive selection of Regulatory T cells 
(Aschenbrenner et al., 2007; Ribot et al., 2007). The discovery of the 
transcription factor AIRE (Autoimmune regulator), which regulates the 
promiscuous gene expression of hundreds of tissue-restricted antigens in 
the thymus, has provided insight into how thymocytes are exposed to 
peripheral self-antigens. AIRE expression is a distinct property of mTECs. 
However, only a small subset of mTECs express this transcription factor, 
and the mechanism by which it contributes to central tolerance is still 
debated (Anderson et al., 2002; Klein et al., 2009). Nonetheless, humans 
with a mutation in AIRE develop APECED (autoimmune 
polyendocrinopathy-candidiasis-ectodermal dystrophy), a severe 
autoimmune disorder (Mathis and Benoist, 2007).    
2.2 Conventional T cell development.  
2.2.1 Stages of T cell development. 
T cell precursors develop in the thymus through distinct stages defined by 
expression of various surface molecules (Figure 2.1). T cell precursors 
express neither CD4 nor CD8 co-receptors and are therefore termed 
double negative (DN). DN cells are further categorised on surface 
expression of CD25 and CD44; CD25-CD44+ (DN1), CD25+CD44+ (DN2), 
CD25+CD44- (DN3) and CD25-CD44- (DN4) (Godfrey et al., 1993).  
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The DN1 subset is heterogeneous, but consists mainly of early thymic 
progenitors (Porritt et al., 2004). Single cell analysis has revealed that 
progenitors that seed the foetal thymus possess T, B and myeloid lineage 
potential (Benz and Bleul, 2005; Kawamoto et al., 1998). Progression to the 
DN2 stage is accompanied by a proliferative phase that expands the 
precursor population in which TCR gene rearrangements occur (Kawamoto 
et al., 2003).  
 
 
 
 
 
 
 
 
Figure 2.1 Stages of T cell development in the thymus. DN T cell precursors 
enter the thymus from the bone marrow and progress through a series of stages 
characterised by expression of various surface molecules. γ, δ and β TCR gene 
rearrangements occur in DN2 cells; marking commitment to the T lineage. DN cells 
that rearrange TCR γ and δ genes successfully, commit to the γδ T cell lineage. β-
selection, mediated by the preTCR, promotes the survival, proliferation and 
differentiation of thymocytes that have undergone successful TCRβ gene 
rearrangements. TCRα rearrangements occur at the DP stage. DP thymocytes are 
subjected to positive and negative selection determined by the self-reactivity of 
their TCRs. Positively selected DPs mature to become either CD4 SP or CD8 SP 
and leave the thymus to populate the periphery. DN, double negative; DP, double 
positive; SP, single positive and TCR, T cell receptor.  
 
Figure 2.1 
30 
 
Evidence of T lineage commitment is apparent in DN2 thymocytes which 
begin to express genes necessary for TCR rearrangement such as RAG1 
and RAG2, as well as genes involved in TCR complex formation such as 
Lck, CD3γ, CD3δ and TCRδ. Importantly, the pre-T cell receptor alpha chain 
(pTα) is also expressed in DN2 cells (Molina et al., 1992; Mombaerts et al., 
1992b; Wilson and MacDonald, 1995). Progression to the DN3 stage 
establishes T lineage commitment as the cells lose the ability to adopt 
alternative fates (Masuda et al., 2007). DN3 cells cease proliferating and 
undergo TCR γ, δ and β gene rearrangements.  DN3 cells that have 
functional γ and δ TCR rearrangements express the γδTCR and are 
diverted from the αβ lineage to differentiate into γδ T cells (discussed later 
in this introduction). 
DN3 cells that have undergone successful TCRβ gene rearrangements 
express the pre T cell receptor (preTCR) which mediates an important 
transition in development known as the “β-selection” checkpoint (Fehling et 
al., 1995a). The preTCR complex is composed of a rearranged TCRβ chain 
paired with the invariant pTα chain and various CD3 molecules. Signalling 
through the preTCR induces downregulation of CD25, cell survival, 
proliferation and differentiation to the DN4 stage and beyond (Hoffman et 
al., 1996; Michie and Zuniga-Pflucker, 2002; von Boehmer et al., 1998). 
DN4 cells subsequently become immature single positive cells (ISPs) by 
acquiring CD8, before rapidly upregulating CD4 to become “double 
positive” (DP) cells. The process of β-selection mediated by the preTCR is 
the focus of this thesis and will be discussed in detail in subsequent 
chapters of this introduction. The proliferative burst that is associated with 
the DN3 to DP transition is necessary for expansion of cells that have 
undergone successful TCRβ rearrangements, providing many progenitors 
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in which subsequent TCRα rearrangements can then occur. The resulting 
TCRαβ complexes are then screened for their ability to recognise and 
interact with MHC-self-antigen expressed by thymic epithelial cells. TCRα 
rearrangements can continue to an extent in DP thymocytes until the 
generation of a TCRαβ capable of engaging MHC-peptide complexes and 
eliciting a productive TCR signal is formed. Signals through the αβTCR 
induce survival, upregulation of CD5 and CD69, and termination of RAG 
gene expression, thereby preventing further TCRα gene rearrangements 
(Bhandoola et al., 1999; Brandle et al., 1992).  
2.2.2 Factors regulating T lineage commitment. 
Commitment of early thymic progenitors to the T lineage involves the Notch 
family of signalling proteins (Rothenberg et al., 2008). There are four known 
Notch receptors in mammals (Notch 1-4) which recognise 5 known ligands; 
Delta-like 1 (DL1) DL3, DL4, Jagged-1 and Jagged-2. Upon ligation, the 
Notch receptor is proteolytically cleaved and the intracellular domain 
migrates to the nucleus where it binds the transcription factor CSL also 
known as recombination site binding protein J (RBPj). Binding of the Notch 
intracellular domain converts CSL from a transcriptional repressor to an 
activator and results in transcription of Notch target genes (Rothenberg et 
al., 2008).  Inactivation of Notch-1 in bone marrow progenitors abrogates 
commitment to the T cell lineage and as a result, progenitor cells in the 
thymus adopt a B cell fate (Radtke et al., 1999). Conversely, retroviral 
transduction of bone marrow hematopoietic stem cells with a constitutively 
active form of Notch-1, promotes T lineage commitment while preventing B 
cell development in the bone marrow (Pui et al., 1999). Indeed, expression 
of DL1 on the bone marrow stromal cell line OP9 generates cells that are 
able to support T cell development (Schmitt and Zuniga-Pflucker, 2002). 
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Importantly, continued Notch signalling is required from the DN1-DN3 
stages to maintain commitment to the T cell lineage (Schmitt et al., 2004). 
Moreover, the Notch-CSL complex upregulates the T lineage specific gene 
expression of Deltex-1, Rag-1, Hes-1 and pTα genes (Reizis and Leder, 
2002; Rothenberg et al., 2008). 
Acting in concert with Notch signals to promote T cell development are E-
proteins, members of the basic-helix-loop-helix family of transcription 
factors (Rothenberg et al., 2008). E-proteins E2A and HEB are expressed 
in early thymic progenitors and throughout development until the late DP 
stage (Engel et al., 2001). E2A knock-out mice display a partial block in T 
cell development at the DN1 stage and rapidly develop lymphomas, 
highlighting the role of these proteins in controlling proliferation (Bain et al., 
1997). E2A and HEB enforce the DN3 phenotype by arresting their 
proliferation which allows for initiation of TCR gene rearrangements (Engel 
and Murre, 2004). Furthermore, E-proteins activate transcription of the pTα 
gene (Takeuchi et al., 2001). E-protein activity is regulated by inhibitory 
factors such as Id2 and Id3 which form heterodimers with E2A and HEB 
and prevent their DNA binding. Id2 is expressed at the DN1 to DN2 
transition concurrent with the proliferation observed at this transition. 
Furthermore, TCRγδ and preTCR signalling both induce expression of Id3 
which is necessary for proliferation of thymocytes that have successfully 
completed TCR gene rearrangements (Bain et al., 2001; Koltsova et al., 
2007; Lauritsen et al., 2009).   
2.2.3 T cell migration in the thymus.  
Interaction of thymocytes with thymic epithelial cells is important for 
differentiation and maturation of both the T cells and stromal cells that 
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provide developmental support (Anderson et al., 1996; Takahama, 2006). 
Various stages of thymocyte development are precisely associated with 
their migration through specialised compartments of the thymus (Figure 
2.2). Chemokines have an important role in guiding the thymocytes as they 
traffic through the organ  (Takahama, 2006).  
Figure 2.2 
 
 
 
 
 
 
 
 
 
Figure 2.2 Migration of developing thymocytes through the thymus is 
precisely regulated by chemokines and is closely associated with their 
differentiation and selection. In the postnatal thymus, early thymic progenitors 
(DN1) enter the thymus through the vasculature in the cortico-medullary junction. 
As they differentiate into DN2 and DN3 they migrate outward towards the 
subcapsular zone (SCZ). CXCR4, CCR7 and CCR9 expression by DN2/DN3 
thymocytes mediates their migration and localisation to the SCZ. DP thymocytes, 
localised within the cortex interact with cTECs for positive and negative selection. 
Positively selected cells upregulate CCR7 through which they are attracted, 
inward, towards the medulla. mTECs mediate the deletion of tissue-specific-
antigen reactive SP cells. Mature SP cells express sphingosine-1-phosphate 
receptor 1 (S1P1), through which the cells are attracted back to the circulation that 
contains a high concentration of sphingosine-1-phosphate. DN, double negative; 
DP, double positive; SP, single positive; cTEC, cortical thymic epithelial cell; 
mTEC, medullary thymic epithelial cell. 
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The seeding of the thymus with lymphoid progenitors occurs as early as 
embryonic day 11.5 in mice and the eighth month of gestation in humans. 
During the early stages of embryogenesis colonisation of the foetal thymus 
by lymphoid progenitor cells is vasculature-independent and requires 
CCL21 and CCL25 which attract progenitors expressing the receptors 
CCR7 and CCR9, respectively. In the postnatal thymus, progenitors enter 
from the blood through the vasculature located close to the cortico-
medullary junction.  In the adult thymus, this process is regulated by 
adhesion mediated by P-selectin glycoprotein ligand -1 (PSGL1) and P-
selectin which is expressed by the thymic endothelium (Takahama, 2006).  
Progenitor thymocytes enter the thymus in waves during foetal and adult 
life (Foss et al., 2001; Jotereau et al., 1987). Experiments with parabiotic 
adult mice have revealed that colonisation of the thymus is a “gated” 
process during which the “open gate” period lasts one week  followed by a 
three week “closed gate” period before the gates open again for 
colonisation with a new wave of progenitor cells (Foss et al., 2001).  
Concomitant with early thymic progenitor cell commitment to the T cell 
lineage, the cells migrate outward from the cortico-medullary junction to the 
subcapsular zone (SCZ) (Takahama, 2006). Development of immature 
thymocytes through the DN1 to DN3 stage appears to correlate with the 
differentiation of keratin-8(+) thymic epithelial cells (TECs) into cortical 
epithelial cells (cTECs) by downregulation of keratin-5. Localisation of DN2 
and DN3 thymocytes to the SCZ is dependent on CXCR4 expression; the 
ligand (CXCL12) for which is abundantly expressed in this compartment of 
the thymus (Plotkin et al., 2003; Trampont et al., 2010). Indeed, CXCR4 is 
essential for DN thymocyte migration to the SCZ and for their differentiation 
past the β-selection checkpoint (Plotkin et al., 2003; Trampont et al., 2010). 
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CCR7 and CCR9 expression by DN thymocytes is also required for their 
localisation to the SCZ (Benz et al., 2004; Misslitz et al., 2004).  
Positive and to some extent, negative selection of DP thymocytes occurs in 
the cortex and involves interactions with peptide-MHC complexes 
expressed on cTECs and dendritic cells in the cortex. Upon positive 
selection DP cells in transition to the SP stage are highly motile and 
migrate rapidly to the medulla, a process mediated by CCR7 that is 
upregulated following TCR engagement (Ueno et al., 2004). Cortex-
medulla migration of positively selected thymocytes plays a crucial role in 
medulla formation (Ueno et al., 2004). Maturation of SP thymocytes occurs 
in the medulla resulting in upregulation of CD62L (L-selectin) and 
downregulation of CD69. Further deletion of self reactive thymocytes also 
occurs in the medulla to establish central tolerance to tissue specific 
antigens through interaction of SP thymocytes with AIRE expressing 
medullary epithelial cells (mTECs). Egress of mature thymocytes from the 
thymus is regulated by sphingosine-1-phospate receptor-1 (S1P1) mediated 
chemotaxis towards sphingosine-1-phospate in the circulation (Matloubian 
et al., 2004).  
2.2.4 Duration and strength of TCR signal dictates CD4/CD8 lineage 
choice. 
The αβTCRs expressed by DP thymocytes constitute a hugely diverse pre-
selected repertoire. Positive selection not only identifies the relatively few 
DPs that express TCRs with useful specificity, but also promotes 
development of SP thymocytes that are committed to either the CD8 
lineage, that recognise MHC-I-presented antigens, or the CD4 lineage that 
recognises MHC-II-presented antigens. CD4 and CD8 function as co-
receptors to the TCR through their ability to bind MHC, enhancing the 
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strength of TCR/MHC binding; CD4 to MHC-II (Doyle and Strominger, 
1987) and CD8 to MHC-I (Bosselut et al., 2000; Norment et al., 1988). 
Furthermore, CD4 and CD8 associate with Lck (Veillette et al., 1988) and 
linker for activation (LAT) (Bosselut et al., 1999) through their intracellular 
domains and therefore augment initiation and propagation of TCR signals 
(Singer et al., 2008).  
Figure 2.3 
 
 
 
 
 
 
Figure 2.3 The kinetic signalling molecule of CD4/8 lineage commitment: 
Regardless of the specificity of their T cell receptor (TCR), positively selecting TCR 
signals induce double-positive (DP) thymocytes to terminate CD8 gene 
transcription and convert into CD4
(+)
CD8
(lo)
 intermediate cells. CD4
(+)
CD8
(lo)
 
thymocytes are lineage uncommitted cells that retain the potential to differentiate 
into either CD4 single-positive (SP) or CD8SP cells. Persistence of TCR signalling 
in CD4
(+)
CD8
(lo)
 thymocytes blocks interleukin-7 (IL-7) signalling and induces 
differentiation into mature CD4SPs. Cessation of TCR signalling in CD4
(+)
CD8
(lo)
  
cells permits IL-7 signalling, which induces CD4
(+)
CD8
(lo)
 intermediate thymocytes 
to undergo co-receptor reversal to become CD8SPs.     
 
Alfred Singer has made a significant contribution to our understanding of 
the events that determine CD4 and CD8 lineage commitment; his kinetic 
signalling model being a widely accepted concept in the field (Singer, 2002; 
Singer et al., 2008; Singer and Bosselut, 2004). The kinetic signalling 
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model of CD4/CD8 T cell lineage commitment (Figure 2.3) suggests that 
positive selection mediated by TCR signalling does not induce DP 
thymocytes to undergo lineage commitment but rather induces termination 
of CD8 expression. This leads to the development of an intermediate 
(CD4(+)CD8(lo)) population that retains the potential to commit to either 
CD4SP or CD8SP fates. At this stage the developing T cell is in a position 
to “test” the MHC specificity of its TCR. Thus, if downregulation of CD8 
does not interrupt TCR signalling the thymocyte “realizes” that CD8/MHC-I 
interactions were not contributing to TCR/MHC binding, so the TCR must 
not recognise MHC-I. However if CD8 downregulation leads to cessation of 
TCR signalling the cell “realizes” that CD8/MHC was important for 
signalling, so the TCR must recognise MHC-I. With this information the 
CD4(+)CD8(lo) DP cell then follows a differentiation pathway appropriate to 
the TCR specificity for either MHC-I or MHC-II. 
Putting the kinetic model in terms of duration of TCR signal, it suggests that 
extended TCR signals commit DP cells to the CD4SP lineage, while short 
duration TCR signals commit DPs to the CD8SP lineage.  Because high 
affinity TCR-peptide-MHC interactions are more likely to be prolonged 
whereas weak affinity interactions are not maintained for long, this model 
encompasses evidence that shows that high affinity ligands and strong 
signalling through the TCR promotes CD4 lineage commitment while low 
affinity or weak signalling promotes CD8 lineage commitment (Singer and 
Bosselut, 2004).  
Interleukin-7 (IL-7) signalling plays an important role in maintaining CD8 
progenitor cell viability in the absence of TCR signalling during transition to 
the SP stage (Brugnera et al., 2000). IL-7Rα is upregulated on DP 
thymocytes following positively selecting TCR signals (Brugnera et al., 
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2000). IL-7 treatment of CD4(+)8(lo) thymocytes in vitro induces upregulation 
of Bcl-2 (Brugnera et al., 2000; Yu et al., 2003) as well as RUNX3 (Park et 
al., 2010) promoting their survival and CD8 CTL lineage commitment, 
respectively. Furthermore, IL-7 signalling in CD4(+)8(lo)  thymocytes results in 
termination of CD4 gene expression through activation of the CD4 silencer 
element (Brugnera et al., 2000).  Importantly, treatment of CD4(+)8(lo) with IL-
7 in the presence of PMA and ionomycin, to mimic TCR signals, prevented 
co-receptor reversal in these cells (Brugnera et al., 2000).  Thus CD4(+)8(lo) 
precursors, committed to the CD4 lineage, avoid the effects of IL-7 through 
persistent TCR signalling (Brugnera et al., 2000; Singer and Bosselut, 
2004).  
2.3 Unconventional T cell development. 
“Unconventional” T cells are so called because they do not follow 
conventional mechanisms for their development and function (Hayday, 
2009; Pennington et al., 2005). These cells share an unconventional gene 
expression profile, and are generally found in the tissues rather than the 
lymph nodes and blood. They are more “innate-like” in their function; 
showing an “activated-yet-resting” phenotype, and having the capacity for 
rapid responses that do not require clonal expansion in lymphoid tissue. 
They have been described as important players in transitional immunity that 
connects innate and adaptive responses (Hayday, 2009). Unconventional T 
cells include γδ T cells and αβ T cells that express CD8αα in the epithelial 
layers such as the gut (Pennington et al., 2005). Since their discovery in the 
1980s γδ T cells have been found to mediate stress surveillance responses 
throughout epithelial layers of the body. In addition, they can function as 
antigen presenting cells and influence adaptive immune responses. 
Furthermore, γδ T cells are important for immunological responses to 
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cancer and infections such as malaria, TB as well as HIV (Hayday, 2009). 
CD8αα(+) intraepithelial lymphocytes (IELs) are TCRαβ(+) T cells that line the 
gut epithelial barrier and possess a regulatory function that is thought to be 
important in epithelial homeostasis (Poussier et al., 2002).  
2.3.1 T cell development 
γδ and αβ T cells develop from a common precursor in the thymus (Hayes 
et al., 2010; Lauritsen et al., 2006; Pennington et al., 2005). Development 
of γδ T cells requires rearrangement of TCRγ and TCRδ chains and 
signalling through the γδTCR. However, it is not known at precisely which 
stage the two lineages diverge, although it is clear that γδ cell commitment 
occurs at some point between the DN2 stage, in which TCRγ and TCRδ 
gene rearrangements occur, and before commitment to the DP stage. 
Indeed DN4 thymocytes are still able to give rise to both αβ and γδ T cells 
(Petrie et al., 1992).    
Figure 2.4 
 
 
 
 
Figure 2.4 The strength of signal model of αβ/γδ T cell lineage commitment. 
The model suggests that double negative (DN) thymocytes that receive strong 
signals through their TCR commit to the γδ T cell lineage, while those receiving 
weak TCR signals commit to a αβ T cell lineage fate. Thus the αβ/γδ lineage 
decision is not instructed but rather dependent on the strength of signal induced by 
their TCR.   
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Rather than αβ/γδ lineage choice being instructed by the preTCR versus the 
γδ TCR, respectively, it is thought that it is the strength of signal emanating 
from a TCR complex that determines αβ/γδ lineage commitment; 
thymocytes receiving strong signals commit to a  lineage fate, while those 
that receive weaker signals commit to an  T cell fate. Evidence for this 
strength-of-signal model was provided by two independent groups (Haks et 
al., 2005; Hayes et al., 2005). Hayes et al used Vγ6/Jγ1Cγ1-
Vδ6/Dδ6/Jδ2/Cδ TCR transgenic mice, in which γδTCR transgene 
expression led to development of both γδ and αβ thymocytes. Crossing the 
transgenic mice onto a TCRδ(+/-) background resulted in a significant 
increase in the percentage of DP cells that developed, while the percentage 
of γδ cells was significantly decreased. Conversely, expression of a TCRδ 
transgene in γδTCR transgenic TCRδ(+/+) mice significantly increased the 
level of TCR on the surface of precursor thymocytes resulting in a 7-fold 
reduction in the percentage of DPs, while favouring γδ T cell development 
(Hayes et al., 2005). Importantly this showed that high surface expression 
of the γδ TCR corresponded to γδ T cell lineage commitment while low TCR 
surface expression favoured αβ lineage commitment. 
To determine whether development promoted by differential surface 
expression of the TCR correlated with signal strength through the γδTCR  
they generated γδTCR transgenic TCRδ(-/-) mice expressing either the full 
length TCRδ construct or a truncated version that lacked the 3 
immunoreceptor tyrosine-based activation motifs (ITAMs) present within the 
cytoplasmic domain of the receptor. Despite the equivalent surface 
expression of TCRγδ on DN thymocytes from these two transgenic mice 
lines CD5 levels (an indicator of signal strength) were drastically reduced 
on DNs from mice expressing the tailless TCRδ transgene. Thus, removal 
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of the ITAMs of TCRδ significantly diminished the strength of signalling 
through the TCR. As a result, fewer γδ T cells developed in these mice 
compared to those expressing full length TCRδ. This result resembled that 
from the γδTCR transgenic TCRδ(+/-) mice which had lower surface 
expression of the TCR and therefore confirmed that high TCRγδ surface 
expression correlates with strong signalling and favours γδ T cell 
development (Hayes et al., 2005). Moreover, analysis of TCRα KO DN 
thymocytes revealed that those expressing TCRγδ expressed higher levels 
of phosphorylated ERK1/2 and ZAP-70 compared to those that expressed 
the preTCR confirming that TCRγδ signals stronger than the preTCR 
(Hayes et al., 2005).  
In the second report, Haks et al generated KN6 γδTCR transgenic mice on 
a RAGKO background (Haks et al., 2005). The KN6 γδTCR recognises the 
non-classical MHC class Ib molecule T22d, the surface expression of which 
requires β2M. Signalling through the receptor was attenuated by 
backcrossing the mice onto either a p56lck-deficient or β2M-deficient 
background. As a result the percentage of mature γδ T cells that developed 
was drastically reduced whereas the percentage of DPs increased from 
0.5% in KN6(+) RAGKO mice to 63% in the absence of p56lck and 94.2% in 
mice deficient for β2M (Haks et al., 2005). Moreover, Lck and β2M 
deficiency resulted in reduced activation of ERK1/2 and expression of Egr1 
and Egr3 in KN6(+) RAG KO DN4 cells consistent with impaired TCR 
signalling. Furthermore, over-expression of Egr1 in KN6(+) RAGKO 
thymocytes in FTOC promoted γδ T cell development while reducing the 
percentage of DP cells (Haks et al., 2005). Together, these reports showed 
that strong signalling at the DN stage promotes γδ T cell development while 
weak signalling favours commitment to the αβ lineage.  
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The signal-strength model of αβ/γδ lineage commitment explains how the 
γδTCR is able to drive DP development in pTα KO and TCRβKO animals 
(Fehling et al., 1995a; Mombaerts et al., 1992a). The model suggests that 
in the absence of the preTCR in these animals, DN cells that have low 
surface expression of TCRγδ may commit to the αβ lineage. It also explains 
how early expression of the αβTCR, the surface expression of which is 
much greater than the preTCR, can promote the development of 
thymocytes that resemble γδ T cells (Bruno et al., 1996; Terrence et al., 
2000).  
The nature of the difference in signal strength delivered by either the γδTCR 
or the preTCR is not well understood. Most likely it is the difference in 
surface expression of the two receptors that regulates strength of signal; as 
the γδTCR is expressed on the surface of DN cells at far greater levels than 
the preTCR (40,000 complexes per cell compared to several hundred of the 
preTCR) (Hayes et al., 2003). Indeed, the preTCR, but not the γδTCR, is 
constitutively endocytosed from the surface of thymocytes in a manner that 
promotes very low surface expression of the receptor (Panigada et al., 
2002) (this subject will be covered in more detail in subsequent chapters of 
the thesis).  
2.3.2 IELs; The controversy between extrathymic and intrathymic T 
cell development. 
2.3.2.1 Extrathymic development.  
The origin of TCRαβ(+)CD8αα(+) gut intraepithelial lymphocytes has been a 
matter of much controversy. These cells are present to some extent in 
athymic nude mice (De Geus et al., 1990), prompting the suggestion that T 
cell development was not solely dependent on the thymus. Certainly, the 
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development of TCRαβ(+)CD8αα(+) IELs is not conventional. They develop in 
mice that lack MHC-I (Das and Janeway, 1999), or in F5 transgenic mice 
that are deficient in Tap-1 and RAG (Levelt et al., 1999). In addition, high-
affinity TCR signalling appears to favour IEL development (Levelt et al., 
1999) and IELs are enriched for “forbidden” TCRβ chains normally deleted 
from the conventional T cell repertoire by endogenously expressed MMLV 
superantigens (Rocha et al., 1991).  
The hunt for a site for extrathymic T cell development initially identified 
small gut-associated lymphoid tissue present in the wall of the large and 
small intestine (called cryptopatches (CPs)) that contained immature 
hematopoietic cells (Saito et al., 1998). Transfer of immature CD25(+) IL-
7R(+) c-Kit(+) CP cells into severe combined immunodeficient (scid) mice 
gave rise to TCRγδ(+) and TCRαβ(+) IELs (Saito et al., 1998). Consistent with 
this, the development of TCRαβ(+)CD8αα(+) IELs is significantly abrogated in 
common cytokine receptor gamma (γc) chain KO mice that have no CPs 
(Oida et al., 2000). Furthermore, transfer of bone marrow (BM) into athymic 
γc KO mice restores CPs and the appearance of TCRαβ
(+)CD8αα(+) IELs 
(Suzuki et al., 2000). Finally, CP precursors of TCRαβ(+)CD8αα(+) IELs 
appear to express markers of early T cell progenitors such as RAG-1 and 
pTα (Lambolez et al., 2002).  
2.3.2.2 Evidence for thymic origin of TCRαβ(+)CD8αα(+) IELs. 
By contrast to the evidence presented in the previous section, a number of 
studies strongly support a thymic origin for TCRαβ(+)CD8αα(+) IELs. Analysis 
of HY-TCR transgenic mice on an athymic/nude background revealed that 
only a small fraction of TCRαβ(+)CD8αα(+) IELs develop extrathymically, 
whereas the majority originate in the thymus (Guy-Grand et al., 2001). 
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Further evidence from H-Y, OT-1, AND and 5C.C7-TCR transgenic mice 
showed that agonist-driven development of TCRαβ(+)CD8αα(+) IELs occurs 
in both an MHC-I and MHC-II-dependent manner (Leishman et al., 2002). 
Importantly TCRαβ(+)CD8αα(+) IEL development was shown to be dependent 
on expression of cognate self-antigen in the thymus as thymic grafts from 
adult TCR transgenic mice that did not express the ligand were unable to 
reconstitute the TCRαβ(+)CD8αα(+) IEL compartment of RAG KO mice 
(Leishman et al., 2002). High affinity self-antigen selection of 
TCRαβ(+)CD8αα(+) IELs was dependent on the connecting peptide domain of 
TCRα known to be essential for positive but not negative selection of 
thymocytes (Leishman et al., 2002). Together these data showed that 
rather than escaping negative selection, TCRαβ(+)CD8αα(+) IELs are 
positively selected in the thymus by agonist self-peptide. This type of 
selection is consistent with observations in normal mice where 
TCRαβ(+)CD8αα(+) IELs are enriched for cells expressing superantigen-
specific “forbidden” Vβ chains that are eliminated from the conventional T 
cell pool by negative selection (Rocha et al., 1991).  
The manner by which TCRαβ(+)CD8αα(+) IELs survive high affinity agonist 
signals in the thymus is not well understood. Circumstantial evidence 
suggests that CD8αα homodimers raise the threshold of signalling through 
the TCR; as T cell lines with a greater CD8αβ to CD8αα ratio appeared to 
be more sensitive to TCR signalling (Cawthon et al., 2001).  As CD8αα 
homodimers are not associated with lipid rafts (Pang et al., 2007) it has 
been postulated that CD8αα homodimers could bind and sequester 
signalling components such as Lck and LAT from CD8αβ containing TCR 
complexes (Cheroutre and Lambolez, 2008; Gangadharan and Cheroutre, 
2004). In addition, TCRαβ(+)CD8αα(+) IELs have been shown to contain 
45 
 
FcεR1γ chains in place of one or both of the TCRδ chains (Guy-Grand et 
al., 1994). Because FcεR1γ chains have one rather than three ITAMs the 
amplitude of signalling through the TCR would be diminished. Furthermore, 
TCRαβ(+)CD8αα(+) IELs express LAT 2 which negatively regulates TCR 
signalling (Denning et al., 2007; Zhu et al., 2006). Thus, it appears that 
TCRαβ(+)CD8αα(+) IELs are set up to dampen signals received through the 
TCR which allows them to be positively selected on high affinity self peptide 
interactions in the thymus.  
Evidence against extrathymic development of TCRαβ(+)CD8αα(+) IELs was 
also observed in RAG-GFP transgenic mice that expressed GFP under the 
control of the RAG-2 promoter. Whether in athymic or euthymic mice, GFP 
expression was not observed in either IELs or cryptopatch cells suggesting 
an absence of recombinase activity in these cells (Guy-Grand et al., 2003). 
However, identification of an intestinal specific isoform of RAG-1 in humans 
raised the possibility that extrathymic TCR gene rearrangement may be 
controlled by alternative tissue specific promoters (Bas et al., 2003).  
Fate mapping by use of mice expressing GFP under the control of the 
RORγt gene concluded that all TCRαβ(+)CD8αα(+) IELs are progeny of 
immature DP thymocytes (Eberl and Littman, 2004). During foetal life 
RORγt is exclusively expressed in lymphoid tissue inducer (LTi) cells, while 
in the adult RORγt is expressed only in thymic DP cells. In the RORγt-GFP 
reporter mice all DP thymocytes and TCRαβ(+) thymocytes were GFP 
positive, whereas TCRγδ(+) T cells were not. Significantly, TCRαβ(+)CD8αα(+) 
IELs of the gut were also GFP positive suggesting that they had arisen from 
DP thymocytes (Eberl and Littman 2004). 
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Recently, Hilde Cheroutre and colleagues identified putative precursors of 
TCRαβ(+)CD8αα(+) IELs within the thymic DP population that express CD4, 
CD8αβ, and CD8αα and are thus termed “triple positive” (TP) cells 
(Gangadharan et al., 2006). TP cells were identified using CD8αα-specific 
tetramers that consist of thymic leukaemia (TL) antigen, a non-classical 
MHC-Ib molecule that binds with high affinity to CD8αα homodimers but not 
to CD8αβ heterodimers. TL(+) TP cells constituted 6-9% of the WT DP 
population. TP cells differ from DPs in their ability to survive and mature in 
response to agonist antigen. TP cells are more immature than DPs as they 
are actively dividing and express lower levels of TCRβ and CD5. They are 
suggested to represent the pre-selection thymic precursors of 
TCRαβ(+)CD8αα(+) IELs as adoptive transfer of TPs into the thymus of 
C57BL/6 recipient mice gave rise to TCRαβ(+)CD8αα(+) IELs and CD5(-) 
TCRαβ(+) DN T cells in the periphery. The TCRαβ(+) DN cells were shown to 
be post-thymic-selection precursors of TCRαβ(+)CD8αα(+) IELs 
(Gangadharan et al., 2006). However, this study failed to investigate the 
thymic origin of TP cells; specifically how their differentiation from the 
earlier DN subset differed from that of DP cells. 
2.3.3 Heterogeneity within the DP population; is heterogeneity in 
preTCR signals a possible explanation? 
Identification of TP cells with a different developmental potential to DP cells 
is strong evidence for heterogeneity within the CD4(+) CD8αβ(+) subset 
(Gangadharan et al., 2006). How would this be achieved? CD4(+) CD8αβ(+) 
DPs are generated from DNs by signalling through the preTCR (Figure 
2.5). Thus heterogeneity within the DP population implies either 
heterogeneity within the DN subset that is a direct precursor of the DP 
population, or in the preTCR signal which drives the DN to DP transition. 
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We propose that the pT  component of the preTCR is central to the 
provision of differential signalling through the preTCR, and that by analogy 
to γδ T cell development, which requires a strong signal at the DN stage, a 
stronger signal through the preTCR is also required for commitment to an 
unconventional fate (i.e. to TCRαβ(+)CD8αα(+) cells) in the αβ T cell lineage. 
Figure 2.5 
 
 
 
 
 
 
Figure 2.5 Hypothesis: Heterogeneity within the DP subset implicates 
heterogeneity in the events regulating commitment to the DP stage. We propose 
that unconventional αβ T cell development requires a different preTCR signal than 
that received by conventional DP precursors, at the DN to DP transition.  
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Chapter 3 
 The pre T cell receptor alpha (pTα).  
 
In the 1980s it was observed that TCRβ chains were rearranged before 
TCRα chains during T cell development (Raulet et al., 1985; Snodgrass et 
al., 1985). Expression of TCRβ transgenes in rearrangement-deficient scid 
and RAG-2 KO mice showed that TCRβ chains were expressed at the 
surface of thymocytes and resulted in proliferation, upregulation of CD4 and 
CD8, and transcription of TCRα (Kishi et al., 1991; Shinkai et al., 1993). 
Analysis of TCRβ KO mice revealed that this chain was critical for the DN to 
DP transition (Mombaerts et al., 1992a). It was clear from studies in 
immature T cell lines and TCRα-deficient thymocytes, that TCRβ was 
forming a complex on the surface of cells with a disulphide linked 33kDa 
glycoprotein as well as the CD3 signalling molecules CD3ε, CD3δ, CD3γ 
and very weakly associated TCRδ chains (Groettrup et al., 1993). The gene 
that encoded this 33kDa glycoprotein was identified as the pre T cell 
receptor alpha gene or pTα (Saint-Ruf et al., 1994). pTα is a type-1 
transmembrane protein of the Ig-superfamily.  
The pTα gene is located on chromosome 17 in mice and spans 
approximately 8.4kb, consisting of four exons (Figure 3.1). The first exon 
codes for the 5’ untranslated region, the leader peptide and the first three 
amino acids of the protein. Exon-2 encodes the extracellular domain of the 
protein and includes two cysteine residues which form a disulphide bridge 
generating an immunoglobulin-like loop. In addition, there are two potential 
glycosylation sites within this domain. Exon-3 is only 45 base pairs in length 
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and encodes a connecting peptide which includes the cysteine residue that 
forms a disulphide bridge with TCRβ. The transmembrane domain, 
encoded by exon-4, consists of about 20 hydrophobic amino acid residues 
and includes two basic residues; arginine and lysine that are similar to 
those found in the transmembrane domain of TCRα. These polar residues 
are thought to be necessary for interactions with the CD3 signalling 
cassettes. Exon-4 also encodes the relatively long cytoplasmic tail of pTα, 
consisting of two tyrosine phosphorlyation sites as well as a proline rich 
region which could constitute an SH3-domain binding sequence. Exon-4 
contains of 540 nucleotides of the 3’ untranslated region including the 
polyadenylation site (Fehling et al., 1995b; Saint-Ruf et al., 1994; von 
Boehmer and Fehling, 1997).  
Figure 3.1 
 
 
 
 
 
 
Figure 3.1 pre-T cell receptor alpha (pTα): (A) An illustration of the pTα gene, 
consisting of four exons; exon-1 (blue), exon-2 (red), exon-3 (green) and exon-4 
(purple). The start and stop sites of the amino acid sequence are shown. LP is 
leader peptide, c----c denotes the cysteine residues in exon 2 which form the 
disulphide bond in the mature protein (B). TM is transmembrane and (P) denotes 
the putative phosphorylation sites within the cytoplasmic tail. A cysteine residue 
encoded within exon-3 forms a disulphide bond with TCRβ in the preTCR complex. 
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3.1 The function of pTα. 
3.1.1 Evidence from pTα-deficient mice. 
To investigate the function of pTα in T cell development two different sets of 
pTα-deficient mice were generated. The first pTα KO was generated by 
deletion of exons 3 and 4 (Fehling et al., 1995a). These animals have a 
vastly reduced thymic cellularity to less than 10% of a WT thymus. The 
majority of pTα KO thymocytes were arrested at the DN3 stage in 
development, confirming the function of the preTCR in promoting 
development past this stage. However, the developmental block is not 
complete as a small number of DP thymocytes are present in the pTα KO 
thymus. Importantly, pTα was shown to divert cells away from the γδ cell 
lineage, as a 3 fold increase in the number of γδ thymocytes was observed 
in the pTα KO thymus. Thus, pTα and the preTCR are necessary for 
development of αβ but not γδ T cell precursors (Fehling et al., 1995a). 
Interestingly, only 40% of pTα deficient DP cells express intracellular TCRβ, 
suggesting that TCRγδ drives development of the majority of DP cells in the 
pTα KO thymus (Buer et al., 1997a).  
A second pTα KO mouse was generated by deletion of Exon-2 and the 
surrounding introns of the pTα by gene by targeting embryonic stem (ES) 
cells (Xu et al., 1996). pTα KO ES-cells were injected into RAG-2-deficient 
blastocysts to generate chimeras. These animals displayed an identical 
phenotype to the pTα KO mice generated by Fehling et al.  
3.1.2 Evidence for β-selection in WT mice. 
Analysis of pre- and post-β-selection thymocytes in C57BL/6 mice revealed 
two populations of DN3 cells; those that were of an expected size (DN3e) 
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and had few in-frame TCRβ rearrangements and those that were large or 
blasting (DN3L) which had significantly more in-frame TCRβ 
rearrangements (Hoffman et al., 1996). The majority of DN3e cells were in 
the G1 phase of the cell cycle with a DNA content of 2n, whereas 66% of 
the DN3L population had a DNA content greater than 2n. Furthermore, the 
DN3L population were enriched for cyclin A and CDK2 expression that 
drive cell cycle entry. These cells also expressed lower levels of RAG-2 in 
comparison to the DN3e subset (Hoffman et al., 1996), consistent with the 
observations that RAG proteins are targeted for degradation by cell cycle 
protein cdc2 kinase (Lin and Desiderio, 1993). These results demonstrate 
that the preTCR appears to induce proliferation of β-selected thymocytes.  
3.2 Signal transduction downstream of the preTCR. 
3.2.1 The signalling components of the preTCR. 
The signalling components that comprise the preTCR complex are 
essentially the same as those that form the TCRαβ complex, with the 
obvious exception of pTα and TCRα (Kruisbeek et al., 2000). However, 
various gene-deficient mouse models have shown that while CD3ε and 
CD3γ are essential for the DN to DP transition, CD3δ is not (Berger et al., 
1997; Dave et al., 1997; Haks et al., 1998; Malissen et al., 1995). TCRδ is 
only weakly associated with the preTCR through interactions with the 
connecting peptide domain of pTα (Kosugi et al., 1997; Trop et al., 1999). 
Nonetheless, TCRδ is phosphorylated upon preTCR signalling (van Oers et 
al., 1995) and TCRδ KO mice exhibit a partial block in the DN to DP 
transition (Love et al., 1993).  Because of the similarities between the 
preTCR and TCRαβ it was assumed that signalling through the two 
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complexes activated the same signal transduction pathways (Kruisbeek et 
al., 2000; Michie and Zuniga-Pflucker, 2002; Rothenberg et al., 2008).  
3.2.2 TCRαβ signal transduction. 
Figure 3.2 summaries the downstream signalling cascade of the αβ T cell 
receptor (Weiss and Littman, 1994). TCR signals are initiated and 
propagated by protein tyrosine kinases such as Lck and Fyn (Weiss and 
Littman, 1994). Lck is associated with the cytoplasmic regions of the co-
receptors CD4 and CD8, while both Lck and Fyn are associated with the 
TCRδ and CD3ε chains (Samelson et al., 1990; Veillette et al., 1988). Upon 
ligation of TCRαβ through interaction with peptide/MHC, the TCRαβ 
complexes cluster at the cell surface. As a result Lck and Fyn become 
activated and phosphorylate the ITAMS of TCRδ and the various CD3 
chains.  
Phosphorylation of ITAMs on TCRδ and CD3 molecules leads to 
recruitment and binding of SH2 (Src Homology 2 domain)-containing 
proteins such as ZAP-70, which in turn phosphorylates the downstream 
adaptor molecules; LAT and SH2-domain containing leukocyte protein 
(SLP)-76 (Janssen and Zhang, 2003; Weiss and Littman, 1994). These in 
turn then activate the three main pathways involved in TCRαβ signal 
propagation; the MAP kinase, calcium and NFκB pathways. This occurs via 
activation of phospholipase C-γ (PLC-γ) which catalyses the conversion of 
phosphatidylinositol bisphosphate (PIP2) to inositol trisphosphate (IP3) and 
Diacylglycerol (DAG). DAG activates RAS-GRP which in turn activates 
RAS. RAS activates the three major MAP-kinase pathways which include 
ERK1/2, JNK and p38 that upregulate transcription factors fos, jun and 
Egr1-3 (Rincon et al., 2001). Concurrent with this, the interaction of IP3 with 
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its receptors in the endoplasmic reticulum releases calcium into the 
cytoplasm, leading to activation of calmodulin, calcineurin and 
subsequently the transcription factor NFAT (Weiss and Littman, 1994). 
DAG and calcium also activate various members of the protein kinase C 
(PKC) family, which activate the transcription factor NFκB (Ruland and 
Mak, 2003). 
Figure 3.2 
 
 
 
 
 
 
 
Figure 3.2 Signalling cascades activated downstream of TCRαβ: Interaction of 
TCRαβ with peptide/MHC induces aggregation of the receptor complexes which 
leads to activation of protein tyrosine kinases such as Lck that is bound to the 
intracellular tail of the co-receptor molecules CD4 and CD8. Lck phosphorylates 
ITAMs present on TCRδ and various CD3 chains, leading to the recruitment of 
SH2-containing protein ZAP-70. Adaptor molecules LAT and SLP-76 are activated 
through phosphorylation by ZAP-70 and in turn, activate PLCγ. PLCγ catalyses the 
conversion of PIP2 to IP3 and DAG. DAG activates RAS GRP which in turn 
activates the three major MAPK pathways; JNK, p38 and ERK which lead to the 
upregulation of transcription factors fos, jun and Egr1-3. IP3 interaction with the 
IP3R in the ER leads to the release of calcium into the cytoplasm that activates 
calmodulin, leading to the activation of calcinuerin and the transcription factor 
NFAT. DAG also activates PKC which phosphorylates IKK which in turn 
phosphorylates IκB targeting it for degradation. This releases NFκB which migrates 
to the nucleus. TCRαβ activation of downstream signalling pathways results in the 
proliferation, survival and differentiation of T cells.  
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3.2.3 PreTCR signalling activates similar pathways to TCRαβ. 
Evidence that preTCR function was mediated by similar signalling 
pathways to TCRαβ initially arose from mice that lacked Lck or Fyn (Molina 
et al., 1992; van Oers et al., 1996).  Mice that lacked both Lck and Fyn 
displayed a complete block at the β-selection checkpoint (van Oers et al., 
1996). Furthermore, expression of an activated Lck transgene rescued the 
developmental block in RAG-1 KO and pTα KO mice (Fehling et al., 1997; 
Mombaerts et al., 1994). A CD4 transgene was also observed to promote 
development of RAG-deficient thymocytes to the DP stage in the presence, 
but not in the absence, of MHC-II (Norment et al., 1997). This was 
proposed to be the result of activation of Lck bound to the cytoplasmic tail 
of CD4. Importantly Lck did not drive development in the absence of CD3ε 
(Norment et al., 1997). These experiments demonstrate that Lck activation 
and subsequent activation of the CD3 signalling cassettes mediates all the 
functions of the preTCR; proliferation, differentiation of thymocytes to the 
DP stage and allelic exclusion at the TCRβ locus. Table 1 summarises the 
gene-targeting experiments that have provided further insight into the 
proteins involved in preTCR signalling. 
The role of MAP kinases in preTCR signalling is apparent from expression 
of a dominant negative mutant of MEK-1 in E14 TCRα KO thymocytes, as 
development to the DP stage was blocked (Crompton et al., 1996). In 
Expression of the preTCR in different T cell lines has also been shown to 
upregulate JNK and p38 activity as well as phosphorylation of ERK1 and 
ERK2 (Michie et al., 1999; Murga and Barber, 2002). At this point in the 
signal transduction cascade, (downstream of SLP-76) the different 
phenotypes of preTCR signalling segregate with different signalling 
effectors; activated c-RAF-1 (RAF-CAAX) and RAS-V12 were sufficient to 
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drive proliferation and differentiation of RAG KO thymocytes, but did not 
induce allelic exclusion of the TCRβ locus (Gartner et al., 1999; Iritani et al., 
1999). However, allelic exclusion was mediated by PKC (Michie et al., 
2001).  
Table 1 
 
Table 1 Mutations that have provided insights into the regulation of preTCR 
signalling. TCR, T cell receptor; DN, double negative; DP, double positive; LAT, 
linker for activation of T cells.  
 
3.2.4 PreTCR signalling promotes cell survival by downregulation of 
p53. 
Double-strand DNA breaks produced by V(D)J recombination trigger p53-
mediated cell cycle arrest to limit the development of cells with oncogenic 
potential (Guidos et al., 1996). In normal cells the double-strand DNA 
breaks are rapidly dealt with by the activity of DNA-dependent protein 
Deficiency Phenotype Reference 
pTα Complete block at DN3 stage 
(Fehling et al 1995a),  
(Xu et al 1996) 
TCRβ Complete block at DN3 stage (Mombaerts et al 1992a) 
TCRα Complete block at DP stage (Mombaerts et al 1992a) 
CD3ε Complete block at DN3 stage (Malissen et al 1995) 
CD3γ Complete block at DN3 stage (Haks et al 1998) 
CD3δ Complete block at DP stage (Berger et al 1997),  
(Dave et al 1997) 
CD3δ Partial block at DN3 stage (Love et al 1993) 
Lck+Fyn Severe block at DN3 stage (van Oers et al 1996) 
ZAP-70+Syk Severe block at DN3 stage (Cheng et al., 1997) 
LAT Complete block at DN3 stage (Zhang et al., 1999) 
SLP-76 Complete block at DN3 stage (Pivniouk et al., 1998) 
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kinase (DNA-PK). Mutations in this gene are the underlying cause of the 
immunodeficiency observed in the naturally-occurring scid mouse (Blunt et 
al., 1995). In these animals, high levels of p53 expression is detected in 
DN3 cells, that mediates cell cycle arrest and apoptosis (Guidos et al., 
1996). Indeed p53 ablation rescued development of scid DN thymocytes to 
the DP stage (Guidos et al., 1996).  PreTCR-deficiency also results in an 
increase in cell death at the DN stage; approximately 40% of DN cells from 
CD3γ or RAG-1 deficient mice stain positive for Annexin V (Haks et al., 
1999). This was shown to be p53 dependent as CD3γ/p53 double-deficient 
mice had restored viability of DN cells and increased development to the 
DP stage (Haks et al., 1999).  Direct evidence that preTCR signalling 
reduced the activation of p53 came from analysis of T cell lines transfected 
with preTCR components, which displayed a reduction in phosphorylation 
of p53 compared to controls (Murga and Barber, 2002). Moreover, gene 
expression of p53 downstream effectors; death gene BAX and cyclin 
dependent kinase inhibitor p21, were reduced in preTCR expressing cell 
lines (Murga and Barber, 2002). Thus, preTCR signalling induces the 
survival of thymocytes by downregulation of p53. 
3.3 Transcription Factors that mediate preTCR function. 
3.3.1 NFκB and NFAT. 
Numerous transcription factors have been implicated in regulating the DN 
to DP transition, including NFκB (Kruisbeek et al., 2000; Michie and Zuniga-
Pflucker, 2002). All thymocytes express activated NFκB, but the highest 
levels are seen in DN3L and DN4 subsets that express the preTCR (Voll et 
al., 2000). Indeed, preTCR expression in a CD3(+) cell line resulted in 
activation of NFκB, suggesting that NFκB is regulated by preTCR signalling 
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(Voll et al., 2000). In transgenic mice expressing a dominant active form of 
IκBα an inhibitor of NFκB, fewer DN cells progressed to the DP stage. 
Conversely expression of a constitutively active form of IκB kinase (IKK) 
that leads to the degradation of IκB, rescued the developmental block of 
RAG KO thymocytes  (Voll et al., 2000).  
The transcription factor NFAT has been shown to be upregulated in a RAG 
KO DN cell line after treatment with α-CD3ε suggesting that preTCR 
signalling induces NFAT expression (Aifantis et al., 2001). The upregulation 
of NFAT downstream of the preTCR was shown to be dependent on PLCγ 
and Ca2+ (Aifantis et al., 2001). Treatment of E14.5 FTOC lobes with 
cyclosporine A (CSA) an inhibitor of NFAT dephosphorylation and nuclear 
transport, resulted in inhibition of DN3 progression, implicating a role of 
NFAT in preTCR function (Aifantis et al., 2001; Koltsova et al., 2007).  
3.3.2 Egr and RORγt. 
The early growth response (Egr) transcription factors play an important role 
in regulating proliferation and differentiation of β-selected cells. Egr1, Egr2 
and Egr3 are all upregulated following preTCR signals induced by anti-
CD3ε treatment of SCID.adh cell line (Carleton et al., 2002). Expression of 
Egr genes in preTCR deficient thymocytes, either by retroviral transduction 
of Egr1, Egr2 or Egr3 in CD3γ-deficient thymocytes in FTOC, or by 
transgene expression of Egr1 in RAG KO mice, induced proliferation and 
differentiation past the DN3 stage (Carleton et al., 2002; Miyazaki, 1997). 
However, Egr-expressing thymocytes developed to the CD8(+) immature 
single positive (ISP) stage, but not to the DP stage suggesting the 
requirement for additional factors in the maturation of ISPs to DPs 
(Carleton et al., 2002).  This would be more consistent with Egr 
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transcription factors inducing proliferation but not differentiation of 
thymocytes post-β-selection. This is supported by Egr3-deficient mice 
which do not exhibit a block in the DN to DP transition, but do have reduced 
thymic cellularity as a result of poor proliferation of β-selected thymocytes 
(Xi and Kersh, 2004a).  
Extensive investigations into the role of Egr transcription factors in β-
selection has provided important insight into the interplay of different 
transcription factors in regulating proliferation and differentiation 
downstream of the preTCR. DP cells that express Egr3 transgenes under 
control of the CD2 promoter fail to develop to the CD4 and CD8 SP stages 
(Xi and Kersh, 2004b). This was due to increased apoptosis of DPs and 
reduced rearrangement of TCRα genes, and as a result the mice displayed 
reduced thymic cellularity. Importantly, the lack of survival of DP cells that 
over-expressed Egr3 was a result of downregulation of Bcl-XL and the 
orphan nuclear receptor RORγt (Xi and Kersh, 2004b). These authors 
performed a time-course experiment in which RAG-1 KO mice were 
injected with anti-CD3ε antibodies to mimic preTCR stimulation. Total RNA, 
was extracted from the thymuses of these mice at various time points, after 
anti-CD3ε showed that while Egr3 expression rapidly increased after 
preTCR stimulation, by 36 hours expression had returned to basal levels. 
Expression of RORγt and Bcl-XL increased at 36 hours and reached a 
maximum at 4 days after preTCR stimulation (Xi and Kersh, 2004b). 
Furthermore, RORγt-deficient DP cells displayed a similar phenotype to 
Egr3 transgenic DP cells, with increased proliferation but poor survival (Sun 
et al., 2000). This suggested that RORγt negatively regulates proliferation 
of β-selected thymocytes. Bcl-XL and RAG-2 were both found to be 
upregulated in RORγt-expressing cell lines (Xi et al., 2006), and RORγt has 
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been shown to bind to the TEA promoter that is necessary for TCRα 
rearrangements (Villey et al., 1999). In summary, it appears that Egr 
transcription factors, in particular Egr3 promote proliferation of β-selected 
thymocytes. Egr3 downregulation of RORγt is one possible mechanism for 
this increased proliferation. However, prolonged proliferation by constitutive 
activation of Egr3 appears to be deleterious for maturing thymocytes, as 
very few progress to the DP stage, and those that do have reduced survival 
and rearrangement of TCRα genes. In normal β-selected thymocytes it 
appears that Egr3 expression is transient and after 36 hours expression 
returns to basal levels. This allows for expression of RORγt and further 
maturation of β-selected DP cells. RORγt expression is therefore necessary 
for sustaining the resting state of DPs to allow for rearrangement of TCRα 
genes and to promote survival of cells undergoing active gene 
rearrangements (Xi et al., 2006).  
3.3.3 E-proteins. 
To complicate matters further it was found that Egr mediated proliferation of 
β-selected thymocytes was dependent on induction of the inhibitor of the 
basic helix-loop-helix (BHLH) E-proteins; Id3 (Koltsova et al., 2007; Xi et 
al., 2006). Id3 forms heterodimers with E-proteins such as E2A and HEB 
and prevents their DNA binding activity. E-proteins play a crucial role in 
regulating T cell development in the thymus (discussed further in other 
chapters of this introduction).  E-proteins are potent inhibitors of 
proliferation prior to TCR rearrangements (Engel and Murre, 2004). E2A-
deficient mice rapidly develop thymic lymphomas, consistent with a role for 
these factors in regulating lymphocyte proliferation (Bain et al., 1997).  
Importantly, E47, an isoform of E2A was described to bind E-box sites in 
the TCRβ promoter and in the enhancer regions regulating TCRβ gene 
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rearrangement. Analysis of E15 thymocytes from E47 heterozygous and 
homozygous mutant mice revealed that TCRβ rearrangement was reduced 
by E47 deficiency in a dose dependent manner (Agata et al., 2007). 
Moreover E47 was shown to control the accessibility of the TCRβ locus, 
and histone H3 acetylation, and expression of Vβ germline transcripts were 
reduced in E47-deficient mice (Agata et al., 2007). Thus E2A expression in 
pre-β-selected thymocytes arrests proliferation and promotes TCR gene 
rearrangement. As already mentioned, preTCR signalling induces 
expression of Id3 through activation of the MAP kinase pathway and Egr 
transcription factors (Bain et al., 2001; Engel et al., 2001; Koltsova et al., 
2007). Id3 upregulation is necessary for inhibition of the E-proteins, 
promotion of proliferation and differentiation to the DP stage. Indeed, the 
DN to DP block in LAT-deficient and in Lck/Fyn double-deficient animals is 
rescued by deletion of E47 (Engel and Murre, 2004). Inhibition of E47 
activity is also required for allelic exclusion at the TCRβ locus, over-
expression of E47 in DO11.10 TCRαβ transgenic thymocytes induced 
excessive Vβ-DJβ rearrangements (Agata et al., 2007).   
HEB KO mice have a similar phenotype to Egr transgenic mice; few DP 
thymocytes but an accumulation of ISPs (Barndt et al., 1999). This 
suggests a delayed role for HEB downstream of the preTCR in establishing 
the DP phenotype. E47, E12 and HEB bind E-box sites in the RORγt 
promoter (Xi et al., 2006). Deletion of 2 out of the 4 of these E-box regions 
drastically reduced the activity of the RORγt promoter. Retroviral 
expression of E47 in T cell lines induced RORγt and E47-deficient DP cells 
show reduced RORγt expression (Xi et al., 2006). This suggests that E-
proteins positively regulate RORγt in thymocytes. 
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Figure 3.3 Different factors regulate the β-selection checkpoint. E proteins 
regulate pTα expression, which in turn initiates formation of the preTCR with TCRβ. 
Signalling through this complex upregulates IL-7Rα, and Egr3 and Id3. These 
factors induce proliferation and differentiation to the ISP stage. Progression and 
establishment of the DP stage requires downregulation of IL-7Rα, Egr3 and Id3 
and upregulation of E-protein activity which induces RORγt. DN, double negative; 
ISP, immature single positive; DP, double positive; TCR, T cell receptor. 
 
These reports reveal an important network of transcription factors that 
controls the DN3 to DP transition (Figure 3.3). To summarise, E-proteins 
are required at the DN3 stage to arrest proliferation and initiate TCRβ 
rearrangements and pTα expression (see the next section). Once 
successful TCRβ rearrangements have been achieved, TCRβ pairs with 
pTα and forms a preTCR complex with CD3 chains which is expressed on 
the surface of DN3 cells. Signalling through the preTCR complex induces 
proliferation through activation of Egr3 and Id3, which inhibits the anti-
proliferative activity of the E-proteins. Id3 inhibition of E-proteins also 
62 
 
contributes to allelic exclusion at the TCRβ locus. However, Egr3 
expression is transient, and after 36 hours returns to basal levels. This 
relieves the inhibition of E-protein activity which upregulates RORγt and 
together these transcription factors arrest proliferation, induce TCRα 
rearrangements, and ensure survival of DP thymocytes. 
3.4 Cytokine signalling: the role of Interleukin-7 (IL-7) at the β-
selection checkpoint. 
IL-7 signals by binding to the IL-7 receptor which consists of the IL-7Rα 
chains and the common cytokine receptor γ chain (γc) (Sudo et al., 1993). 
IL-7/IL-7R signalling is crucial for thymocyte survival, proliferation and 
differentiation throughout T cell development (Peschon et al., 1994; 
Rothenberg et al., 2008). IL-7/IL-7R signalling is mediated by janus kinase-
1 (JAK-1), janus kinase-3 (JAK-3), and signal transducer and activator of 
transcription-5 (STAT-5). Injection of anti-CD3ε antibodies into RAG-
deficient mice resulted in upregulation of IL-7Rα transcripts (Trigueros et 
al., 2003), suggesting that preTCR signalling induces IL-Rα expression. 
This was confirmed by retroviral expression of TCRβ in RAG-deficient 
thymocytes in FTOC, which induced upregulation of IL-7Rα protein on the 
surface of transduced thymocytes (Trigueros et al., 2003). The expression 
of IL-7Rα transcripts peaked at 6 hours after preTCR stimulation, preceding 
CD25 downregulation by DN3s and the increase of cells entering the cell 
cycle. This implicated IL-7 signalling in the proliferation and differentiation 
of β-selected thymocytes. Blocking IL-7 signalling, either by IL-7Rα 
deficiency or through antibody treatment of DN4 cells resulted in reduced 
proliferation and increased cell death of β-selected thymocytes, confirming 
the role of IL-7 downstream of the preTCR (Trigueros et al., 2003).  
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In accordance with these data, retroviral expression of an inhibitor of JAK-
STAT signalling, the suppressor of cytokine signalling-1 (SOCS-1) in RAG 
KO E14 thymocytes in FTOC drastically reduced the proliferation of 
transduced thymocytes. Furthermore, SOCS-1 expression is transiently 
suppressed following preTCR signalling in WT thymocytes (Trop et al., 
2001). 
Importantly, inhibition of signalling through the IL-7R has a more severe 
effect on DN4 cells and ISP cells, when compared to  DP thymocytes 
(Trigueros et al., 2003). This suggests that IL-7 is more crucial for the 
proliferation and survival of the DN4 and ISP stages. Also, because IL-7Rα 
upregulation appears to be transient and is decreased after 12 hours post 
preTCR stimulation, it appears that the IL-7R may be regulated in a similar 
manner to Egr3. Indeed, ISP accumulation was promoted by IL-7 treatment 
of WT E16 FTOCs and the effect was made more profound by expression 
of an IL-7Rα transgene (Yu et al., 2004). The block in ISP to DP transition 
induced by IL-7, was accompanied by downregulation of RORγt expression 
in ISP cells (Yu et al., 2004).   
3.5 Chemokine signalling: CXCR4 promotes β-selection. 
Chemokines and their receptors regulate thymocyte migration during 
development (Takahama, 2006). Recently it has emerged that the 
chemokine receptor CXCR4 and its ligand CXCL12 participate in promoting 
survival and proliferation of β-selected thymocytes (Janas et al., 2010; 
Trampont et al., 2010). Evidence for the involvement of CXCR4 in T cell 
development came from competition assays in mixed chimeras where 
donor foetal liver cells from CXCR4-deficient mice showed impaired 
reconstitution compared to WT cells (Ara et al., 2003). Because CXCR4 is 
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expressed in DN2 thymocytes and upregulated at the DN3 stage before 
downregulation in the DN4 subset (Ara et al., 2003; Trampont et al., 2010), 
it seems likely that this receptor functions in and around the β–selection 
checkpoint. Using a mouse model in which CXCR4 is deleted at the DN2 
stage, Trampont and colleagues demonstrate that deletion of CXCR4 
hindered development past the DN3 stage and dramatically reduced thymic 
cellularity (Trampont et al., 2010). Development of CXCR4-deficient DN3 
cells cultured on the OP9-DL1 stromal cell line was severely blocked 
compared to WT and loss of CXCR4 resulted in increased apoptosis of 
cortical thymocytes (Trampont et al., 2010).   
CXCL12 is expressed in the subcapsular zone (SCZ) of the thymus and 
expression co-localised with DN2 and DN3 thymocytes (Trampont et al., 
2010). CXCR4-deficient DN thymocytes exhibited aberrant distribution 
throughout the thymic cortex, suggesting a role for CXCR4 and CXCL12 in 
their SCZ localisation (Trampont et al., 2010).  
CXCR4 is a G-protein coupled receptor (GPCR) that is dependent on the 
class 1A and class 1B phosphatidylinositol-3-kinase (PI3K)  subunits 
p110δ, p110γ and p101 for signalling (Janas et al., 2010). Activated PI3K 
phosphorylates phosphatidylinositol-4,5-trisphosphate (PIP2) to generate 
phosphatidylinositol-3,4,5,-trisphosphate (PIP3) which is bound by 
pleckstrin-homology domain containing effector molecules such as Akt and 
PDK1 (Fruman and Bismuth, 2009). p110δ-deficient DN4 thymocytes, 
unlike WT DN4 cells were unable to phosphorylate Akt after preTCR 
signalling (Janas et al., 2010). Moreover, T cell development past the DN3 
stage was impaired in mice deficient for both p110δ and p110γ and in mice 
deficient for both p110δ and p101, confirming the role of PI3K in β-
selection. CXCL12/CXCR4 signalling was shown to induce phosphorylation 
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in WT DN3 thymocytes but not in thymocytes lacking both p110δ and 
p110γ, confirming the role of PI3K in mediating CXCR4 signals (Janas et 
al., 2010).  
3.6. WNT signalling; the role of β-catenin and TCF-1/LEF-1 at the β-
selection checkpoint. 
IL-7 signalling in β-selected thymocytes downregulates expression of two 
transcription factors that are components of the canonical WNT signalling 
pathway, TCF-1 and LEF-1 (Melichar and Kang, 2007; Verbeek et al., 
1995; Yu et al., 2004). Although LEF-1 deficient mice do not show any 
defects in T cell development (van Genderen et al., 1994), TCF-1-deficient 
mice display a profound block at the ISP stage (Verbeek et al., 1995). A 
more severe block is seen in LEF-1/TCF-1 double knock-out mice 
(Okamura et al., 1998). This suggests a redundant role for these two 
transcription factors in promoting the ISP to DP transition. TCF-1 and LEF-
1 both bind to the transcriptional co-activator β-catenin (Melichar and Kang, 
2007). β-catenin deletion induced by LCK-promoter-driven Cre resulted in a 
developmental block at the β-selection check-point (Xu et al., 2003). In the 
absence of WNT signals β-catenin is targeted for degradation by 
phosphorylation of sites encoded by exon-3 of the gene (Wodarz and 
Nusse, 1998). Deletion of exon-3 of β-catenin resulted in a stable form of 
the protein which was constitutively active (Gounari et al., 2001). 
Expression of this protein on a RAG-2 KO background rescued 
development of thymocytes in the absence of the preTCR (Gounari et al., 
2001). Analysis of DP thymocytes from transgenic mice expressing the 
stabilised form of β-catenin under control of the CD4 promoter showed 
increased survival as a result of upregulation of Bcl-XL (Xie et al., 2005). 
However, expression of a truncated form of β-catenin that lacked the tail of 
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the protein that targets it for degradation, resulted in arrested αβ T cell 
development at the DN4 and ISP stage (Xu et al., 2009a). The DN4/ISP 
cells in these mice have abnormally high levels of IL-7Rα and Egr-3 but low 
levels of RORγt (Xu et al., 2009a). β-catenin is upregulated after preTCR 
signalling and in turn upregulates IL-7Rα and Egr gene expression through 
binding TCF-1 (Xu et al., 2009b). Analysis of expression of β-catenin 
transcripts and protein in WT thymocytes revealed that DN3 cells had much 
higher levels than DN4 or ISPs (Xu et al., 2009a). This suggests that like 
Egr-3 and IL-7Rα, β-catenin upregulation may only be transient in post β-
selection thymocytes.  
3.7 Regulation of expression of pTα.  
pTα expression is initiated in DN1 thymocytes and is upregulated in DN2 
cells concomitant with commitment to the T cell lineage. Expression 
reaches its peak in DN3 thymocytes before decreasing in the DN4 and ISP 
subsets. pTα transcripts are detected in blasting DPs but are absent in 
mature SPs from both the thymus and lymph nodes, and are absent in γδ T 
cells. (Saint-Ruf et al., 1994). pTα is also expressed at sites of extrathymic 
T cell development such as the cryptopatches of the gut (Bruno et al., 
1995).  Characterisation of the pTα upstream genomic region revealed two 
specific DNase hypersensitive sites corresponding to a proximal promoter 
and an upstream enhancer (Reizis and Leder, 1999). The enhancer 
element is located 4kb upstream of the gene and is essential for pTα 
expression as deletion of this region abolished expression of a pTα BAC 
reporter construct in transgenic mice (Reizis and Leder, 2001). The 
enhancer element of the human pTα gene shares a high degree of 
homology (60%) with the mouse regulatory element, confirming the central 
role of the pTα enhancer in regulation of pTα gene expression (Reizis and 
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Leder, 2001). The pTα enhancer element contains potential binding sites 
for different transcription factors; c-Myb, ZBP-89, Sp1, CSL, as well as E-
box sites recognised by E-protein transcription factors (Reizis and Leder, 
2001).  
3.7.1 c-Myb. 
c-Myb is a member of the tryptophan cluster family of transcription factors 
and is essential for early T cell development (Allen et al., 1999). c-Myb was 
shown to bind and activate the c-Myb consensus binding sequence in the 
pTα enhancer using electrophoretic mobility shift assay (EMSA) and β-
galactosidase assays (Reizis and Leder, 2001). Moreover, c-Myb is 
abundantly expressed in cortical pre-selection thymocytes, but not in post-
selection medullary thymocytes or in resting peripheral cells (Ess et al., 
1999), consistent with pTα expression.  
3.7.2 E-proteins.  
E2A and HEB transcription factors recognise and bind the E-box sites 
(CANNTG) in the pTα upstream enhancer region (Petersson et al., 2002). 
Expression of luciferase under control of these pTα-specific E-box sites was 
upregulated upon co-expression with E2A and HEB (Takeuchi et al., 2001). 
However, upregulation did not occur for mutant E-box constructs (Takeuchi 
et al., 2001), confirming the ability of E2A and HEB to activate pTα 
transcription by binding to the E-box sites upstream of the pTα gene. 
Moreover, E2A and HEB expression follows a very similar pattern to that of 
pTα throughout T cell development (Tremblay et al., 2003). Importantly 
E2A- and HEB-deficient DN thymocytes show reduced expression of pTα 
compared to WT (Tremblay et al., 2003). Thus E-protein transcription 
factors directly regulate pTα gene expression.  
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3.7.3 Notch. 
The pTα enhancer is activated by Notch signalling and contains binding 
sites for the Notch nuclear effector CSL (CCTGGGAA) (Reizis and Leder, 
2002). Upon ligand binding Notch is protealitically cleaved releasing its 
intracellular domain which translocates to the nucleus where it binds the 
transcription factor CSL. Notch binding changes CSL from a transcriptional 
repressor to an activator inducing transcription of target genes (Rothenberg 
et al., 2008). CSL was shown to bind to the target site within the pTα 
enhancer by EMSA (Reizis and Leder, 2002).  Use of eGFP under the 
control of the CSL binding site of the pTα enhancer region, led to GFP 
expression in DN2 cells and upregulation DN3 cells, consistent with the 
expression pattern of pTα (Reizis and Leder, 2002). No GFP expression 
was detected in reporter mice which expressed eGFP under control of the 
enhancer region containing a mutated CSL binding site (Reizis and Leder, 
2002).  Furthermore, surface expression of Notch-1 can be detected in DN1 
cells and is upregulated at the DN2 stage, peaking in DN3s, followed by 
downregulation in the DN4 and ISP subsets. Mature CD4 and CD8 SP 
thymocytes do not express detectable surface levels of Notch1 (Huang et 
al., 2003; Yashiro-Ohtani et al., 2009). This expression pattern is similar to 
that of pTα, consistent with regulation of pTα expression by Notch 
throughout T cell development.  
Notch-1 signalling is central for progression through the β-selection 
checkpoint (Ciofani et al., 2004; Maillard et al., 2006). Inhibition of Notch-1 
activation by dominant negative mastermind-like 1, arrests T cell 
development at the DN3 stage (Maillard et al., 2006). Moreover anti-CD3ε 
induction of RAG-1 KO thymocytes does not occur in the absence of Notch 
ligand Delta-like-1 (DL-1) (Ciofani et al., 2004).  
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Sustained expression of Notch and pTα is associated with ontogenesis in 
acute lymphoblastic leukaemia (TALL) (Bellavia et al., 2002; Li et al., 2008). 
Taken together with the observation that constitutive expression of pTα 
induces apoptosis of DP cells (Lacorazza et al., 2001a) and leads to the 
development of an abnormal peripheral T cell subset that express CD8αβ 
and low levels of TCRβ (Ito et al., 2002; Schnell et al., 2006), it suggests 
that tight control of pTα and Notch is crucial for appropriate T cell 
development. Expression of pTα and Notch is downregulated post β-
selection by negative feedback inhibition controlled by upregulation of the 
E-protein inhibitor Id3 via preTCR signals (Yashiro-Ohtani et al., 2009). 
Notch1 regulatory regions also contain E-box elements that bind E47 and 
HEB (Yashiro-Ohtani et al., 2009). An E47-mediated increase in Notch-1 
reporter activity was abrogated by Id3 expression (Yashiro-Ohtani et al., 
2009). The binding activity of E2A to the Notch-1 promoter was significantly 
reduced after PMA/ionomycin treatment of SCID.adh cells, consistent with 
induction of Id3 downstream of preTCR signals (Yashiro-Ohtani et al., 
2009).   Furthermore preTCR signalling was shown to disrupt the positive 
feedback loop of Notch-1 transcription (Yashiro-Ohtani et al., 2009). Thus, 
preTCR signals induce expression of Id3 which inhibits E-protein 
transcriptional activation of pTα and Notch-1. Suppression of Notch-1 
transcription reduces the amount of Notch-1 protein available to activate 
pTα transcription, further amplifying the negative feedback loop. In addition, 
p53 has been shown to activate transcription of Notch-1 in epithelial cells 
(Sasaki et al., 2002). Therefore preTCR mediated downregulation of p53 
could be another mechanism for suppression of Notch and subsequently 
pTα in β-selected thymocytes.  
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3.7.4 Regulation of the surface expression of pTα.  
PreTCR complexes on the surface of cells are constitutively endocytosed 
and degraded (Panigada et al., 2002). Endocytosis of the preTCR is 
dependent on activation of Lck and degradation of the complex is mediated 
by the c-Cbl ubiquitin ligase (Panigada et al., 2002). In addition, preTCR 
complex formation in DP cells is thought to be inhibited by expression of 
the newly rearranged TCRα chain (Trop et al., 2000). Indeed, TCRα chains 
are thought to out-compete pTα for pairing with TCRβ and CD3 in the 
endoplasmic reticulum, which leads to reduced levels of the preTCR on the 
cell surface (Trop et al., 2000).  
3.8 Ligand-independent signalling by the preTCR.  
Despite considerable knowledge of the downstream signalling events that 
are initiated from the preTCR, the mechanism by which preTCR signalling 
is initiated is still not clear. PreTCR surface expression is very low on DN 
thymocytes compared to that of TCRαβ on mature thymocytes. Thus, it is 
possible that the preTCR complex does not need to reach the cell surface 
for productive signalling to occur. However, transgenic mice expressing a 
TCRβ transgene fused to an ER retention motif from the adenoviral E19 
glycoprotein demonstrated that surface expression of the preTCR was 
necessary for initiation of signalling through the complex (O'Shea et al., 
1997). If surface expression of the preTCR was required for signal initiation 
the issue of whether this was dependent on ligand binding was addressed. 
For the αβTCR, ligand recognition is mediated by regions within the variable 
domains of the TCRα and β chains. However, truncated forms of both TCRβ 
and pTα that lacked any Ig-loops formed receptors on the surface of RAG 
KO DN thymocytes that were able to signal and promote development to 
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the DP stage (Irving et al., 1998). Moreover, expression of full length TCRβ 
and pTα in the Jurkat T cell line induce NFAT activation in the absence of 
cross-linking by antibodies for CD3ε or TCRβ (Irving et al., 1998). The DN 
to DP transition is also unaffected in mice lacking MHC-I or MHC-II 
molecules (Grusby and Glimcher, 1995; Koller et al., 1990). Thus it appears 
that the preTCR is able to signal independent of ligand binding. 
Confocal microscopy of preTCR-expressing DN thymocytes or cell lines 
revealed a punctate staining pattern for pTα and TCRβ compared to the 
uniform distribution of CD25 or the γδTCR (Saint-Ruf et al., 2000). The 
patchy distribution of the preTCR on the surface of the cell was reminiscent 
of αβTCR after ligand binding and localisation to lipid rafts. Indeed, Cholera 
toxin B, which binds to the lipid raft constituent ganglioside GM1, was 
shown to localise to the pTα “patches” on the surface of transfected T cell 
lines (Saint-Ruf et al., 2000). Importantly, Lck was also shown to co-localise 
with pTα on the surface of transfected cells (Saint-Ruf et al., 2000). PreTCR 
localisation to lipid rafts in the presence of Lck results in the 
phosphorylation of CD3ε, TCRδ and Zap-70, but phosphorylation was not 
evident after disruption of lipid raft integrity by depletion of membrane 
cholesterol using methyl-β-cyclodextrin (Saint-Ruf et al., 2000). Targeting of 
CD3ε to lipid rafts drives preTCR independent development of RAG KO 
thymocytes (Ferrera et al., 2008). Because palmitoylation of cysteine 
residue in LAT has been shown to target the protein to lipid rafts (Zhang et 
al., 1998), it was proposed that palmitoylation of the juxtamembrane 
cysteine in the cytoplasmic tail of pTα was necessary for lipid raft 
localisation of the preTCR (Saint-Ruf et al., 2000). However, mutating this 
residue to alanine did not abolish preTCR signalling (Aifantis et al., 2002; 
Haks et al., 2003). Indeed, removal of the whole cytoplasmic tail of pTα 
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does not appear to affect the activity of the preTCR (Gibbons, Douglas et 
al.2000). Just how much preTCR is localised to lipid rafts is disputed, as 
analysis of surface CD3 expression on preTCR and αβTCR expressing scid 
cell lines revealed that only 10% of preTCR complexes localised to lipid 
rafts, a figure comparable to the number of TCRαβ complexes that 
associate with lipid rafts (Haks et al., 2003).  
It has also been suggested that the nature of DN3 cells themselves is what 
determines ligand independent signalling at this stage of T cell 
development (Haks et al., 2003). Using a luciferase reporter system to 
detect ERK activity, a large proportion of DN3 cells, but not DN4 or DP 
cells, from TCRα KO mice were shown to have high levels of endogenous 
activated ERK. Moreover, TCRα-deficient DN4 cells stimulated with anti-
TCRβ antibody produced more cytosolic calcium than DP cells. DN cells 
also have a higher lipid raft content than DP cells (Haks et al., 2003). 
Together this suggests that DN cells may have a lower threshold for 
signalling than other thymocytes, this increased sensitivity to TCR signals 
driving ligand-independent signalling at the β-selection checkpoint.  
Further evidence to suggest that ligand-independent signalling of the 
preTCR is not due to a unique intrinsic property of pTα, is the ability of 
TCRαβ (and TCRγδ) to drive development past the β-selection checkpoint. 
TCRα expression in pTα-deficient thymocytes in FTOC was sufficient to 
promote development to the DP stage (Haks et al., 2003). However, TCRαβ 
does not appear as efficient as the preTCR at promoting proliferation and 
differentiation of thymocytes (Borowski et al., 2004; Buer et al., 1997a). 
Moreover, other reports have suggested that early expression of TCRαβ at 
the DN stage impairs αβ T cell development (Borowski et al., 2004; 
Lacorazza et al., 2001b; Steff et al., 2001), instead promoting development 
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of DN cells to cells which have characteristics of the γδ lineage (Terrence et 
al., 2000). It is not clear whether αβTCR replacement of the preTCR 
requires MHC-ligand interaction. TCRα constructs were shown to promote 
efficient development and proliferation of pTα KO thymocytes in MHC-I/ 
MHC-II double knockout FTOCs in the additional presence of MHC 
blocking antibodies (Haks et al., 2003). This suggests that MHC is not 
required for TCRαβ signal initiation in DN thymocytes and that TCRαβ is 
able to also signal ligand-independently. Conversely transgenic HY-TCRs 
expressed in pTα-deficient mice appeared to be most efficient at driving β-
selection in the presence, rather than the absence, of their positively 
selecting MHC molecules (Croxford et al., 2008). Thus the issue remains 
unresolved.  
Despite the evidence listed above, ligand-independent signalling is widely 
accepted to be an intrinsic property of pTα (Borowski et al., 2004; von 
Boehmer, 2005). A recent study by Yamasaki and colleagues reported a 
mechanism of ligand-independent signalling that involved the spontaneous 
clustering of preTCR complexes at the surface of DN cells (Yamasaki et al., 
2006). These clusters form independently of ligand binding and were 
suggested to explain the punctuate pattern of expression observed for pTα 
on the surface of preTCR expressing cells (Saint-Ruf et al., 2000).  
Clustering of the preTCR led to constitutive internalisation of the preTCR 
complex, in a manner that resembled ligand-mediated endocytosis of the 
αβTCR (Yamasaki et al., 2006). By fusing the extracellular domain of pTα to 
the transmembrane and cytoplasmic domains of the human erythropoietin 
receptor (EPOR) the authors determined that the pTα-EPOR construct 
formed dimers in the IL-3 dependent BAF3 cell line. They ascribed 
constitutive dimerization to pTα but not to TCRα, and demonstrated that this 
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was due to the presence of four charged amino acids in the extracellular 
domain (aspartic acid at position 22 (D22), arginine at position 24 (R24), 
arginine at position 102 (R102)  and arginine at position 117 (R117)) of pTα 
that were essential for oligomerization; mutating any of them to alanine 
abolished the ability of pTα-EPOR to dimerize and induce growth of the 
BAF3 cell line (Figure 3.4) (Yamasaki et al., 2006). 
Figure 3.4 
 
 
 
 
Figure 3.4 Charged residues in pTα extracellular domain mediate 
oligomerization of the preTCR. An illustration of the positions of the four charged 
amino acid residues; D22, R24, R102 and R117, located on the extracellular 
domain of pTα that are implicated in oligomerization of the preTCR. The colours 
represent the regions of pTα encoded by the different exons; exon-1 is blue; exon-
2 is red, exon-3 is green and exon-4 is purple.   
 
Expression of an R102/R117 double mutant of pTα in TCRα-deficient T 
cells resulted in higher surface expression of the mutant preTCR 
(Yamasaki et al., 2006), consistent with a role for these residues in 
promoting oligomerization and internalisation. Importantly, when expressed 
in pTα-deficient thymocytes in RAG KO mixed bone marrow chimeras, the 
R102/R117 double mutant pTα chain was unable to promote development 
to the DP stage (Yamasaki et al., 2006). Thus the authors of this study 
proposed that ligand-independent signalling of the preTCR is initiated by 
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cell autonomous oligomerization mediated by charged amino acids in the 
extracellular domain of pTα (Yamasaki et al., 2006). However, this report 
did not discuss truncated pTα chains, which lack the extracellular domains 
of the protein yet are able to signal and drive development past the β-
selection checkpoint (Gibbons et al., 2001; Irving et al., 1998).  
3.9 The two isoforms of pTα; pTαa and pTαb.  
It was demonstrated well over ten years ago that two forms of pTα exist, 
formed by differential splicing of the pTα transcript; pTαa and pTαb. pTαa is 
the “full length” version of the gene, using all four exons to construct the 
protein (Figure 3.5). This protein is the one exclusively referred to as pTα in 
the vast majority of research articles. By contrast, pTαb lacks exon-2 that 
codes for the extracellular Ig-loop of the protein (Figure 3.5) (Barber et al., 
1998). pTαb was first identified in CD4(+) “β-only” peripheral T cells from 
TCRα-deficient mice (Barber et al., 1998). The human pTα gene also 
splices to form both pTαa and pTαb (Saint-Ruf et al., 1998), the conserved 
splicing across species suggesting an important role for the second isoform 
of pTα in T cell development. 
The pTαb isoform appears functional. In a T cell line, pTαb was shown to 
form surface complexes with TCRβ (Barber et al., 1998). Expression of a 
pTαb transgene in pTα KO mice relieved the αβ T cell developmental block 
and promoted development to the DP stage (Gibbons et al., 2001). In 
addition, the pTαb transgene reduced the percentage and absolute number 
of γδ T cells consistent with the preTCRs function of promoting αβ lineage 
development at the expense of γδ T cells (Gibbons et al., 2001).  
Although pTαb appears to have the ability to form a functioning preTCR, the 
reason for having two different preTCRs, conserved across species, has 
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not been addressed. Initial characterisation of the two preTCRs in vitro 
revealed that preTCRb exhibits higher surface expression than preTCRa 
(Barber et al., 1998). Furthermore preTCRb appeared to signal stronger 
than preTCRa in 4G4 cell lines inducing greater phosphorylation of p38 and 
JNK (Murga and Barber, 2002). 
Figure 3.5 
 
 
 
 
 
 
 
Figure 3.5 pTα codes for two isoforms. Schematic representation of the pTα 
gene consisting of four exons that undergoes alternative splicing to generate two 
isoforms; pTα
a 
and pTα
b
. pTα
a 
is a “full length” version of the gene, while pTα
b
 is a 
truncated spliced-isoform that lacks exon-2 that codes for the extracellular Ig-loop 
of the protein. Exons are colour coded; exon-1 is blue, exon-2 is red, exon-3 is 
green and exon-4 is purple.  
The differential surface expression and signalling capabilities described for 
pTαa and pTαb suggests the two isoforms may have different roles in T cell 
development. Indeed, a recent report has found that pTαb expression is 
much greater than that of pTαa in peripheral regulatory T cells and 
expression was necessary for the normal function of these cells (Campese 
et al., 2009). Despite the value of pTαb transgenic mice in demonstrating 
some degree of functionality for preTCRb, the quality of T cell development 
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was not addressed and a direct comparison with preTCRa was not 
performed. Moreover, because the transgenes were expressed under 
control of the Lck proximal promoter, the proteins were not expressed in a 
physiological manner and would have continued into the later stages of 
thymocyte development instead of terminating at the DP stage. Thus a 
comparative analysis of pTαa and pTαb has yet to be carried out, and a 
definitive function for pTαb has yet to be described. This thesis has 
attempted to address these two issues.   
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Differential signal quality/strength at DN to DP transition:
Provided by differential use of preTCRa and preTCRb
Hypothesis 
 
We hypothesise that pTαa and pTαb have non-redundant roles in T cell 
development. We hypothesise that pTαa and pTαb form preTCR complexes 
that signal differently to promote differential developmental outcomes. We 
hypothesise that use of preTCRa or preTCRb will differentially determine 
conventional vs. unconventional T cell development (Figure 4.1).  
Figure 4.1 
 
 
 
 
 
Figure 4.1 A schematic of the hypothesis: Differential use of preTCR
a
 and 
preTCR
b 
promotes differential signal quality/strength driving alternate 
developmental outcomes. 
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Aims  
 
 To characterise expression of pT a and pT b in the thymus. 
 To determine whether individual DN progenitors express one or 
both isoforms of pTα. 
 To investigate the function of pT a and pT b when expressed in 
isolation in pT -deficient thymocytes. 
 To investigate whether oligomerization is necessary for signal 
initiation of the preTCR. 
 To generate “pTαa-only” and “pTαb-only” BAC transgenic mice on a 
pTα-deficient background where expression of the transgenes will 
be appropriately controlled through development. 
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Methods 
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Chapter 1  
Molecular Biology. 
 
1.1 Gel electrophoresis.  
Gel electrophoresis was used for separating DNA, either for visualisation of 
PCR products or restriction digest fragments or for isolation of DNA. 
Agarose (Melford labs) was dissolved in 1% TAE (see Table 1) with 
Ethidium Bromide (VWR) the gels were run in 1% TAE buffer.  
Table 1 
X50 stock TAE 242g Trizma Base (Sigma) 
 
57.1ml Glacial Acetic Acid 
(Sigma) 
 
100ml 0.5M EDTA, pH 8.0 
(Gibco, Invitrogen) 
 dH2O to total volume of 1L 
 
Table 1 Recipe for Tris-acetate-EDTA (TAE) stock solution. The stock solution 
was diluted 1/50 for electrophoresis.  
 
For plasmids and PCR products 1% agarose gels were used and the gels 
were run at 110V for 45-60 minutes. To separate larger fragments, such as 
the BAC digests; 0.7% agarose gels were run at 39 volts for 5hours to 
achieve better resolution of the bands.  6X orange loading dye (Fermentas) 
was added to samples to facilitate loading of DNA into wells and 1kb DNA 
ladder (Fermentas) was run along samples to determine the size of the 
DNA in the samples.  
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1.2 DNA isolation. 
1.2.1 Plasmids. 
1.2.1.1 DNA gel extraction. 
Plasmid DNA extraction was carried out using QIAquick gel extraction kit 
(QIAGEN) according to manufacturer’s instructions. To summarise, the 
required DNA fragment was cut from the agarose gel (Melford Labs) using 
a sterile scalpel (Swann-Morton). The gel fragment was dissolved in 3 
volumes buffer QG to 1 volume of gel, at 50oC for approximately 10 
minutes, vortexing every 3 minutes. The solution was added to the 
QIAquick spin columns and centrifuged at 13,000rpm for 1 minute using a 
Bench-top centrifuge, to bind the DNA. Columns were washed with a 1ml 
buffer QG to remove any residual agarose, and subsequently with buffer 
PE (with ethanol) to remove any salts. DNA was eluted in 30µl of sterile 
water and stored at -20oC. 
1.2.1.2 Miniprep. 
In order to isolate plasmid DNA; single clones were retrieved from selection 
LB agar (Invitrogen) plates and left shaking, over night at 37oC in 5ml LB 
broth (Invitrogen) containing the appropriate antibiotic for selection. Plasmid 
DNA was isolated from 5ml overnight cultures using QIAGEN miniprep kits 
(QIAGEN). In summary, the cultures were centrifuged at 7000rpm for 3 
minutes and the pellets resuspended in 250μl buffer P1.  250μl lysis buffer 
(P2) was added and the tubes inverted. 350μl N3 was added for 
neutralisation and the samples were centrifuged at 13000rpm for 10 
minutes. The supernatant was added to the QAIprep spin columns followed 
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by 1 minute centrifugation. Columns were washed with buffer PE (with 
ethanol) and DNA was eluted with 50μl sterile water.  
1.2.1.3 Maxiprep. 
In order to obtain large amounts of plasmid DNA 100ml bacterial cultures in 
LB broth containing the appropriate antibiotic were inoculated with a 5ml 
overnight culture. 100ml cultures were left shaking overnight at 37oC before 
isolation of the DNA using JetStar Maxiprep kits (Genomed). To summarise 
the protocol, the bacteria were pelleted by centrifugation and all traces of 
media removed. 10ml buffer E1 was used to resuspend the pellet. 10ml 
lysis solution E2 was then added and mixed gently by inverting. The 
mixture was incubated at room temperature for 5min before adding 10ml 
buffer E3 for neutralization. The tubes were centrifuged at 12000xg for 10 
min, and the supernatant was loaded onto an equilibrated column. The 
lysate was left to run through the column by gravity flow and the column 
was then washed with 60ml solution E5. Plasmids were eluted with 15ml 
solution E6 and precipitated by addition of 10.5ml isopropanol (Sigma 
Aldrich) and centrifugation at 12000xg for 30min at 4oC. Plasmid DNA was 
washed with 70% ethanol (VWR) and re-centrifuged before air drying the 
pellet, and re-dissolving the DNA in suitable volume of water.   
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1.2.2 Bacterial artificial chromosomes (BACs). 
1.2.2.1 DNA gel extraction. 
BAC DNA fragments ≥ 20kb were isolated from 0.8% Agarose (Melford 
Laboratories) gels using the QIAEX II kit from QIAGEN. Gel fragments 
were collected in 1.5ml eppendorf tubes and weighed. 3 volumes of Buffer 
QX1 and 2 volumes of dH2O to 1 volume of the gel (1g=1µl) were added to 
the tubes. QIAEX II silica beads were resuspended by vortexing and 30µl 
was added to the tubes containing gel fragments. The samples were 
incubated in a 50oC water-bath for 10 minutes, and mixed by flicking the 
tubes every 2 minutes. Samples were then centrifuged at 10000xg for 30 
seconds and the supernatant removed and discarded. The pellet was 
washed by resuspending in 500µl Buffer QX1 and then washed twice with 
buffer PE (with ethanol). DNA pellets were dried for 10 minutes before 
being resuspended in 20µl dH2O by incubation at 50
oC for 10 minutes. The 
sample was centrifuged at 10000xg for 30 seconds to remove the silica 
particles and the DNA was stored at 4oC. 
1.2.2.2 Miniprep.   
This method of isolation of BAC DNA was used only to isolate small 
quantities for restriction enzyme analysis of the BAC clones. The DNA 
produced using this protocol was not clean or pure enough to use for 
subsequent recombineering steps. SW102 E.coli cells (Warming et al., 
2005) containing the pTα BAC were grown overnight in 5mL of LB-Luria 
broth (0.5g/L NaCl – Sigma) with 12.5µg/ml chloramphenicol (Sigma) at 
32oC. The bacteria were pelleted by centrifugation and resuspended in 
250μL of QIAGEN buffer P1. Then 250μL of QIAGEN buffer P2 and 350μL 
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of QIAGEN buffer P3 were added to each tube, and the tubes were spun 
for 4 min. The supernatant fluid was transferred to new 1.5mL eppendorf 
tubes, which were spun for another 4 min. 750μL of isopropanol (Sigma 
Aldrich) was added to precipitate the DNA, at room temperature for 10 min, 
and DNA was collected by spinning the tubes for 10 minutes at the maximal 
speed. The DNA pellet was washed once with 1mL of 70% ethanol (VWR), 
dried, and resuspended in 50μL of dH2O. 
1.2.2.3 Maxiprep. 
The Phaseprep BAC DNA kit (Sigma Aldrich) was used to isolate large 
quantities of pTα BAC DNA. The DNA isolated using this kit was of 
excellent quality and was therefore used for sequencing and subsequent 
recombineering steps. In summary of the protocol; 150ml LB-Luria broth 
(0.5g/L NaCl – Sigma) with 12.5µg/ml chloramphenicol was inoculated with 
a colony from a freshly streaked plate of SW102 cells transformed with the 
pTα BAC. The cultures were shaken overnight at 32oC and centrifuged at 
5000Xg for 10 minutes to harvest the cells. 12ml RNase-A/resuspension 
solution was added to the bacterial pellet and the cells were resuspended 
by pipetting up and down. 12ml Lysis-solution was added and the bottles 
inverted. 12ml chilled Neutralisation-solution was added to the lysate and 
mixed by inversion. The lysate was centrifuged at 15000xg for 30 minutes 
at 4oC to pellet the cell debris. The supernatant was transferred to a clean 
bottle and 22ml of room temperature isopropanol (Sigma) was added and 
mixed by inversion before centrifugation at 15000xg for 5 minutes at 4oC to 
pellet the DNA. DNA was air dried for 5 minutes before being dissolved in 
5ml Elution solution. Residual RNA was removed by digestion with 5µl 
RNase cocktail at 60oC for 15 minutes. The solution was then transferred to 
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a 15ml conical tube and 400µl of 3M sodium acetate buffer solution (pH 
7.0) was added to adjust the salt concentration before endotoxin removal.   
0.9ml endotoxin removal solution was added to the tube and the tube was 
inverted for 30 seconds. The samples were chilled on ice for 10 minutes 
before warming at 37oC in a water-bath for 5 minutes and centrifuged at 
4000xg for 5 minutes to separate the phases. The clear aqueous phase 
was collected into a clean tube. Endotoxin removal was then repeated to 
ensure complete removal of all impurities. The clear aqueous phase was 
transferred to a 50ml tube and 5.4ml room-temperature DNA precipitation 
solution was added before centrifugation at 15000xg for 30 minutes at 4oC 
to pellet the DNA. The pellet was washed in 5ml 70% ethanol and dried for 
5 minutes before dissolving in 1ml dH2O. 
1.2.3 Genomic DNA isolation.  
Genomic DNA was isolated from ear pieces of 21-day-old mice for 
genotyping. The ear pieces were suspended in 1ml of SNET buffer (20mM 
Tris-Cl (pH 8.0, Sigma Aldrich), 5mM EDTA (pH 8.0, Invitrogen), 400mM 
NaCl (Sigma Aldrich), 1% SDS and 400µg/ml Proteinase K (QIAGEN)) in 
2ml eppendorf tubes. Samples were incubated overnight at 55oC on a 
rocking platform. 1ml phenol: chloroform: isoamyl alcohol (pH8.0, Sigma) 
was added to the digested ear samples followed by incubation at room 
temperature for 30 minutes on a rocking platform. Organic and aqueous 
phases were separated by centrifugation at 10000xg for 5 minutes at room 
temperature and the aqueous layer was transferred to a fresh eppendorf 
tube. DNA was precipitated by addition of 1ml of isopropanol (Sigma) and 
pelleted by centrifugation at 10000xg for 15 minutes at 4oC. The 
isopropanol was removed with a pipette and after drying for 5 minutes, the 
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DNA pellet resuspended in 700µl dH2O. 10µl of the DNA was removed at 
this stage and frozen to test by PCR. The rest of the DNA was further 
cleaned by addition of 1 x volume of phenol: chloroform: isoamyl alcohol, 
the tubes were shaken and then centrifuged at maximum speed for 5 
minutes at room temperature. The aqueous phase was collected into fresh 
tubes and 10% volume 3M sodium acetate solution pH5.2 was added 
followed by 2 x volume 100% ethanol (VWR). The samples were incubated 
on ice for 20 minutes and then centrifuged at maximum speed for 10 
minutes at 4oC. The liquid was removed and the DNA pellet resuspended in 
100µl of dH2O. 1µl of DNA was used for subsequent PCR reactions.  
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1.3 DNA restriction digests. 
1.3.1 Plasmids. 
For routine restriction digests 0.5-1µg of plasmid DNA was used per 20µl 
reaction. For cloning, 2-5µg of plasmid DNA was used. Reaction 
components were; (x)µl DNA, 2µl 10x buffer (see Table 2 for the 
appropriate buffer), 1µl enzyme and dH2O to make the volume 20µl. 
Reactions were set up in 1.5ml eppendorf tubes and incubated in a 37oC 
heat block for 1-2 hours. Table 2 shows the details of all the restriction 
endonucleases and buffers used for this project. All restriction 
endonucleases were purchased from New England Biolabs. 
Table 2 
Enzyme Restriction site Buffer 
AccII (BstUI) 
5’-CG^CG-3’ 
3’-GC^GC-5’ 
NEB buffer 4 
BamH1 
5’-G^GATCC-3’ 
3’- CCTAG^G-5’ 
NEB buffer 3 
Dpn1 
5’-GA(CH3)^TC-3’ 
3’-CT^A(CH3)G-5’ 
NEB buffer 4 
EcoR1 
5’-G^AATTC-3’ 
3’-CTTAA^G-5’ 
NEB EcoR1  
Hha1 
5’-GCG^C-3’ 
3’-C^GCG-5’ 
 
NEB buffer 4 
Hpa1 
5’-GCG^C-3’ 
3’-C^GCG-5’ 
NEB buffer 4 
Spe1 
5’-A^CTAGT-3’ 
3’-TGATC^A-5’ 
NEB buffer 4 
Xba1 
5’-T^CTAGA-3’ 
3’-AGATC^T-5’ 
NEB buffer 4 
Xho1 
5’-C^TCGAG-3’ 
3’-GAGCT^C-5’ 
NEB buffer 4 
 
Table 2 List of Restriction endonucleases used in the experiments for this 
thesis. Restriction enzymes are shown along with the recognition sequence and 
the corresponding buffer used for DNA digest reactions. All enzymes were 
obtained from New England Biolabs.  
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1.3.2 BACs. 
3-5µg of BAC DNA was used for restriction digests with a total reaction 
volume of 50µl. Reaction components were; (x)µl DNA, 5µl 10x buffer (see 
Table 2 for the appropriate buffer), 2µl enzyme and dH2O to make the 
volume 50µl. The reactions were set up in 1.5ml eppendorf tubes and left 
overnight in a 37oC heat block before running on a 0.8% agarose gel 
(Melford Laboratories).  
1.4 DNA quantitation. 
The concentration of DNA was measured using a Nanodrop ND-100 
spectrophotometer (Labtech International) at a wavelength of 260nm.  
1.5 RNA isolation. 
RNA was isolated from C57BL/6 thymocytes sorted using the Fluorescence 
activated cell sorter. The cells were lysed in Trizol (Invitrogen) by repetitive 
pipetting; 1ml of Trizol is used per 5-10x106 cells. Trizol is a mono-phasic 
solution of phenol and guanidine-isothiocyanate that maintains the integrity 
of the RNA while disrupting cells and dissolving cell components. 
Homogenised samples were incubated at room temperature for 5 minutes. 
50μg RNase-free glycogen (Fermentas) was used as carrier to improve 
efficiency of recovery and enable the visualisation of the RNA pellet. 200μl 
of chloroform was added per 1ml of Trizol and the tubes were shaken 
vigorously. The samples were centrifuged at 13,000xg for 5 minutes to 
separate the organic and aqueous phases. The aqueous phase containing 
the RNA was transferred to a fresh eppendorf tube on ice. The RNA was 
precipitated by addition of 500μl of isopropanol and incubation at room 
temperature for 15 minutes. The samples were then centrifuged for 8 
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minutes at 13,000xg. The supernatant was removed carefully so as not to 
disturb the pellet. The RNA pellet was washed once with 500μl 70% 
ethanol (VWR) to remove any salt. The pellet was left to air dry, until it 
acquired a glassy look. 
The next step was DNase treatment of the RNA pellet. First the pellet was 
resuspended in 34μl of dH2O. 4μl of DNase buffer (Promega), 2μl DNase 
(Promega) was added and mixed by slow repetitive pipetting at a 40μl final 
reaction volume. The reaction was left to incubate at 37°C for 20-30 
minutes before protein removal.  160μl ddH2O was added to each sample 
and 200µl phenol: chloroform: isoamyl alcohol. The tubes were shaken 
then centrifuged for 5 minutes at maximum speed. The top aqueous phase 
was collected in a fresh tube and 200μl of chloroform added. The mixture 
was shaken then centrifuged for 5 minutes at top speed. The top aqueous 
phase was removed and approximately 10% final volume (20μl) of a 3M 
sodium acetate solution pH 5.2 was added.  2.5 volumes of 100% ethanol 
were added and the samples were incubated on ice for 20 min. RNA was 
pelleted by centrifugation at top speed for 10-12 min. The RNA pellet was 
resuspended in 11µl dH2O ready for cDNA synthesis.  
1.6 cDNA synthesis.  
11μl of ddH2O was used to resuspend the RNA pellet. 1μl of Oligo dT (500 
ng/μl solution, Fermentas) was added to the RNA and the mixture was 
heated to 70°C for 10 min, followed by immediate cooling on ice before 
spinning down and adding the rest of the synthesis reaction components; 
4μl 5x first-strand buffer (Takara Bio-Clontech), 2μl dNTP mix at a 
concentration of 10mM of each nucleotide (Takara Bio-Clontech), 2μl DTT 
(100mM-BD) and 1μl of PowerScript Reverse Transcriptase (RT) (Takara 
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Bio-Clontech). The cDNA synthesis reaction final volume was 20μl. The 
reaction was incubated at 42°C for 50-90 minutes and was terminated by 
heating at 70°C for 15 min. cDNAs were stored at -20oC. 
Alternatively SuperScript III Reverse transcriptase (Invitrogen) was used for 
the first strand cDNA synthesis reactions. The reaction was set up 
according to the kit protocol. In summary, 0.5μl 100μM oligo dT, 1μl 10mM 
dNTP mix was mixed with up to 5μg RNA and sterile distilled H2O, added to 
a total volume of 13μl. The reaction mix was heated at 65oC for 5 minutes 
and immediately put on ice for at least 1 minute. The reaction mix was 
centrifuged briefly and the following reagents were added; 4μl 5X First-
strand buffer, 1μl 0.1M DTT 1μl SuperScript III RT (at 200units/μl). The 
reaction was heated at 50oC for an hour before inactivating by heating at 
70oC for 15 minutes. cDNAs were stored at -20oC. 
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1.7 Polymerase Chain Reaction (PCR). 
To prevent contamination of PCR reactions the reactions were set up in a 
separate room to where the DNA template was added. The basic 
components of each PCR reaction is summarised in Table 3. Table 4 
shows the reaction conditions for a typical PCR reaction. The PCR 
programmes used followed the same steps; the denaturing temperatures 
vary depending on the enzymes used and the annealing temperatures also 
vary depending on the primer pairs.  
Table 3 
Component: Volume/reaction: 
Template DNA 1µl 
10X Buffer 2µl 
dNTP mix (25mM) 2µl 
Forward primer: 
(25pmol/µl) 
1µl 
Reverse primer: 
(25pmol/µl) 
1µl 
Enzyme 0.1µl 
dH2O 12.9µl 
Total Volume 20µl 
Table 3 Reaction components for a typical PCR. The reaction mix was made 
and aliquoted into PCR tubes before transferring to a separate room to add the 
DNA.  
 
PCR primers were designed, and ordered from Eurofins MWG Operon, and 
melting temperatures (TM) were obtained from the oligo-property scan 
online (www.eurofinsdna.com), or the data-sheet provided. TMs used in 
each PCR reaction were identified by performing a gradient PCR for each 
primer pair. The temperature gradient used ranged from ~3oC below the 
lowest TM to the temperature of the highest TM. For all PCRs, with 
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exception of the single cell PCRs, DYAD DNA engine thermo-cyclers (MJ 
Research) were used. Because the PCR conditions varied for each 
different experiment, they have been further outlined below. 
Table 4 
Step Conditions 
1 DT for 30-60 seconds 
2 DT for 15 seconds 
3 TM for 30 seconds 
4 72oC 1 minute/kb 
5 
Cycle to step 2 -37 more 
times 
6 72oC for 5 minutes 
7 4oC forever 
 
Table 4 Reaction conditions for a typical PCR: DT is denaturing temperature, 
which was specific to the enzyme used and TM is melting temperature which 
specific to the primer pair used.  
 
1.7.1 Semi-quantitative PCR. 
Semi-quantitative PCR analysis pTαa and pTαb was performed on cDNAs 
synthesised from C57BL/6 thymocytes. The cDNA levels were normalised 
by β-actin PCR. Taq polymerase (New England Biolabs) and the 
corresponding Taq polymerase buffer were used for the PCR reactions at a 
denaturing temperature of 94oC. The primers used for these experiments 
and the corresponding melting temperatures are described in Table 5. 
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Table 5 
Primer Sequence TM 
pTα F2 (pTα
a 
forward) 5’-TCTGAAGAGCTGGAAGCCTGGGAGC-3’ 67
o
C 
pTα F1-3 (pTα
b 
Forward) 5’-TCAGGCTCTACCATCAGGGGAATC-3’ 63
o
C 
pTα R (Reverse) 5’-GCTATCCTATCAGAGACTGGGCTCT-3’ n/a 
β- actin Forward 5’-CAGTTCGCCATGGATGACGATATC-3’ 62
o
C 
β- actin Reverse 5’-GTGTTGAAGGTCTCAAACATGATC-3’ 62
o
C 
 
Table 5 Primers for semi-quantitative PCR. The table shows the primers used in 
semi-quantitative PCR analysis for pTα
a 
and pTα
b
 and the β-actin
 
PCR. The same 
reverse primer (R) was used for pTα
a 
and pTα
b 
PCRs.  
 
1.7.2 PCR for cloning pTαa and pTαb. 
Phusion polymerase (Finnzymes) was used to clone pTαa and pTαb from 
C57BL/6 DN4 thymocyte cDNA. Phusion is a high fidelity polymerase which 
creates blunt ended PCR products. The denaturing temperature for 
Phusion was 98oC and the TM for the reaction was 67 oC. The primers were 
pTα F4 (forward) 5’-TAGCCCACACCTCAGAGCTGCAG-3’ and pTα R2 
(Reverse) 5’-GCTATCCTATCAGAGACTGGGCTCT-3’. 
1.7.3 Site directed mutagenesis PCR.  
PfuTurbo DNA polymerase-AD (Stratagene) was used for the mutagenesis 
PCRs. The reaction conditions were; denaturing temperature 95oC, 
extension at 68oC for 4.5 minutes (approximately 4.5kb plasmid template) 
and 18 cycles. pTα R24A primers were used to generate pTαa-R24A (Table 
6) with pBlunt-pTαa plasmid as the template. Two mutagenesis steps were 
carried out generate pTαa-DRRA; the first using pTαa-D22R24A primers 
(Table 6) with pBlunt-pTαa plasmid as the template (10-20ng), the second 
using pTαa-R102A primers (Table 6) with pBlunt-pTαa-D22R24A mutant 
plasmid as the template (10-20ng). 
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Table 6 
 
Table 6 Primers used for site directed mutagenesis of pTα
a
 and pTα
b
. The 
table shows the sequences of each of the primers (and corresponding TMs) used 
to generate pTα
a
-R24A, pTα
a
-DRRA and pTα
b
-R117A alleles. Underlined text 
denotes the desired mutation; F is forward and R is reverse. 
 
To generate pTαb-R117A the pTαb-R117A primers were used (Table 6) with 
pBlunt-pTαb plasmid as a template. The primers for mutagenesis were 
designed according to the guidelines provided in the Quick change II XL 
Site directed mutagenesis kit manual (Stratagene). Both mutagenic primers 
for each construct contained the desired mutations and annealed to the 
same sequence on opposite strands of the plasmid. The primers were 
between 25 and 45 base pairs in length with a melting temperature of 
≥78oC.  
The following formula was used for estimating the TM 
Tm = 81.5 + 0.41(%GC) - 675/N - % mismatch   
(Where N is the primer length in bases and the percentage of Gs and Cs 
and mismatch are whole numbers). The desired mutation was located in 
the middle of each primer with 10-15 bases of correct sequence on both 
Primer Sequence TM 
pTα R24A F 5’-CTGCTGGTAGATGGAGCGCAGCACATGCTGG-3’ 72.8
o
C 
pTα R24A R 5’-CCAGCATGTGCTGCGCTCCATCTACCAGCAG-3’ 72.8
o
C 
pTα D22R24A F 
5’-TCACACTGCTGGTAG 
CTGGAGCGCAGCACATGCTG-3’ 
73.2
o
C 
pTα D22R24A R 
5’-CAGCATGTGCTGCGCTC 
CAGCTACCAGCAGTGTGA-3’ 
73.2
o
C 
pTα R102A F 5’-TGGGGGACAGAACGCGAGCACACACC-3’ 69.7
o
C 
pTα R102A R 5’-GGTGTGTGCTCGCGTTCTGTCCCCCA-3’ 69.7
o
C 
pTα R117A F 5’-TCTTCGACAGCCGCGAGCTGCTTTCCG-3’ 69.9
o
C 
pTα R117A R 5’-CGGAAAGCAGCTCGCGGCTGTCGAAGA-3’ 69.9
o
C 
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sides. In addition the primers had a GC content of at least 40% and 
terminated in one or more G or C bases. The melting temperature used 
was 5oC lower than that calculated using the formula above. The primers 
were diluted to 62.5ng/µl and 125ng of each primer was used in each 
reaction.   
1.7.4 Recombineering PCR. 
1.7.4.1 PCR amplification of galK. 
The galK sequence to be inserted into the pTα BAC for the first 
recombineering step (covered in more detail later in the Methods) was 
amplified by PCR from 2ng of a pGalK plasmid obtained from 
(www.recombineering.ncifcrf.gov). Primers p21 and p22 (Table 7) were 
used to amplify galk generating “homology arms” for homologous 
recombination into intron-1 of the pTα gene. p21 consisted of 75bp 
homology to intron-1 of pTα and 24bp homology to the 5’-region of galK. 
p22 consisted of 75bp homology to intron-1 of pTα and 25bp homologous 
to the 3’-end of galK.  
Table 7 
Primer Sequence 
p21 
 
5’-GACAGGGTTTCTCTGTGTAGCTCCGGCTGTCCTGGAACTCACTCTGTAGA 
CCAGGCTGGCCTCGAACTCAGAAATCCTGTTGACAATTAATCATCGGCA-3’ 
 
p22 
 
5’-TGGGTTGTTGGTGGGTGGGCGGTTGTTAGTTGGTTGCTGTCAGT 
CTTGGCTTGCTAAGTAGTCGTGGGCAAAGAATCAGCACTGTCCTGCTCCTT-3’ 
 
 
Table 7 primers p21 and p22 for amplifying galK and generation of 
“homology arms” for insertion into the pTα BAC. The primers possess 75bp of 
homologous sequence to intron-1 of pTα and 25bp homology to the galK gene 
(underlined).  
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Phusion polymerase (Finnzymes) was used to amplify galk. The reaction 
was heated at; 98°C for 15 seconds, 60°C for 30 seconds, 72°C for 1 min, 
for 30 cycles.  
1.7.4.2 Generating double stranded oligos for galK replacement. 
The primers used for generating double-stranded DNA oligos to replace the 
galK sequence in the pTα BAC, for generating pTαa-only and pTαb-only 
BAC constructs are shown in Table 8. P23 and P24 were used to replace 
galk and fuse exons 1 and 2 of pTα to generate the pTαa-only BAC 
construct. p23 consisted of 85bp homology to the 3’ -end of exon-1 and the  
15bp of homology to the 5’-end of exon-2 of pTα.  p24 consisted of 15bp of 
homology to the 3’-end  of exon-1 and 85bp homologous to the 5’-end of 
exon-2.  
Table 8 
Primer Sequence 
p23 
 
5’-TGGGTCATGCTTCTCCACGAGTGGGCCATGGCTAGGACATGGCTGCTGCT 
GCTTCTGGGCGTCAGGTGTCAGGCCCTACCATCAGGCATCGCTGGCACCC-3’ 
 
p24 
5’-
AGGCAAACCACCAGCATGTGCTGCCTTCCATCTACCAGCAGTGTGATGGGT 
GGAGCCAGAGACGGAAAGGGGGTGCCAGCGATGCCTGATGGTAGGGCCT-3’ 
 
p31 
5’-
TGGGTCATGCTTCTCCACGAGTGGGCCATGGCTAGGACATGGCTGCTGCTG 
CTTCTGGGCGTCAGGTGTCAGGCCCTACCATCAGGGGAATCTTCGACAG-3’ 
 
p32 
 
5’-TTCCCAGCCACCGTCCCTCCCTCACCCACTGGTGACTTACCCCCGAGAGG 
CTCCGGAAAGCAGCTCCTGGCTGTCGAAGATTCCCCTGATGGTAGGGCCT-3 
 
 
Table 8 Primers for generating double-stranded oligos for the second 
recombineering step. The table shows primers for generating double-stranded 
DNA oligos to replace galk in the pTα BAC and subsequently generate pTα
a
–only 
(with p23 and p24 by fusion of exons 1 and 2 of pTα) and pTα
b
–only (with p31 and 
p32 by fusion of exons 1 and 3 of pTα) BAC constructs: The underlined sequence 
denotes regions of homology to exon-1 of pTα. 
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p31 and p32 were used to replace galk and fuse exons 1 and 3 of pTα to 
generate the pTαb-only BAC construct. p31 consists of 85bp of homologous 
sequence to the 3’-end  of exon-1 and 15bp homology to the 5’-region of 
exon 3 of pTα. Because exon 3 of pTα is only 45bp long, p32 was designed 
to contain 25bp homology to the 3’-end of exon-1, 45bp homology to all of 
exon-3 and 40bp homology to intron-3 of pTα.  
Each primer pair was annealed and extended to generate a double-
stranded DNA oligo. 10µg of each primer was used with 2µl dNTPs (25nM) 
and 5µl 5X PCR buffer (Phusion High Fidelity polymerase kit, Finnzymes) 
with dH2O to a total volume of 50µl. The mixture was heated in a thermo-
cycler at 98oC for 5 min, and then cooled from 90oC to 80oC at 1oC/ minute. 
After 2 minute incubation at 80oC, 0.2µl Phusion polymerase was added for 
extension of the annealed primers. The mixture was further cooled from 
80oC to 72oC by 1oC every 2 minutes and then incubated on ice. The 
double-stranded DNA oligos were gel purified to a final concentration of 
200ng/ml in ddH20. 200ng was used in the recombineering experiments 
(which will be described later in this chapter). 
1.7.5 Single cell Multiplex PCR. 
Single cell multiplex PCR was used to determine expression of pTαa and 
pTαb in single DN3 and DN4 C57BL/6 thymocytes. Because of the 
sensitivity and accuracy of the assay it was essential that the reagents 
were kept separate from the template or amplified product. Therefore 
separate rooms were used for 1) aliquoting reagents and making the 
master mixes, 2) aliquoting the master mix into the PCR tubes, 3) adding 
the template DNA and 4) gel electrophoresis of the PCR products. The 
PCR was performed in 5 steps; 1) Single cell sort, 2) lysis of single cells 3) 
99 
 
Reverse transcription (RT), 4) Multiplex PCR and 5) 2nd round nested-PCR.   
The DN3 and DN4 single cells used in this experiment were sorted into 
individual PCR tubes in 5µl PBS (Invitrogen) and stored at -80oC. 
1.7.5.1 Primers for Single cell multiplex PCR. 
The primers used in this experiment are shown in Table 9. The primers 
were reconstituted in 1X TE buffer (Promega); 30µl 1000nM aliquots were 
stored at -80oC for stock solutions. The stocks were further diluted using 
nuclease-free water (Invitrogen) to 100nM aliquots and frozen at -80oC. The 
working dilutions were made at 25nM solutions using the nuclease-free 
water and these were stored at -20oC. The primer aliquots (25nM) were 
used only 3 times to avoid decreased amplification efficiency due to primer 
degradation after repeated freeze/thaw cycles.  
Table 9 
Primer Sequence RT Mltplx 2nd 
pTα
a 
Fwd_1 5’-TCAGGCTCTACCATCAGGCA-3’     
pTα
a 
Fwd_2 5’-TTCTGAAGAGCTGGAAGCCT-3’    
pTα
b 
Fwd_1 5’-TCAGGCTCTACCATCAGGGG-3’    
pTα
a 
+ pTα
b
 
 
Rev_1 5’-TAGGCTCAGCCACAGTACCT-3’    
pTα
a 
Fwd_3 5’-TTGCCTTCTGAAGAGCTGGA-3’    
pTα
a 
Fwd_4 5’-TTCTGAAGAGCTGGAAGCCT-3’    
pTα
a 
+ pTα
b
 
 
Rev_2 5’-CATCGGAGCAGAAGCAGTTTG-3’    
EF1a Fwd_1 5’-ACACGTAGATTCCGGCAAGT-3’    
EF1a Fwd_2 5’-TGGTGGAATCGACAAGCGAA-3’    
EF1a Rev_1 5’-ACGCTCACGCTCAGCTTTCA-3’    
 
Table 9 Primers for single cell multiplex PCR. Reverse primers were used in all 
three reactions; reverse transcription (RT), multiplex PCR (Mltplx) and the nested, 
2
nd
 PCR. Forward 1 (Fwd_1) primers for each gene were used in the multiplex 
reactions only and the Fwd_2 primers for the second PCR, with the exception of 
pTα
b 
Fwd_1.  
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1.7.5.2 Lysis and reverse transcription.  
Cells were removed from the -80oC freezer and thawed on ice before lysis 
by heating at 65oC in an Applied Biosystems-GeneAmp thermo-cycler for 2 
minutes. The cells were kept on ice before adding the reverse transcription 
(RT) mix to each tube (10µl). Table 10 shows the reaction components for 
the RT step. The primers for RT were diluted to 12.2µM and the dNTPs 
(Amersham) were mixed and diluted to 10mM before setting up the 
reaction.  RT was achieved by heating the sample at 37oC for 60 minutes in 
the thermo cycler and then at 95oC for 3 minutes before cooling at 10oC. 
The samples were kept on ice until the Multiplex reaction mix was added.  
 
Table 10 
Order Reagents 1x 
1 H2O (nuclease free) X µl 
2 PCR Buffer II (10x) 1.5 μL 
3 MgCl2 2 μL 
4 dNTPs (10 mM each) 1.5 μL 
5 Primer (12.2 μM each) 0.16 μL 
6 RNAse Block 1 μL 
7 MMLV RT 0.7 μL 
 Final Volume 10 μL 
 
Table 10 Reverse transcription reaction components for the single cell 
multiplex PCR. The PCR buffer and magnesium chloride used for RT were from 
an AmpliTaqGold kit (Applied Biosystems). MMLV reverse transcriptase was 
purchased from Applied biosystems and the Rnase Block, ribonuclease inhibitor 
was purchased from Stratagene.  
  
1.7.5.3 Multiplex PCR. 
The Multiplex PCR components are described in table 11. 70µl of the 
Multiplex PCR mix was added to the RT reaction products and the tubes 
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were capped, vortexed and centrifuged briefly to ensure that the samples 
were mixed. The samples were then put through the Multiplex-PCR 
programme (Table 12).  
Table 11 
Reagents 1x 
H2O (nuclease free) X µl 
PCR Buffer II (10x) 8.5 μL 
MgCl2 7 μL 
dNTPs (2.5 mM each) 7 μL 
Oligo (25μM each) 0.05 μL 
Taq polymerase 0.6 μL 
Final Volume 70 μL 
 
Table 11 Multiplex PCR reaction components. The PCR buffer, MgCl2 and Taq 
polymerase for this reaction were from an AmpliTaqGold PCR kit (Applied 
Biosystems) and the dNTPs used were TWELVEPAQ-Gene-dNTPs from Applied 
Biosystems  
 
Table 12 
95
o
C 10 minutes hold 
 94
o
C 45 seconds 
15X  60
o
C 1 minute 
 72
o
C 1.5minutes 
72
o
C 10 minutes hold 
 
Table 12 Multiplex PCR programme. Table shows the PCR programme used for 
the first round, Multiplex PCR.  
 
1.7.5.4 Second-round nested PCR. 
The multiplex PCR products were then subjected to second round nested 
PCR. Table 13 shows the reaction mix for the nested, 2nd PCR. Three 
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different 2nd PCR reaction mixes were made up, one for each of the three 
transcripts being amplified; EF1A, pTαa and pTαb.  
Table 13 
Reagents 1x 
H2O (nuclease free) X µl 
PCR Buffer II (10x) 2 μL 
MgCl2 1.6 μL 
dNTPs (2.5 mM each) 2 μL 
Primer (25μM each) 0.2 μL 
Taq polymerase 0.1 μL 
Final Volume 18 μL 
 
Table 13 Nested 2
nd
 PCR reaction components. The table shows the 
components for the 2
nd
 round PCR for the single cell multiplex PCR protocol. This 
PCR reaction was performed on the products of the multiplex PCR and a separate 
reaction was set up for each of the three transcripts; EF1a, pTα
a 
and pTα
b
. 
 
Table 14 
95
o
C 10 minutes hold 
 94
o
C 30 seconds 
2x  70
o
C 45 seconds 
 72
o
C 1 minute 
 94
o
C 30 seconds 
2x  66
o
C 45 seconds 
 72
o
C 1 minute 
 94
o
C 30 seconds 
2x  62
o
C 45 seconds 
 72
o
C 1 minute 
 94
o
C 30 seconds 
48x  66
o
C 45 seconds 
 72
o
C 1 minute 
72
o
C 10 minutes hold 
 
Table 14 The 2
nd
 PCR programme.  
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As with the other reaction mixes, the 2nd PCR reaction mixes were made up 
in PCR room 1, the cleanest room. The mixes were aliquoted in room 2 and 
then taken to room 3 where 5µl of the Multiplex PCR product (or 2µl cDNA 
template) was added to each of the tubes (total volume 20µl). The 2nd PCR 
programme is shown in table 14.  
1.7.5.5 Primer optimization. 
To test primer efficiency individual PCR reactions were set up using DN4 
cDNA for each of the primer sets, i.e. Fwd_1 with the reverse, and Fwd_2 
with the reverse for pTαa, pTαb or EF1A. These reactions were performed in 
triplicate using quantitative real-time PCR. For primer competition a 
multiplex 1st PCR was set up with pTαa Fwd_1, pTαb Fwd_1, EF1A Fwd_1 
and the two reverse primers. 1st PCR reactions for each individual sets of 
primers were run in parallel and 2nd PCRs were then set up using 5μl of 
each of the 1st PCR products (i.e. from the multiplex or from each of the 
individual 1st PCRs.) These PCRs were done in triplicate using quantitative 
real-time PCR. SYBRGreen master mix (Applied Biosystems) was used for 
the real-time PCRs. The master mix was aliquoted into wells of a MicroAmp 
optical 96-well reaction plate (Applied biosystems) and 0.2µl of each 
corresponding primer, at 25µM concentration was added with 4.6µl of water 
(total volume 5µl). The plate was taken, on ice, to room 3 where 2µl of the 
cDNA (or 5μl of the 1st PCR product) was added to each of the wells. The 
plate was sealed using MicroAmp 96 optical adhesive film (Applied 
Biosystems) and spun down at 1200rpm for 30 seconds in a bench-top 
centrifuge. The plate was inserted into an Applied Biosystems 7500 real-
time machine, the programme is shown in Table 15. The data was collected 
at 72oC and the Ct values were used for analysis of primer efficiency and 
competition.   
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Table 15 
95
o
C 10 minutes hold 
 94
o
C 30 seconds 
40X  60
o
C 30 seconds 
 72
o
C 45 seconds 
 
Table 15 The real-time PCR programme: 
 
1.7.6 Genotyping pTαa-transgenic mice by PCR. 
To test the quality of the genomic DNA extracted a PCR was performed 
using primers pTα1s and pTα2 (Table 16) that amplified a 466bp intronic 
sequence 9.5kb upstream of the pTα gene. Taq polymerase was used for 
the PCRs (using a TM of 65oC) and 2ng TCRδ KO genomic DNA was used 
for the positive control. PCR for detection of the pTαa transgene was 
performed using primers pTαF4 and pTαa-transgene-R (Table 16) that 
amplified a 450bp sequence traversing the exon 1 and 2 boundary of pTα. 
This sequence is unique to the pTαa-only BAC transgenic construct. Thus, 
for the positive control 2ng TCRδ KO genomic DNA was spiked with a 
single copy of the pTαa targeted BAC. Taq polymerase was used in the 
PCR at a TM of 65oC.  
Table 16 
Primer Sequence 
pTα 1s 5’-CAACTACCAAACTGCCTCTGCTCG-3’ 
pTα
  2 5’-AGTCTGGACACTTGCCACCTGTGG-3’ 
pTα
 F4 5’-TAGCCCACACCTCAGAGCTGCAGC-3’ 
pTα
a  
Transgene R 5’- CAGGCTTCCAGCTCTTCAGAAGGCA-3’ 
 
Table 16 Primers used for genotyping pTα
a
 transgenic mice genomic DNA. 
pTα1s and pTα2 were used to test the quality of the genomic DNA and pTαF4 and 
pTα
a
-transgene-R were used to identify the presence of the pTα
a
-only  transgene.  
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 1.8 Cloning. 
1.8.1 Cloning into pCR-Blunt Vectors (Invitrogen). 
Zero blunt cloning kit (Invitrogen) was used to clone blunt ended PCR 
products into the pCR-Blunt (pBlunt) vector (provided with the kit). The 
pBlunt vector contains a lethal E.coli ccdB gene fused to the C-terminus of 
LacZα. Ligation of a blunt PCR fragment separated the lacZα-ccdB gene 
fusion from the lac promoter, disrupting expression of the lethal gene. This 
allows for negative selection of non-recombinant vectors. In addition, the 
pBlunt vector contains Zeocin and Kanamycin resistance genes for positive 
selection of transformants.   
Blunt ended PCR products were generated using Phusion polymerase 
(Finnzymes) and isolated using gel electrophoresis and extraction from the 
gel. The constructs were then ligated into the pBlunt plasmid at a 10:1 
molar ratio of insert: vector for optimal ligation efficiency. Ligation reactions 
were set up with 5ng of vector; and the formula below was used to estimate 
the amount of PCR product needed for the ligation: 
X ng insert = (10) (Ybp PCR product) (5 ng linearized pCR-Blunt) 
(3500 bp pCR-Blunt) 
Where X ng is the amount of PCR product of Y base pairs to be ligated. 
The ligation reaction was set up as follows; 5ng pBlunt, PCR product, 10x 
Ligation buffer, T4 DNA ligase (4u/µl, Invitrogen) and sterile water to 10μl 
total reaction volume. The ligation reaction was incubated at 16oC for 1 
hour before transforming into One-ShotTOP10 E.coli competent cells 
(Invitrogen). 2µl of ligation reaction was added to 50µl of competent cells 
on ice and left to incubate on ice for 30 minutes. The cells were then heat-
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shocked for 45 seconds at 45oC and then kept on ice for 2mins. 250µl of 
Luria–Bertani (LB) broth (Invitrogen) with no antibiotic was added to 
transformed cells and the vials were shaken at 37oC for 1 hour. 100µl of 
transformed cells were spread at varying concentrations on LB Agar 
(Invitrogen) plates containing 50ug/ml Kanamycin (Sigma). The plates were 
incubated over-night at 37oC. Positive transformants were analysed by 
restriction digest and sent to MWG for sequencing from M13 reverse and 
the T7 priming sites (see Figure 1).  
 Figure 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 pCR-Blunt vector map and sequence of the multiple cloning site. 
Plac is the lac promoter which is separated from the lethal lacZ-ccdB gene fusion 
by the multiple cloning site. Thus pBlunt plasmids that self-ligate are selected 
against, ensuring high cloning efficiency. pUC ori is the origin of replication of the 
plasmid. The Kanamycin resistance gene allows for positive selection of 
transformed bacteria on Kanamycin containing medium. (Figure obtained from the 
Zero Blunt cloning kit protocol – Invitrogen).  
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1.8.2 Cloning into pLZRS-IRES-eGFP (pLZ) vectors.  
The pLZRS-IRES-eGFP (pLZ) vector (Heemskerk et al., 1997) is a 
retroviral vector possessing two long terminal repeat (LTR) sequences 
between which, lies the multiple cloning site (MCS) (Figure 2). Downstream 
of the cloning site and between the two LTRs there is an internal ribosomal 
entry site (IRES) followed by the reporter gene, enhanced Green 
Fluorescent Protein (eGFP) which allows translation of eGFP with the gene 
of interest in transduced target cells.  Upstream of the MCS is a packaging 
signal (ψ) for packaging of the plasmid into virus particles. pLZ contains 
Ampicillin and Puromycin resistance genes for selection of positive 
transformants (bacteria) and transfected phoenix cells respectively.  
Figure 2 
 
 
 
 
 
 
 
Figure 2 pLZRS-IRES-eGFP (pLZ) vector map. The pLZ retroviral vector multiple 
cloning site (MCS) lies between two long terminal repeats (LTRs) which allow for 
constitutive expression of the cloned gene. An internal ribosomal entry site (IRES) 
upstream of eGFP allows for detection of cells transduced with the retroviral 
constructs. The Amp gene conveys Ampicillin resistance and puro conveys 
puromycin resistance for selection of transformed bacteria cells and transfected 
phoenix cells, respectively. 
MCS: 
BamH1 
EcoR1 
Xho1 
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To clone into pLZ the plasmid was digested, alongside the pBlunt plasmid 
containing the insert (pTα cDNA) with BamHI (NEB) and XhoI (NEB) 
enzymes, and the reaction left for 2 hours at 37°C. The digests were run on 
0.7% agarose gel for 1 hour 40 minutes at 110v. The linear pLZ vector 
(12.4kb) and the insert (gene of interest) were extracted from the gel and 
eluted in sterile water. The water was warmed to 70oC for efficient elution of 
large fragments; the amount of DNA in each sample was measured using a 
Nanodrop spectrophotometer.  
The isolated digest fragments were ligated into the linearized pLZ vector at 
a 20:1 insert to vector ratio, using 20ng of pLZ plasmid. The amount of 
insert to be added was calculated using the below formula: 
X = (20) (Y insert bp) (20ng linearized pLZ) 
12443 (pLZ bp) 
To the vector and insert the following was added for the ligation reaction; 
1.5µl of 10x T4 Ligase buffer (New England Biolabs), 0.5µl T4 DNA Ligase 
(New England Biolabs) and sterile water to 15µl reaction volume. The 
reaction was incubated over night at 16°C. The next day 5µl of ligation 
reaction was added to 50μl XL GOLD E.coli competent cells (Invitrogen). 
The cells were incubated on ice for 30 minutes then heat shocked for 30 
seconds at 42°C. The cells were then placed on ice for 2 minutes before 
addition of 250μl LB broth medium and incubation at 30oC in a shaking 
incubator for one hour. The transformed cells were spread on LB Agar 
(Invitrogen) plates containing 100μg/ml Ampicillin (Sigma) and incubated 
overnight at 30oC. Single colonies of the positive transformants were 
cultured overnight in 5ml of LB broth (Invitrogen) and the plasmid DNA was 
isolated. Restriction enzyme digests were performed on plasmid DNA to 
characterize the transformant and to confirm the presence of the insert, and 
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the plasmids were sent to MWG for sequencing using the pLZ-gag primer; 
5’-TCTTGTCTGCTGCAGCATCG-3’.  
1.9 Recombineering of BAC DNA. 
1.9.1 Introduction to recombineering. 
pTαa and pTαb targeted BAC constructs were be generated using the 
recombineering technique (Warming et al., 2005). Detailed protocols were 
obtained from (http://recombineering.ncifcrf.gov). Recombineering stands 
for genetic engineering by homologous recombination and uses modified 
E.coli strains to modify the cloned DNA. The E.coli cells (SW102) contain 
three phage lambda (λ) red recombination genes; exo, bet and gam. exo 
encodes a 5’ to 3’ exonuclease that creates 3’ overhangs from introduced 
double stranded DNA targeting cassettes. bet encodes a protein that binds 
to the 3’ overhang and mediates homologous recombination with the 
complimentary sequence present in the BAC. gam encodes an 
exonuclease inhibitor that protects the double stranded DNA cassette from 
being degraded. The three λ-phage genes are regulated by a temperature 
controlled promoter in SW102 cells. Thus, at 32oC the promoter is inactive 
but after 15minutes incubation at 42oC the genes are expressed and 
recombination can take place.   The E.coli galactose operon consists of 
four genes; galE, galT galK and galM, in the SW102 strain the galK gene 
has been deleted. galK encodes galactokinase; the first enzyme in the 
galactose degradation pathway, however this enzyme also catalyses the 
phosphorylation of 2-deoxy-galactose, leading to the toxic build up of 2-
deoxy-galactose-1-phosphate which cannot be further metabolised. 
Therefore the presence of galK confers both positive and negative selection 
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and this enables efficient selection of clones that have undergone 
homologous recombination.  
In the first recombineering step the galK PCR product containing homology 
to the targeted region of the BAC is inserted into the BAC by homologous 
recombination and galK(+) clones are selected for by growing the bacteria 
on minimal media with galactose as the only carbon source. In the second 
recombineering step the galK sequence is substituted by a double-stranded 
DNA oligo with homology flanking the galK sequence in the BAC. In this 
case galK(+) clones were selected against by growing the bacteria on 
minimal media with glycerol and 2-deoxy-galactose.  This process can be 
repeated to modify the target gene as many times as necessary.  
Table 17 
Primer sequence For sequencing: 
15s 5’-CCTATGAAGTGCTCTTCAGACAGG-3’ Exon 1 (forward) 
16s 5’-AACTGGAGAAGGCTGGGAGTGACC-3’ Exon 1 (reverse) 
17s 5’-AAACTTCTGGTGGCTGGGCAGTGG-3’  Exon 2 (forward) 
18s 5’-TCTTAGCAAACACAGATCAGAGCC-3’ Exon 2 (reverse) 
19s 5’-GACTACCATTACCTGTTTGCTTGC-3’ Exon 3 (forward) 
20s 5’-GCTGCAGGAACGAGCTTCTGATGC-3’ Exon 3 (reverse) 
 
Table 17 Primers used for sequencing the pTα BAC at the targeting sites. 
 
The pTα BAC (BMQ452P20) was purchased from www.ensemble.org, and 
consists of 46kb of C57BL/6 mouse chromosomal sequence, which 
included the pTα gene. The chromosomal DNA had been cloned into the 
BamH1 site of the BAC vector pBACe3.6. The BAC possesses a 
chloramphenicol resistance gene for positive selection of transformants.    
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All recombineering plasmid vectors and E.coli strains were purchased from 
http://recombineering.ncifcrf.gov. Table 17 shows the primers used for 
sequencing BMQ452P20. The BAC was sequenced to confirm the 
presence of the pTα gene, but also to identify the sequence of the targeting 
locus to design the oligonucleotides used for recombineering.  
1.9.2 Transforming SW102 cells. 
The first step was to transform SW102 cells with the pTα BAC by 
electroporation. To do this the SW102 cells had to be made 
electrocompetent. The SW102 agar stab was streaked onto an LB agar 
plate containing 12.5µg/ml Tetracycline (Sigma). A single colony was 
picked and cultured overnight in LB broth without tetracycline. 500 µl of the 
overnight SW102 culture was diluted in 25 ml LB medium with12.5µg/ml 
Tetracycline in a 50 ml baffled conical flask and grown at 32oC in a shaking 
water-bath to an OD600 of 0.6 (3-5 hours). The bacteria were cooled in an 
ice/water-bath slurry and then transferred to pre-cooled 15 ml Falcon tubes 
(BD Biosciences). The cells were pelleted by centrifugation at 5000 rpm at 
0oC for 5 minutes. The supernatant was poured off and the pellet was 
resuspended in 1ml ice-cold dH2O by gently swirling the tubes in an 
ice/water-bath slurry. Subsequently, 10 ml ice-cold dH2O was added and 
the samples pelleted again. This step was repeated once more. After the 
second washing and centrifugation step, the supernatant was removed, 
and the pellet was resuspended in the residual dH2O; approximately 50µl. 
The cells were transferred to ice cold 0.1cm cuvettes (BioRad) and mixed 
with 5µg BAC DNA. The now electrocompetent bacteria were transformed 
by electroporation at 25 µF, 1.75 kV and 200Ω. 1ml LB broth was added to 
the transformed cells and the tubes were shaken at 32oC for 2 hours before 
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plating the transformants on LB agar plates (Invitrogen) with 12.5µg/ml 
Chloramphenicol (Sigma).  
 1.9.3 The recombineering step: galK selection. 
Insertion of galK was performed as follows; to make electrocompetent cells, 
500ml of an overnight SW102 (E.coli) culture containing the BAC was 
diluted in 25 ml LB medium with 12.5µg/ml Chloramphenicol in a 50ml 
baffled conical flask and grown at 32oC in a shaking water-bath to an 
OD600 of 0.6. 10 ml was transferred to another baffled 50ml conical flask 
and heat-shocked at 42oC for exactly 15 minutes in a shaking water-bath 
for activation of the recombineering machinery. The remaining culture was 
left at 32oC as the uninduced control. After 15 minutes the two samples, 
induced and uninduced, were briefly cooled in an ice/water-bath slurry and 
then transferred to two pre-cooled, 15ml Falcon tubes (BD Biosciences) 
and pelleted by centrifugation at 5000rpm at 0oC for 5 minutes. The 
supernatant was poured off and the pellet was resuspended in 1 ml ice-cold 
dH2O by gently swirling the tubes in an ice/water-bath slurry. Subsequently, 
10ml ice-cold dH2O was added and the samples pelleted again. This step 
was repeated once more. After the second washing and centrifugation step, 
the supernatant was removed, and the pellet was resuspended in the 
residual dH2O (50µl). The cells were kept on ice until electroporated with 
the galK PCR product. 
The galK PCR product as generated using p21 and p22 to create a 
construct with the galK gene at the centre and two 75bp homology arms 
either end (see Section 1.7.4.1 for PCR details). After amplification of galK, 
2µl DpnI (NEB) was added to the 20 µl reaction and incubated at 37°C for 1 
hour. This step serves to remove any plasmid template. The DpnI digested 
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PCR product was extracted from an agarose gel and eluted in 50µl ddH20. 
30ng of the DNA was used for electroporation. 
An aliquot of 25µl of electrocompetent SW102 cells was used for each 
electroporation in a 0.1 cm cuvette (BioRad) at 25µF, 1.75 kV and 200Ω. 
After electroporation the bacteria were recovered in 1ml LB broth for 2 
hours in a 32oC shaking water-bath. After the recovery period, the bacteria 
were washed twice in 1xM9 salts as follows: 1 ml culture was pelleted in an 
eppendorf tube at 13,200 rpm for 15 seconds and the supernatant was 
removed with a pipette. The pellet was resuspended in 1 ml of 1x M9 salts 
(Sigma Aldrich) and pelleted again. This washing step was repeated once 
more. After the second wash, the supernatant was removed and the pellet 
was resuspended in 1 ml of 1x M9 salts before plating serial dilutions (100 
ml, 100 ml each of 1:10, 1:100 and 1:1000 dilutions) on M63 minimal agar 
(Table 18) with 20% galactose, 10mg/ml L-leucine, 0.2mg/ml d-Biotin and 
12.5µg/ml chloramphenicol. Washing in M9 salts is necessary to remove 
any rich media from the bacteria prior to selection on minimal medium. 
Plates were left at 30oC for 3 days to allow bacteria to grow on the minimal 
medium. Recombinant clones were analysed by restriction digest. 
Table 18 
1L M63 medium: 
10g (NH4)2SO4 
68g KH2PO4 
 2.5mg FeSO4-7H2O 
 Adjust to pH with KOH 
Autoclave and 
add 200ml to: 
Agar Base in 800ml dH2O (Autoclaved) 
 
Table 18 M63 minimal agar plate components. Components of M63 minimal 
agar used for recombineering are shown. All chemicals were purchased from 
Sigma Aldrich, agar base contains no sugars.  
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Once the recombinant DNA was isolated and sequenced; to confirm 
homologous recombination had taken place and the galK gene was 
inserted. It was then necessary to re-transform SW102 cells with the 
recombinant BAC clone in order to remove any DNA that may have been 
carried through. This was done before each subsequent recombineering 
step.  
1.9.4 The second recombineering step: galK counter selection. 
The galK(+) BAC was transformed into fresh SW102 cells as described 
above and 200ng of the double-stranded DNA oligo (see Section 1.7.4.2 of 
Methods) was electroporated into the electrocompetent cells as described 
for the first targeting step. For the counter selection step, the bacteria were 
recovered in 10ml LB in a 50ml baffled conical flask and incubated for 4.5 
hours in a 32oC shaking water-bath. The cells were pelleted and washed in 
1x M9 salts (Sigma Aldrich) as before and dilutions were plated onto M63 
minimal agar with 20% glycerol, 10mg/ml L-leucine, 0.2mg/ml d-Biotin, 
12.5µg/ml Chloramphenicol and 20% 2-deoxy-galactose. Transformants 
were analysed by restriction digest and sequenced.  
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Chapter 2 
Cell Biology. 
 
2.1 Flow Cytometry analysis. 
2.1.1 Isolation of thymocytes and surface staining for flow cytometry. 
Adult mouse thymuses were obtained by dissection and stored on ice in 
RPMI (Gibco, Invitrogen). The thymuses were transferred to eppendorf 
tubes containing 0.5ml 1x PBS (Gibco, Invitrogen) with 2% Heat inactivated 
Foetal Calf Serum (HI-FCS- Gibco, Invitrogen). The lobes were crushed 
with a pestle and strained using a 40μm cell strainer (BD Falcon) before 
adding 0.5ml 2% PBS for a total volume of 1ml and kept on ice. The cell 
suspension was counted using a haemocytometer and approximately 1x106 
cells were aliquoted for each single colour control. The samples were 
stained in 2% PBS at 1x106 cells in 100µl, in glass BD FACS tubes. 1µl of 
antibody was used to stain 1-2 X106 cells. Table 1 shows the details of the 
antibodies used in this project that have not been described elsewhere in 
the methods section. All antibodies used were anti-mouse and conjugated 
to fluorochromes (unless specified in the text). The samples were incubated 
on ice, in the dark for 30-45 minutes. After staining the cells were washed 
in 2mls 2% PBS and centrifuged in a bench-top centrifuge for 5 minutes at 
1100rpm. After centrifugation the medium was removed from tubes by 
aspiration, leaving approximately 400µl 2% PBS to resuspend the cells. 
The cells were resuspended by vortexing the tubes and were analysed for 
surface markers using the LSRII or the CANTOII Flow cytometers (BD).  
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Thymocytes were isolated from foetal thymic organ cultures (FTOCs) as 
previously described. The lobes had to be first removed from the filters and 
this was done by repetitive pipetting 2% PBS over the FTOC filters to 
dislodge the lobes. Because FTOCs produced very few cells 
(approximately 200,000) only 0.5µl of each antibody was used.   
Table 1 
Epitope Fluorchrome clone Supplier 
CD4 Pacific Blue GK 1.5 EBiosciences 
CD4 PE cy7 GK 1.5 EBiosciences 
CD4 FITC GK 1.5 EBiosciences 
CD8α FITC 53-6.7 EBiosciences 
CD8α APC cy7 53-6.7 EBiosciences 
CD8a Pacific Blue 53-6.7 EBiosciences 
CD8β FITC H35 17.2 BD Pharmingen 
CD3ε PEcy 7 145-2C11 BD Pharmingen 
CD3ε PE 145-2C11 Ebioscience 
CD5 PE 53-7.3 BD Pharmingen 
CD69 PE H1.2F3 EBiosciences 
CD127 PE SB14 BD Pharmingen 
CD25 APC PC61 EBiosciences 
CD44 Pacific Blue IM7 EBiosciences 
CD24 Pacific Blue M1/69 BioLegend 
TCRδ FITC GL3 EBiosciences 
TCRδ APC GL3 EBiosciences 
TCRδ PE GL3 EBiosciences 
TCRβ Percp cy5 H57-597 EBiosciences 
TCRβ FITC H57-597 BD Pharmingen 
Vα 2 PE B20.1 EBiosciences 
Vα 8 PE CTVA-8 EBiosciences 
Vα 11 PE RR8-1 BD Pharmingen 
Vβ 5 PE MR9-4 BD Pharmingen 
Vβ 6 FITC RR4-7 BD Pharmingen 
Vβ 8 FITC MR5-2 BD Pharmingen 
HNGFR PE C40-1547 BD Biosciences 
B220 FITC RA3-6B2 BD Pharmingen 
NK1.1 FITC PK1 36 EBiosciences 
DX5 FITC DX5 EBiosciences 
Foxp3 Pacific Blue FJK-16s EBiosciences 
 
Table 1 Antibodies used for this thesis. All antibodies used for the experiments 
in this thesis, that are not mentioned in the methods are shown in this table. All 
antibodies are anti-mouse and the clone and supplier are shown. APC is 
Allophycocyanin, FITC is Fluorescein isothiocyanate, PE is phycoerythrin, TCR is T 
cell receptor and HNGFR is human nerve-growth-factor receptor.  
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2.1.2 Depletion of CD4(+) and CD8(+) cells for isolation of DN 
thymocytes. 
Adult C57BL/6 mouse thymuses were obtained by dissection and 
resuspended in plain fresh RPMI (Gibco-Invitrogen). The thymuses were 
crushed with a pestle and strained using a 40μm cell strainer (BD Falcon) 
on a Petri dish or in an eppendorf tube. The cell suspension were made up 
to 7ml with RPMI, 500μl of hybridoma supernatant was added (a mix of 
anti-CD4 and anti-CD8 antibodies IgM isotype for complement lysis.) The 
cell suspensions were incubated at 37°C for 10min. 1ml of resuspended 
complement (Cedar lane Laboratories) was added and mixed by inversion. 
Cell suspensions were then incubated with complement at 37°C for 30 min. 
To separate live thymocytes, including DN cells, from dead complement-
lysed thymocytes that were CD4(+) and/or CD8(+), 4mls lymphocyte 
separation medium (MP Biomedical) was layered underneath each cell 
suspension. Tubes were centrifuged for 20 minutes at 1,600 rpm at room 
temperature (22°C) in a bench-top centrifuge with no brake. Live 
thymocytes were removed from the Ficoll interface by pipetting the 
interface out using a glass pasteur pipette and transferred to a FACS tube. 
Lysed dead cells, i.e. cells that expressed CD4 and/or CD8, form a pellet at 
the bottom of the tube. The cells were washed with 2% PBS before staining 
for sorting. The Aria-II Cell Sorter (BD) was used to sort the thymocytes.  
2.1.3 Intracellular staining. 
For all thymocyte intracellular staining the Ebioscience anti-mouse FOXP3 
staining kit was used, with exception to the phospho-ERK staining which is 
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described in the next section. Prior to staining the Fixation/Permeabilization 
Concentrate was diluted (1 part) into the Fixation/Permeabilization Diluent 
(3 parts) and kept on ice. The 10x Permeabilization buffer was diluted 1/10 
with dH2O and kept on ice.  
1x106 cells were stained with surface antibodies as described in the 
previous sections. After staining the cells were washed in 2% PBS. The 
cells were centrifuged (5 minutes at 1100rpm) and the pellet was 
resuspended in 1ml Fixation/Permeabilization working solution and 
vortexed. The samples were then incubated on ice for 1 hour in the dark. 
The samples were then washed twice with 2ml 1x Permeabilization buffer, 
followed by centrifugation and removal of the buffer by aspiration. 1μl Fc- 
Block (Purified anti-mouse CD16/32 clone 93, Ebiosciences) was used to 
stain the samples in 100µl 1X Permeabilization buffer on ice, in the dark, for 
15 minutes. 1µl of the anti-mouse antibody for intracellular staining was 
then added to the cells and the samples were incubated for a further 30 
minutes on ice in the dark. The samples were then washed twice with 2ml 
1x Permeabilization buffer, followed by centrifugation and removal of the 
buffer by aspiration and resuspended in 400µl 2% PBS for analysis on the 
cytometer.  
2.1.4 Assay for intracellular phosphorylated-ERK. 
To assay for intracellular phosphorylated-ERK1/2 MAP kinase, thymocytes 
were isolated as described in previous sections and diluted to 4x106 cells/ml 
in 2.5ml RPMI without L-glutamine (Invitrogen) and with 10% FCS 
(Invitrogen) in 50ml falcon tubes (VWR). 23µl of 10 µg/ml anti-CD3ε (2C11, 
a gift from Patrick Costello, CRUK (Costello et al., 2004)) was added, and 
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the cells were incubated on ice for 15 minutes. The cells were then washed 
in 10mls RPMI 10% FCS and pelleted by centrifugation at 1100 RPM for 5 
minutes in a bench-top centrifuge. The cells were resuspended in 2.5ml 
RPMI 10% FCS and rested for 10 minutes in a 37oC water-bath. While the 
cells were resting, 0.5ml 8% Formaldehyde solution (37-41% from Fisher 
Scientific, diluted in 1xPBS from Invitrogen) was aliquoted into each of the 
sample tubes. After 10 minutes 0.5ml of the cells was removed and 
transferred to a FACS tube containing 0.5ml 8% Formaldehyde. This 
sample is the zero time point. 125µl (75μg/ml) of the cross-linking anti-
Armenian hamster IgG antibody (Jackson Immunoresearch Labs) was 
added to the remaining 2.0ml cells in water-bath, the tube was swirled to 
mix the timer was started. 0.5ml aliquots of activated cells was removed at 
1, 1.5, 2, 5 and 10 minute time points and transferred to separate tubes 
containing 0.5ml 8% Formaldehyde for fixing. The cells were then fixed for 
10 minutes at room temperature and pelleted by centrifugation. All fixative 
was removed and the cells were kept on ice. 1ml 100% ice cold methanol 
(Sigma- stored in -20oC freezer since the morning) was added to the fixed 
cells drop-wise while vortexing. The samples were incubated on ice for 30 
minutes to 2 hours. The cells were then washed three times with 10% PBS 
and resuspended in 100µl 10% PBS before adding 1µl anti-Phospho-ERK 
antibody (NEB/Cell Signalling - stored at -20oC). The cells were stained at 
room temperature for 1hour in the dark. The samples were washed with 2% 
PBS before staining with conjugated antibodies such as those for CD4 and 
CD8 as well as the secondary for the phospho-ERK, the anti-rabbit cy5 
(Jackson Laboratories) for 30 minutes on ice in the dark. After staining the 
cells were washed again and resuspended in 2% PBS for analysis on the 
cytometer.  
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2.1.5 Staining with thymic leukaemia antigen (TL) tetramer. 
The mouse thymic leukaemia antigen (TL) is a non-classical MHC-I 
molecule that binds the CD8αα homodimer with high affinity (Attinger et al., 
2005) . Biotinylated-TL monomers were kindly provided by Dr Hilde 
Cheroutre La Jolla Institute for Allergy and Immunology.  The TL monomers 
were conjugated by addition streptavidin PE (Molecular Probes) and 
incubation in the dark for 15 minutes on ice. E16 and E17 thymocytes were 
obtained from embryos from C57BL/6 timed pregnancies. The thymocytes 
were stained in 100µl 2% PBS with 1µl Fc Block (Purified anti-mouse 
CD16/32 clone 93, Ebiosciences) on ice for 20 minutes. Subsequently the 
conjugated antibodies for surface staining were added (CD4 Pacific Blue 
and CD8α FITC see Table 1) and the cells incubated on ice for 30 minutes 
in the dark. The cells were washed in 2ml 2% PBS and centrifuged and the 
pellet was resuspended in 100µl 2%PBS. 1.5µl of conjugated TL tetramer 
was added to the cells and the samples were incubated for 30 minutes at 
room temperature in the dark. The samples were washed twice with 2% 
PBS before flow cytometry.  
2.1.6 Cell cycle analysis: 7-AAD staining. 
For analysis of DNA content thymocytes were stained first for surface 
markers as described above then washed in 2% PBS before resuspending 
in 2% PBS with 0.3% Saponin. The cells were stained with 7-amino-
antinomycin-D (7AAD) solution (Ebioscience) at 0.25μg (5μl)/1 million cells 
in 0.3% saponin at room temperature for 20 minutes. The cells were then 
washed in 2mls 2% PBS and analysed by flow cytometry (7-AAD emission 
is at 650nm).    
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2.2 Cell culture: the Phoenix Ecotropic Packaging Cell line. 
Phoenix Ecotropic (phoenix) cells were kindly provided by the Nolan 
Laboratory (www.stanford.edu/group/nolan/). The cells were cultured in 
phoenix media: DMEM with Glutamax (Invitrogen), 10% HI FCS (Gibco- 
Invitrogen) with 1% Penicillin/Streptomycin (Invitrogen) at 37°C and 5% 
CO2. For maximally healthy cells, cultures were split when cells reached 
70-80% confluency. Cells were frozen in 10% DMSO (Sigma), and aliquots 
kept in liquid nitrogen storage.  
2.3 Transfection of phoenix cells. 
18-24h prior to transfections approx 1x106 phoenix cells were plated per 
6cm culture dish in 7ml of culture media, for 60% confluency at the time of 
transfection. 2μg of plasmid DNA was used for transfection. Fugene-6 
reagent (Roche) was used for transfections. A DNA-Fugene complex was 
prepared with a 3:1 ratio (μl Fugene: μg DNA) in DMEM with a total volume 
of 200µl. The 200µl transfection complex was added drop wise to cells and 
left to incubate for 48 hrs at 37oC and 5% CO2. 
Two days after transfection, Cells were removed from 6cm2 plates 
containing Fugene and plated in T175 flasks (BD-Falcon) in 5ml phoenix 
media with 2μg/ml of Puromycin (Sigma). Puromycin selection allows for 
stable transfection of the packaging cell line. Cells were cultured at 37°C, 
5%CO2 until they reached 70-80% confluency, then split or harvested the 
retroviral supernatants. Cells were visualised under the UV microscope to 
see green fluorescent protein (GFP) expression from the transfected pLZ 
vectors.  
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2.4 Harvesting Retroviruses. 
Removal of growth medium containing puromycin, from cells was 
necessary for harvesting retroviral supernantants. 25 ml of filtered-sterilized 
DMEM with 20% FCS was added to the cells. This media did not contain 
antibiotics. Cells were incubated overnight at 32°C. 
 The media on the cells or the supernatant contains the viral particles 
produced by the cell line.  This retroviral supernatant was collected the 
following day and kept on ice. The supernatants were centrifuged for 3 
minutes at 1,000 rpm using a bench top centrifuge to remove any cells; and 
then filtered using a 0.45 μm filter (Millipore). 1ml of the filtered supernatant 
was aliquoted into 1.5ml eppendorf tubes. The retroviruses were 
concentrated by centrifuging the 1ml aliquots at 18,000rpm (13,000g) in a 
table-top micro centrifuge for 45 minutes at 4°C. The surface liquid was 
discarded and 100µl of the retroviral “pellet” from 8 aliquots were pooled 
into one. Concentrated sups were snap frozen in liquid nitrogen and stored 
at -80oC until used for transduction. 
2.5 Retroviral transduction of E14 thymocytes. 
Immature E14 thymocytes were transduced with retroviruses in the 
presence of a surface-bound transduction enhancer Retronectin (RN-
Takara Bio Inc). 3.5cm2 tissue culture dishes were coated with 12 μg/ml of 
RN in 1 ml PBS (Invitrogen). Dishes were incubated at room temperature 
for 2 hours then blocked with 2% BSA (Sigma) for half an hour before 
washing twice with 1xPBS.  
E14 embryos were dissected using Dumont forceps and a dissection 
microscope; their thymic lobes extracted. The lobes were crushed in an 
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eppendorf containing 250µl FTOC media (RPMI + 10% FCS + 1% 
Pen/strep, 2mM L-glutamine and 50µM 2-mercaptoethanol - all from Gibco, 
Invitrogen) using a conical tissue homogenizer and strained to make a 
single cell suspension. The E14 thymocytes were counted and made up to 
1ml in FTOC media. Each 1ml aliquot of cells was then added to 1ml of 
thawed, concentrated retroviral supernatant in a FACS tube and mixed by 
gentle repetitive pipetting. The retrovirus/ thymocyte mixture was added to 
RN coated plates and incubated at 37°C for 5 hours for transduction to take 
place. 
2.6 Foetal thymic organ culture (FTOC).  
C57BL/6 E15 embryos were dissected using Dumont forceps under a 
dissecting microscope and their thymic lobes extracted for organ culture. 
Lobes were cultured on nucleopore membrane filters (Whatman) in 3ml 
FTOC media (RPMI + 10% FCS + 1% Pen/strep, 2mM L-glutamine and 
50µM 2-mercaptoethanol (all from Gibco, Invitrogen)) in 6 well plates.  
For depletion of lymphocytes from FTOCs the lobes were cultured on 
FTOC medium containing 1.35mM 2-deoxy-guanosine (Sigma) for 5 days. 
After 5 days the lobes were moved to fresh FTOC media without 2-
deoxyguanosine, to rest for 24 hours before reconstitution with E14 
thymocytes. 
2.7 Reconstitution of Depleted thymic lobes by hanging drop culture. 
Following the 5 hour transduction of E14 thymocytes, the cells were 
removed from the retronectin coated plates by repetitive pipetting. 1ml of 
cell suspension was pelleted by centrifugation at 2500rpm for 2 minutes in 
1.5ml eppendorf tubes. The supernatant was removed and the second 1ml 
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of cell suspension was added to the pellet and centrifuged again. The 
retronectin plates were then washed with 1ml FTOC media to ensure that 
all the cells had been collected. The pelleted cells were resuspended in the 
appropriate volume of FTOC media considering that 25µl of cell suspension 
was used for each hanging drop culture. The cell suspension was carefully 
pipetted into the wells of a 96 well Terasaki plate (Nunc, VWR).  
Depleted lobes were removed from filters and added to wells containing 
25μl of FTOC media with the transduced thymocytes. The plates were 
turned upside down with care to ensure all the lobes drift to the bottom of 
each droplet. Hanging drop cultures were incubated at 37°C for 48 hours 
until the lobes were reconstituted. After the 48 hour incubation the 
reconstituted FTOC lobes were transferred onto nucleopore membrane 
filters on 3ml of FTOC media in a 6 well plate. The FTOCs were cultured for 
5-15 days.  
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Mice. 
 
C57BL/6 and DBA/2 mice were obtained from Harlan Laboratories. pTα-/- 
(Fehling et al., 1995a), TCRδ-/- (Itohara et al., 1993), were obtained from 
Jackson Laboratories. pTα-/- x TCRδ-/- mice were obtained by breeding. 
Embryos were obtained by setting up of timed pregnancies. “pTαa-only” and 
“pTαb-only” transgenic CD1 founders were generated within the Transgenic 
Core Facility at Queen Mary University of London. Mice were bred and 
maintained in the specific pathogen–free animal facilities at Queen Mary 
University of London. All experiments involving animals were done in 
compliance with relevant laws and institutional guidelines, and were 
approved by a local ethics committee. 
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Chapter 1 
Expression of pTαa and pTαb during thymic ontogeny. 
 
1.1 Introduction.  
Despite pTαa and pTαb being conserved throughout evolution from mice to 
humans (Fehling et al., 1995b), and the knowledge that both these isoforms 
can form functional preTCRs (Gibbons et al., 2001), little is known about 
the function of pTαb and whether it differs to that of pTαa. Thus to begin to 
determine whether the two isoforms of pTα have non-redundant roles in 
development, it was first necessary to ascertain the precise expression 
pattern of pTαa and pTαb throughout thymic ontogeny. Differential 
expression of the two isoforms would suggest different functions for the two 
proteins while overlapping expression may be indicative of more redundant 
functions for pTαa and pTαb. To date, it is not known how the expression of 
pTαa and pTαb is regulated through development. To this end, we sought to 
determine expression patterns of pTαa and pTαb in thymocytes from 
different stages of development. 
Developing thymocytes were isolated by Fluorescence activated cell sorting 
(FACS). Figure 1.1 shows the markers used to isolate the different 
thymocyte populations; early thymic progenitors are double negative for 
CD4 and CD8 and are known as DNs. DNs are subdivided on expression 
of CD44 and CD25; DN2 cells are CD4(-)CD8(-)CD44(+)CD25(+), DN3 cells 
are CD4(-)CD8(-)CD44(-)CD25(+), and DN4 cells are CD4(-)CD8(-)CD44(-
)CD25(-). Immature single positive (ISP) thymocytes in transition to the 
double positive (DP) stage are marked by expression of CD8 and low levels 
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of TCRβ. DP cells are CD4(+)CD8(+), and mature thymocytes express high 
levels of TCRβ. There are several different lineages of mature T cells that 
develop in the thymus; CD8(+) cytotoxic T cells, CD4(+) T helper cells and 
CD4(+)FOXP3(+) regulatory T cells, as well as NKT cells which express NK 
markers such as NK1.1 and DX5.  
Figure 1.1 
 
 
 
 
 
 
 
 
 
Figure 1.1: Identification of different subsets of thymocytes by their surface 
marker expression. A schematic of thymic ontogeny; DN is double negative; DP 
is double positive; TP is triple positive; T regs are regulatory T cells, NKT is natural 
killer T cells and IEL is intraepithelial lymphocyte. CD8αα was detected with a TL 
tetramer. 
 
CD8αα(+) intraepithelial lymphocytes of the gut are not found in the thymus 
but are shown here because a putative thymic precursor of these cells was 
identified within the DP population (Gangadharan et al., 2006). These 
unconventional T cell precursors express CD4 and both the heterodimeric 
form of CD8; CD8αβ, and the homodimer CD8αα. These cells are known as 
“triple positives” or TPs. γδ T were identified using a TCRδ antibody.   
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1.2 Semi-quantitative PCR for pTαa and pTαb expression. 
Thymocyte populations were obtained from C57BL/6 adult thymus by 
FACS (Figure 1.2). Live thymocytes are first characterised by using forward 
scatter (FSC) and side scatter (SSC) which measure the size and 
granularity of the cells, respectively. For the DN sort, markers for unwanted 
subsets such as B cells (B220), NK/NKT cells (NK1.1 and DX5) and γδ T 
cells (δTCR) as well as CD4 and CD8 were used to gate out these cells 
from the sort.  The different DN subsets were then selected according to 
CD25 and CD44 expression, as described previously. DPs, CD4SPs, 
CD8SPs and ISPs were selected on expression of CD4 and CD8.The 
isolated populations were lysed in Trizol, RNA was extracted and cDNA 
synthesis was performed.  
Figure 1.2 
 
 
 
 
 
 
 
 
 
Figure 1.2: Fluorescence activated cell sort to obtain different thymocyte 
subsets. FACS profiles of adult C57/Bl6 thymocytes. CD4
+
CD8
+
 thymocytes were 
depleted using complement for the DN sort. FSC is forward scatter a measure of 
cell size; SSC is side scatter a measure of cell granularity. DN is double negative; 
DP is double positive; ISP is immature single positive, SP is single positive. Cells 
were sorted with 95-98% purity. Depleted sort refers to cells that were subjected to 
complement lysis to remove CD4
(+)
 and CD8
(+)
 cells.  
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cDNA levels were normalised using PCR for β-actin. In order to distinguish 
pTαa and pTαb transcripts, PCRs for pTαa were performed using a forward 
primer homologous to 25bp of exon-2 and a reverse primer that recognises 
25bp within exon-4 of pTα (Figure 1.3A). pTαb transcripts do not possess 
exon-2 and therefore only pTαa transcripts were amplified with these 
primers. To amplify pTαb transcripts, a forward primer was used that 
recognised 16bp of the 3’ end of exon-1 and 6bp of the 5’ end of exon-3, 
and therefore was homologous to the exon-1-3 join that is exclusive to pTαb 
transcripts. Using these primers, transcripts for both isoforms were 
detected in DN2 thymocytes and at high levels within the DN3 and DN4 
populations undergoing β-selection (Figure 1.3B). 
Figure 1.3 
 
 
 
 
 
 
Figure 1.3 pTα
a 
and pTα
b 
are differentially expressed throughout thymic 
ontogeny: (A) pTα
a 
and pTα
b
 transcripts with primers specific for pTα
a 
and pTα
b
 
indicated. (B) Semi-quantitative PCR of thymocyte subsets for pTα
a 
and pTα
b
: 
cDNA samples extracted from C57BL/6 adult DN2, DN3, DN4, ISP, DP and 4SP 
subsets were normalised by PCR for β-actin.  
  
Signalling through TCRαβ has been described to regulate expression of the 
pTα gene (Bruno et al., 1995). Thus we would not expect DP cells and 
mature cells which possess the αβTCR to express pTαa and pTαb. However, 
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the DP population expressed low levels of both transcripts. pTαa expression 
appears to be extinguished at this stage but not that of pTαb (Figure 1.3B). 
pTαb expression continued into mature stages of T cell development (i.e. 
CD4SPs). pTαa transcripts were not detected in these cells at this level of 
sensitivity (Figure 1.3B). These data show that expression of pTαa and pTαb 
are differentially regulated during thymic ontogeny, and suggest a non-
redundant role for the two isoforms in T cell development.  
1.3 Semi-quantitative PCR for pTαa and pTαb expression in TPs from 
embryonic day-16-17 C57BL/6 mice. 
Low level expression of pTαb but not pTαa in DP thymocytes (at least at this 
level of detection) may be due to a small population of DPs retaining 
expression of this isoform within the larger DP population. TP cells, that 
have been proposed to be the thymic precursors to the CD8αα(+) gut IEL 
populations express the CD8αα homodimer as well as CD8αβ and CD4 on 
their surface (Gangadharan et al., 2006). TPs can be identified using TL 
tetramers which bind CD8αα homodimers with high affinity (Attinger et al., 
2005). The TP subset was reported to represent 7-10% of DPs in the adult 
thymus but are enriched to 60% of DP cells at embryonic day-16-17 
(Gangadharan et al., 2006). TL(+) and TL(-) DP thymocytes from E16 and 
E17 C57BL/6 thymuses were isolated as shown in Figure 1.4. pTαa and 
pTαb expression were then determined by semi-quantitative PCR. 
Similar levels of both pTαa and pTαb were expressed in TL(+) and TL(-) DP 
cells from both E16 and E17 thymuses (Figure 1.5). Curiously, embryonic 
DP thymocytes (whether CD8αα(+) or not) express pTαa and pTαb at similar 
levels, whereas adult DPs did not (levels of pTαa were lower than pTαb)  
(Figure 1.3). This result suggests that differential expression and use of 
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pTαa or pTαb is not responsible for the generation of TP cells, and thus is 
unlikely to underlie the mechanism involved in IEL development.  
Figure 1.4 
 
 
 
Figure 1.4: Isolation of TP cells by FACS: C57BL/6 E17 thymocytes were 
stained with the Thymic leukaemia antigen (TL) tetramer for isolation of 
CD4
(+)
CD8αβ
(+)
 CD8αα
(+) 
cells (that are postulated to be gut IEL progenitors). Cells 
were sorted to 98% purity.  
 
Figure 1.5 
 
 
 
Figure 1.5 E16 and E17 TPs express both pTα
a 
and pTα
b
: TL
(-)
 and TL
(+)
 DPs 
were isolated from day 16 and 17 C57BL/6 embryos. Semi-quantitative PCR for 
pTα
a 
and pTα
b
 was performed on the cDNA extracted from sorted cells. cDNA 
levels were normalised by β-actin PCR. TL
(-)
 and TL
(+)
 DPs express similar levels of 
both pTα
a 
and pTα
b
. 
 
1.4 Single cell multiplex PCR analysis of C57BL/6 adult DN3 and DN4 
thymocytes.  
Differential regulation of expression of pTαa and pTαb at the population level 
throughout thymocyte development may be a reflection of differential 
expression of the two isoforms in individual cells within a given population. 
Indeed, this scenario would perhaps be indicative of different roles for the 
two isoforms in T cell development. In order to determine whether individual 
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cells differentially expressed either pTαa or pTαb it was necessary to 
optimise a single cell quantitative PCR (SCPCR) assay (Figure 1.6).  
Figure 1.6 
 
 
 
 
 
 
 
Figure 1.6 Schematic of Single cell Multiplex PCR: RNA is reverse transcribed 
using specific reverse (Rev) primers. The first PCR reaction uses multiple primer 
pairs to amplify 3 different genes. These PCR products are then amplified a 
second time, but this time separately using nested primer sets.   
 
For SCPCR analysis, DN3 and DN4 single cells were sorted by FACS into 
strips of PCR tubes containing 5µl of PBS. After reverse transcription using 
specific reverse primers for pTαa, pTαb and a house-keeping gene EF1A, 
the cDNA was amplified a first time by multiplex PCR in the same reaction 
(Figure 1.6). These PCR products were then amplified a second time 
separately for EF1A, pTαa and pTαb in 3 different reactions. The 2nd PCR 
reactions are semi-nested in which the forward primer lies within the 
sequence amplified by the first set of PCR primers (Figure 1.6). To be able 
to compare PCRs for EF1A, pTαa and pTαb from the same cell it was 
essential that the primers amplified the genes efficiently. This was 
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assessed by quantitative PCR in the second round. Primer efficiencies for 
each primer pair were 2 +/- 0.2 (i.e. a doubling of product in each round of 
PCR) (Figure 1.7). This is sufficient to perform multiplex PCR.  
Figure 1.7 
 
 
 
Figure 1.7 SCPCR Primer efficiencies: Primers for the RT, multiplex and 2
nd
 PCR 
reactions were tested by real-time PCR for efficiency of product amplification. Each 
primer pair had an efficiency of approximately 100% (2 fold increase in product per 
cycle). Graph represents three experiments, in which DN4 cDNA was used as the 
template.  
 
The next stage in optimization was to ensure there was no competition 
between primer sets used in the first PCR (multiplex). Primer competition 
leads to inefficient amplification of the target sequence and would produce 
misleading PCR results. To compare competition between primer sets Ct 
values were compared for the different PCR reactions in triplicate, using 
DN4 thymocyte cDNA as a template. No difference was seen between Ct 
values from reactions in which the first round was performed as a multiplex, 
to reactions in which the first round was performed with just a single primer 
set (Figure 1.8). This therefore established that these primers were fit for 
use in the comparative SCPCR analysis. 
Single cell PCR of eight WT DN4 cells were carried out for EF1A, pTαa and 
pTαb (Figure 1.9). EF1A transcripts were detected in six of the eight cells 
suggesting that only wells 1-6 contained a DN4 cell. Only one of these six 
cells appeared positive for pTαa transcripts (cell number 3) and none of the 
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cells appeared to express pTαb. PCRs for these genes was carried out on a 
further two strips of DN4 cells and on a strip of DN3 cells. However, on 
average only 1/8 cells tested positive for pTαa transcripts and only 1/24 
were positive for pTαb (data not shown). Because it was not possible to 
determine whether the lack of pTα transcripts in the single cell PCR was 
due to lack of expression of pTα transcripts, or limited sensitivity of the 
protocol it was necessary to determine the sensitivity of the assay. This 
was done by performing the SCPCR protocol on a series of titrated 
samples from one hundred DN4 cells down to one cell. These PCRs 
showed that despite detecting EF1A transcripts in all the samples from one 
hundred cells down to one cell, it was only possible to detect pTαa 
transcripts in fifty cells or more, and only possible to detect pTαb in twenty 
cells or more (Figure 1.10). Thus, the sensitivity of the assay was poor and 
this could explain why very few DN4 cells appeared to express either pTαa 
or pTαb. It was therefore necessary to design and optimise new primer sets 
for pTαa and pTαb for use in this assay. New forward primers for the 1st and 
2nd pTαa PCR reaction and a new reverse primer for use at all stages of pTα 
amplification, were designed. 
Figure 1.8 
 
 
 
 
 
Figure 1.8 No competition between SCPCR primer sets: Similar Ct values are 
observed for 2
nd
 round PCR on pTαa, pTαb and EF1A, when the template used 
was from either a multiplex 1
st
 round PCR reaction (MTPX) or from a 1
st
 round 
PCR that used just a single primer set (SPX). Reactions were performed in 
triplicate on cDNA from DN4 cells. 
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Figure 1.9: SCPCR analysis of 8 DN4 cells: 500 DN4 cells were used for the 
positive control and PBS was used for the negative control. Adult C57BL/6 DN4 
thymocytes were used in this analysis.  
 
Figure 1.10 
 
 
 
 
Figure 1.10: Limited sensitivity of pTα
a 
and pTα
b 
SCPCR: Unlike EF1A, 
transcripts for pTα
a 
and pTα
b
 were not detected in fewer than 20 cells. PBS was 
used for the negative control. .  
 
Figure 1.11 
 
 
 
 
Figure 1.11: Improved sensitivity of pTα
a 
and pTα
b
 SCPCR: New PCR primers 
allowed greater detection of pTα
a 
and pTα
b
 transcripts in DN4 cells.   
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These primers were initially tested for sensitivity, before subsequent 
efficiency and competition analysis. Figure 1.11 shows EF1A, pTαa and 
pTαb SCPCRs for DN4 cell titration from one hundred cells down to three 
cells. The sensitivity of the pTαa PCR was vastly improved with pTαa 
transcripts being amplified from as few as three DN4 cells. pTαb PCR 
sensitivity was also improved but pTαb transcripts could not be detected in 
fewer than five DN4 cells. The optimisation of these new primer sets was 
only achieved right at the very end of the experimental work that constitutes 
this thesis. Thus, whether individual DN cells differentially express pTαa and 
pTαb remains unresolved, but is a focus of ongoing work in the lab. 
Furthermore, the lessons learned from optimization of SCPCR has 
provided an important tool that is currently being utilised by other lab 
members.    
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Chapter 2 
pTαa and pTαb expression in FTOC 
 
2.1 Introduction. 
To assess the differential effects of pTαa and pTαb in T cell development the 
two proteins were expressed in isolation in pTα KO DN thymocytes in foetal 
thymic organ culture (FTOC). FTOC is a culture system in vitro that 
supports T cell development that largely resembles that seen in vivo 
(Jenkinson et al., 1992; Mandel and Kennedy, 1978; Owen and Ritter, 
1969). The system is easy to manipulate by addition of antibodies or 
chemicals/drugs to the culture medium. It is also possible to use a retroviral 
delivery system to express various genes in thymocyte progenitors before 
culture. This culture system allows the two isoforms of pTα to be expressed 
alone in pTα-deficient thymocytes. The developmental consequences of 
this expression is then followed for up to 15 days.  
Semi-quantitative PCR had revealed that pTαa and pTαb had different 
expression patterns throughout development, suggesting that the two 
isoforms of pTα may be regulated differently during T cell development. 
Thus, we sought to determine whether expression of pTαa alone or pTαb 
alone had different effects in developing thymocytes. To do this, retroviral 
constructs were generated that permitted delivery of pTαa or pTαb (Figure 
2.1). The vector used was pLZRS (pLZ) (Heemskerk et al., 1997). This 
contained two long terminal repeats (LTRs) between which the cloned pTα 
cDNA was placed. The LTRs allow for integration of the construct into 
cellular DNA but also serve as promoter elements for transcription of the 
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cloned gene. An enhanced green fluorescent protein (GFP) gene is 
present, preceded by an internal ribosomal entry site (IRES). This IRES lies 
downstream of the cloned gene, which allows for translation of GFP as well 
as pTα. This feature permits detection of transduced cells.  
Figure 2.1 
 
 
 
 
 
 
 
Figure 2.1 pTα
a 
and pTα
b
 retroviral constructs: A schematic of the pTα
a 
and 
pTα
b 
cDNAs that were cloned into the multiple cloning site (MCS) of the pLZ 
retroviral vector. pTα
a 
is the full length isoform of pTα and consists of four exons. 
The second isoform of pTα, pTα
b 
lacks exon-2 that codes for the extracellular Ig- 
loop of the protein. LTR, long terminal repeat; IRES, internal ribosomal entry site; 
GFP, green fluorescent protein and ψ denotes the retroviral packaging signal.  
 
Figure 2.2 illustrates the experimental method used in these investigations. 
The pLZ plasmids containing the pTα cDNAs were transfected into the 
Phoenix ecotropic packaging cell line (www.stanford.edu/group/nolan/). 
Phoenix cells are stably transfected with plasmids carrying retroviral genes 
env, gag and pol for the generation of virus particles. The pLZ plasmid 
possesses a packaging signal (ψ) that allows full length (i.e. between the 
two LTRs) pLZ transcripts to be incorporated into the virions. Retroviruses 
carrying the pTα cDNAs were collected from the supernatant of the phoenix 
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cells and used to transduce E14 pTα KO thymocytes for 5-15-day culture in 
FTOC and subsequent analysis by flow cytometry. 
Figure 2.2 
 
 
 
 
 
 
 
 
Figure 2.2: A schematic of the experimental method used for cloning pTα 
cDNAs into pLZ retroviral vectors and retroviral transduction of pTα KO E14s 
in FTOC. pTα
a 
and pTα
b 
were amplified by PCR from DN4 cDNA. The PCR 
products were cloned into pLZ via the pBlunt cloning plasmid. pLZ plasmids 
containing the pTα cDNAs were transfected into the phoenix ecotropic packaging 
cell line. The pTα constructs were packaged into retroviral particles which were 
used to transduce pTα-deficient E14 thymocytes. Transduced thymocytes were 
seeded into empty E15 thymic lobes and cultured in FTOC for 5-15-days before 
subsequent analysis by flow cytometry.  
 
2.2 Generating pTαa and pTαb retroviral constructs. 
Forward and reverse primers homologous to the first 25bp of exon-1 and a 
region, 238bp downstream of the stop codon in exon-4, respectively, were 
used to amplify pTαa and pTαb in a single PCR reaction from adult C57BL/6 
DN4 thymocytes (Figure 2.3). pTαa is the longer of the two isoforms at 
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956bp in length, while pTαb lacks exon-2 (320bp) and is therefore 636bp in 
length (Figure 2.3).  
Figure 2.3 
 
 
 
 
 
 
Figure 2.3 PCRs used to sub-clone pTα
a 
and pTα
b
: (A) schematic displaying the 
4 exons of pTα with the primers used to amplify pTα
a 
and pTα
b
. (B) Agarose gel 
showing bands corresponding to pTα
a 
(p65bp) and pTα
b
 (636bp). DN4 cDNA from 
adult C57BL/6 mice was used as a template. 
 
Figure 2.4 
 
 
 
 
 
Figure 2.4: pBlunt-pTα
a 
and pBlunt-pTα
b
: Restriction digest analysis of pBlunt-
pTα
a
 (A) and pBlunt-pTα
b 
(B) cut with BamH1/Xho1 to release pTα cDNAs. The 
digested pBlunt backbone is approximately 3.5kb. 
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PCR products corresponding to pTαa and pTαb were isolated from an 
agarose gel and ligated into the pBlunt cloning plasmid. Figure 2.4 shows a 
BamH1/Xho1 digestion for pBlunt-pTαa and pBlunt-pTαb. The BamH1 site 
lies 39bp upstream of the insert, while the Xho1 site lies 37bp downstream 
of the insert. Digestion with these enzymes releases the pTα cDNAs; pTαa 
is 1041bp and pTαb is 721bp long. The pTαa and pTαb cDNAs were then 
sub-cloned into the retroviral pLZ plasmid. pLZ-pTαa and pLZ-pTαb were 
once again analysed by BamH1 and Xho1 restriction digest, the pTαa 
plasmid generating a band of 1041bp in length, while the pTαb plasmid 
giving a band of 721bp (Figure 2.5). 
Figure 2.5 
 
 
 
 
 
 
Figure 2.5 pLZ-pTα
a 
and pLZ-pTα
b
: Restriction digest analysis of (A) pLZ-pTα
a 
and (B) pLZ-pTα
b
 with BamH1/Xho1 to release the pTα
a 
and pTα
b 
cDNAs. The 
backbone of the pLZ plasmid is approximately 12.4kb.  
 
The plasmids pLZ-pTαa, pLZ-pTαb and pLZ alone, were then transfected 
into the phoenix ecotropic packaging cell line and transfection was 
confirmed by the presence of GFP detected under a UV microscope 
(Figure 2.6).  
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Figure 2.6 
 
 
 
 
 
 
Figure 2.6 Analysis of transfected phoenix cells. Photograph of (A) non-
transfected, or (B) transfected (with pLZ) phoenix cells, viewed under a UV light, 
24hrs after transfection.  
 
Retrovirus harvested from phoenix cells, transfected with pLZ, pLZ-pTαa 
and pLZ-pTαb were then used to transduce pTα KO E14 thymocytes. The 
transduced cells were seeded into empty C57BL/6 E15 thymic lobes that 
had been treated with 2-deoxyguanosine for 5 days to remove endogenous 
thymocytes. The re-seeded lobes were cultured for 5-15 days to allow for 
development and maturation of the transduced precursor T cells. 
Transduced thymocytes could, by GFP expression be detected by flow 
cytometry. FACS profiles of GFP expression for pLZ, pLZ-pTαa and pLZ-
pTαb after 11 days in FTOC demonstrate that transduction efficiency was 
high for each of the constructs (Figure 2.7). Generally, transduction 
efficiencies were between 25% and 75% for all retrovirus used. GFP 
positive cells were further analysed to determine the effects of expression 
of pTαa and pTαb on developing thymocytes. 
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Figure 2.7 Good transduction efficiency for pLZ, pLZ-pTα
a 
and pLZ-pTα
b
. GFP 
expression as a read-out of transduction efficiency for pTα KO E14 thymocytes 
transduced with retroviruses generated from the pLZ, pLZ-pTα
a 
and pLZ-pTα
b 
retroviral vectors. Percentages are out of cells in the live gate.  
 
2.3 Both pTαa and pTαb form signal competent preTCRs able to rescue 
αβ T cell development in a pTα KO background. 
2.3.1 pTαa and pTαb form preTCRs on the surface of transduced 
thymocytes 
Cell surface expression of TCRβ is low on most DN cells from pTα-deficient 
mice as a preTCR cannot form.  preTCR surface levels can be estimated 
by the analysis of mean fluorescence intensity (MFI) of TCRβ staining. The 
MFI for TCRβ in E14 pTα KO thymocytes transduced with pLZ vector was 
~250 units after 8-11 days in FTOC (Figure 2.8). Note that TCRβ(hi) cells 
were excluded from this analysis, as these cells would likely express 
TCRαβ. By contrast, pTα-deficient cells transduced with either pTαa or pTαb, 
showed increased surface expression of TCRβ.  On average MFI for TCRβ 
was ~550 units in the presence of pTαa and ~800 units in the presence of 
pTαb (Figure 2.8). These data are consistent with a preTCR being formed 
with both pTα isoforms. Thus expression of pTαa and pTαb in pTα KO 
thymocytes restores surface expression of a preTCR. Importantly, surface 
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TCRβ expression is significantly higher with pTαb (MFI of 816 units +/- 111), 
than with pTαa (544 units +/- 62) (p≤ 0.01). 
Figure 2.8 
 
 
 
 
 
 
Figure 2.8 pTα
a 
and pTα
b 
both form preTCR complexes in pTα-deficient cells. 
(A) representative histograms of E14 pTα KO thymocytes transduced with vector 
alone, pTα
a 
or pTα
b 
and analysed after 11 days in FTOC. Cells are GFP
(+) 
TCRδ
(-)
 
and gates shown exclude TCRβ
(hi)
 cells. MFI for TCRβ
(lo)
 cells is shown. (B) Bar 
chart showing (n=7) experiments of data shown in (A). * p≤0.05, ** p≤0.01, *** 
p≤0.001.   
 
This suggests that preTCRb is expressed at higher surface levels than 
preTCRa. If signal strength is proportional to the number of receptor 
complexes at the surface of the cell, this would suggest that preTCRb 
signals stronger than preTCRa. Differential preTCR signal strength could 
have very significant consequences for T cell development as it is 
described as the mechanism by which different developmental fates are 
achieved; for example, in γδ/αβ lineage choice (Hayes et al., 2005), as well 
as for CD4 vs. CD8 development (Singer and Bosselut, 2004).  
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2.3.2 PreTCRa and preTCRb are signalling competent TCR complexes. 
Although surface expression of the preTCR (as judged by TCRβ) was 
increased in the presence of pTαa and pTαb, it was important to determine 
whether these preTCR complexes were able to signal. To avoid 
complicated assays for downstream signal activation a simple method that 
would determine whether the preTCRs were signalling was required. The 
pTα KO thymus has a profound developmental block at the DN3 stage of αβ 
T cell differentiation (Fehling et al., 1995a). As a result, more progenitor 
cells commit to the γδ lineage (Buer et al., 1997b) resulting in a 5 to 10-fold 
increase in the percentage of γδ T cells compared to a WT thymus (Figure 
2.9).  
Figure 2.9 
 
 
 
 
Figure 2.9 preTCR
a
 and preTCR
b
 are signal competent receptors. 
Representative FACS plots (from n = 7 experiments) of (A) a WT E15 thymic lobe, 
or (B) E14 pTα KO thymocytes transduced with vector only, pTα
a 
or pTα
b
, in 
depleted thymic lobes, after 8 day FTOC. Plots show live cells analysed for
 
TCRδ 
and CD3ε expression. Numbers refer to percentage of cells in gates. 
 
The introduction of a functional preTCR into pTα KO thymocytes rescues αβ 
T cell development and diverts cells away from the γδ lineage restoring the 
percentage of γδ T cells to ~2-3% of the thymus (Figure 2.9A) (Gibbons et 
al., 2001). Thus it is possible to utilise the percentage of γδ cells in the 
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thymus as a clear and simple readout of the functionality of the preTCR. 
pTα KO thymocytes transduced with vector alone generated ~30% γδ cells 
over the course of the FTOCs (Figure 2.10). A similar number of γδ cells 
were also seen in untransduced cells from all infections (Figure 2.10 black 
bars). However, by contrast, E14 pTα KO thymocytes transduced with pTαa 
or pTαb generated only ~10% γδ cells in the 5-15 day FTOCs (Figure 2.10).   
Figure 2.10 
 
 
 
 
 
Figure 2.10: preTCR
a
 and preTCR
b
 are signal competent receptors. Bar chart 
(from n=19 experiments) of pTα KO E14 thymocytes transduced with vector alone, 
pTα
a 
or pTα
b
 and cultured for 5-15 days in FTOC. Live cells were analysed for 
TCRδ and CD3ε. The percentage of TCRδ
(+)
 CD3ε
(+)
 cells are shown for 
untransduced thymocytes (black bars) and transduced thymocytes (hatched bars). 
ns is not significant, *** p≤0.001.   
 
2.3.3 Analysis of consequences of preTCRa or preTCRb expression. 
The low surface expression of preTCRa compared to preTCRb may indicate 
that preTCRa signals with a lower signal strength than preTCRb. To 
determine whether we could detect differences in the strength of signal 
produced by preTCRa and preTCRb, we analysed DN cells transduced with 
pTαa and pTαb for CD5 expression. CD5 is a cell surface glycoprotein, 
described to be a negative regulator of TCR-mediated signalling (Azzam et 
al., 2001). CD5 is upregulated on thymocytes as a result of preTCR 
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signalling (Azzam et al., 1998). Surface levels of CD5 on DPs and SPs are 
reported to be proportional the affinity of MHC-peptide-TCR interactions 
(Azzam et al., 1998). Therefore, it was possible that stronger signals 
through the preTCR would induce higher surface levels of CD5. To 
investigate, DN3 and DN4 pTα KO thymocytes transduced with vector, pTαa 
or pTαb were analysed for levels of CD5 after 7-8 days in FTOC. DN3 cells 
transduced with vector, pTαa or pTαb had low surface expression of CD5 
(~1460, ~1530 and ~1260 MFI units, respectively) (Figure 2.11). CD5 levels 
significantly increased on DN4 cells transduced with vector, pTαa or pTαb 
(~2830 (p≤0.01), ~3000 (p≤0.01) and ~2760 (p≤0.001) MFI units, 
respectively), consistent with the induction of CD5 through signalling of a 
receptor at the β-selection checkpoint (Figure 2.11). However, no significant 
difference was observed in the surface levels of CD5 on DN4s in the 
presence of vector only, pTαa or pTαb. It is known that TCRγδ can promote 
the DN3 to DN4 transition in pTα KO mice (albeit inefficiently), that could be 
responsible for the increase in CD5 expression. Nonetheless, if CD5 is an 
indicator of signal strength, it suggests little difference between preTCRa, 
preTCRb (and TCRγδ) at the β-selection checkpoint. 
Figure 2.11 
 
 
 
 
Figure 2.11 CD5 is upregulated on post β-selection thymocytes: Bar chart 
showing E14 pTα KO cells transduced with vector alone, pTα
a 
or pTα
b
 that were 
analysed for CD5 MFI on DN3 (black bars) and DN4 (hatched bars) cells, after 7-8 
days in FTOC.
 
*** p≤0.001, ** p≤0.01, ns is not significant.  
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PreTCR signalling induces proliferation of β-selected DN4 cells, a 
mechanism for expansion of the αβ T cell progenitor pool (Hoffman et al., 
1996; von Boehmer et al., 1998). To further analyse the function of 
preTCRa and preTCRb, the cell cycle status of cells transduced with pTαa 
and pTαb was analysed using 7-Amino-Actinomycin-D (7-AAD) (Rabinovitch 
et al., 1986). 7-AAD is a fluorescent dye that intercalates into double-
stranded DNA allowing the DNA content of a cell to be determined by 
FACS. Resting cells in G0 or G1 have two copies of each chromosome and 
therefore a DNA content of 2n. Cells undergoing division enter the S-phase 
and undergo synthesis of new DNA, resulting in an increase in the DNA 
content and a proportional increase in the fluorescence produced by 
excitation of 7-AAD. Cells in G2 have fully replicated their DNA and are 
about to divide; they have a DNA content of 4n.  
Figure 2.12 
 
 
 
 
Figure 2.12 preTCR
a
 and preTCR
b
 induce cell cycle entry of DN thymocytes. 
Graph showing the percentage of pTα KO DN cells transduced with vector alone, 
pTα
a
, or pTα
b
, after 8-day FTOC, with a >2n DNA content as judged by 7-AAD 
staining. DN cells were GFP
(+) 
TCRδ
(-) 
CD4
(-) 
CD8
(-)
.  
 
At day 8 of FTOC ~17% of vector transduced pTα KO DN thymocytes had a 
DNA content greater than 2n (Figure 2.12). Transduction of pTα KO cells 
with either pTαa or pTαb increased the proportion of cycling DN cells to 
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~23% and ~26%, respectively (Figure 2.12). Therefore, it appears that both 
preTCRa and preTCRb have a similar capacity to induce proliferation of 
progenitor thymocytes. 
2.4 pTαa and pTαb promote divergent T cell development. 
Although preTCRa and preTCRb appeared to have very similar capabilities 
to divert developing thymocytes away from the γδ lineage, we next 
investigated whether these preTCR complexes promoted αβ T cell 
development with similar characteristics. To do this we analysed the 
number and percentage of various αβ-committed thymocyte populations; 
ISP cells, DP cells and mature CD4SP cells and CD8SP cells.  
Figure 2.13 shows representative FACS plots from an experiment analysed 
at FTOC day-15, which illustrates the development promoted by pTαa and 
pTαb. After fifteen days in culture the majority (~55%) of pTα KO 
thymocytes transduced with the vector alone develop as γδ cells. Only 
~39% of the TCRδ(-) thymocytes have developed to the DP stage and only 
~9% of the TCRδ(-) cells are mature αβTCR(+) cells. By contrast, pTα KO 
cells transduced with pTαa or pTαb generate far fewer γδ cells, as previously 
discussed. Indeed, the majority of cells are TCRδ(-) (~85%), emphasising 
the ability of the two preTCRs to divert thymocytes away from the γδ 
lineage. However, a striking difference is observed between cells 
expressing pTαa and pTαb when comparing the TCRδ(-) population; whereas 
the majority of TCRδ(-) cells expressing pTαa are TCRβ(lo) (~85%), ~70% of 
those expressing pTαb are mature T cells that have high surface levels of 
TCRβ (Figure 2.13). The majority of TCRβ(lo) thymocytes (~60%) 
transduced with pTαa are ISPs. This is not the case for pTαb (~35%) or the 
vector alone (~20%). Indeed, when considering the largest population of 
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cells represented in each FTOC; ~55% of vector-only transduced cells are 
γδ cells, ~43% of pTαa transduced cells are ISPs, while ~65% of pTαb 
transduced cells are TCRβ(hi) (Figure 2.13).  
Figure 2.13 
 
 
 
 
 
 
 
 
 
Figure 2.13 Divergent T cell development promoted by preTCR
a 
and preTCR
b
 
at FTOC day 15: Representative FACS plots of pTα KO thymocytes transduced 
with vector alone, pTα
a
, or pTα
b
 and cultured in FTOC for 15 days. Total live cells 
were gated for expression of GFP and then analysed as described. Numbers are 
percentage of cells in indicated gates.  
 
ISPs are a highly proliferative intermediate population in transition from the 
DN4 to the DP stage. These cells express low levels of TCR but have 
upregulated CD8. Taking into consideration data from many experiments, it 
is evident that in 5-11 day FTOCs, ISPs account for ~10% of vector-only 
transduced pTα KO thymocytes and ~13% of those transduced with pTαb. 
However, a significantly greater proportion (~23%) of pTαa-transduced cells 
are ISPs (p≤0.001, Figure 2.14A). This phenotype was significantly more 
pronounced when FTOCs were run for 12-15 days (Figure 2.14B). Thus, 
still only ~10% of vector-only-transduced cells and ~11% of pTαb-
transduced cells were ISPs, but over ~35% of pTαa transduced cells 
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displayed this phenotype (p≤0.001). Therefore, the difference in ISP 
numbers promoted by pTαa and pTαb became greater over time. This is 
more consistent with distinct functions of the two preTCRs, rather than 
differential kinetics.    
Figure 2.14 
 
 
 
 
 
 
 
Figure 2.14 preTCR
a
 expression promotes the development and 
accumulation of ISPs: (A) Bar chart (from n=8 experiments) of pTα KO E14 
thymocytes transduced with vector alone, pTα
a 
or pTα
b
 and cultured for 5-11 days 
in FTOC. (B) Bar chart showing similar cells as (A) but from 12-15 day FTOC 
cultures (from n=10 experiments). Live cells were analysed for TCRβ and CD8. 
The percentage of TCRδ
(-)
 TCRβ
(+)
 CD8
(+)
 cells are shown for untransduced 
thymocytes (black bars) and transduced thymocytes (hatched bars). ns is not 
significant, *** p≤0.001.   
 
In addition to the analysis of ISPs, we also investigated the generation of 
mature SP cells; both CD4SP and CD8SP subsets. In FTOC run for 5-11 
days only, a very small percentage, ~3%, of vector-only-transduced pTα KO 
thymocytes develop to a mature αβ stage as detected by high surface 
levels of the TCRβ chain (Figure 2.15A). In these shorter FTOCs the 
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transduction of pTαa or pTαb did not significantly promote the development 
of more mature T cells when compared with non-transduced cells from the 
same cultures. However, when FTOCs were run longer for 12-15 days, a 
profound difference in development of TCRβ(hi) cells was observed in 
cultures expressing pTαa or pTαb (Figure 2.13 and 2.15B). Whereas only 
~15% of pTαa-transduced thymocytes expressed high levels of TCRβ, 
~45%, of cells transduced with pTαb were TCRβ(hi) (p≤ 0.001) (Figure 
2.15B).  
Figure 2.15 
 
 
 
 
 
 
 
 
Figure 2.15 preTCRb expression promotes the development of TCRβ(hi) cells: 
(A) Bar chart (from n=8 experiments) of pTα KO E14 thymocytes transduced with 
vector alone, pTα
a 
or pTα
b
 and cultured for 5-11 days in FTOC. (B) Bar chart 
showing similar cells as (A) but from 12-15 day FTOC cultures (from n=10 
experiments). Live cells were analysed for TCRβ. The percentage of TCRδ
(-)
 
TCRβ
(hi)
 cells are shown for untransduced thymocytes (black bars) and transduced 
thymocytes (hatched bars). ns is not significant, ** p≤0.01 *** p≤0.001.   
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Taken together these data suggest that the expression of pTαa or pTαb does 
not result in the same consequences for developing DN thymocytes. pTαa-
expressing cells accumulate at the ISP stage, while pTαb-expressing cells 
preferentially transit to a mature TCRβ(hi) phenotype. Importantly, this does 
not appear to be a consequence of delayed kinetics as developmental 
differences became greater the longer the cultures were run. 
The results presented above suggest that constitutive expression of pTαa 
was inhibiting the maturation of ISPs. If this was the case, then perhaps 
introducing pTαb into pTαa-transduced cells would correct their development 
and promote their maturation to the DP stage and beyond.  To investigate 
this, a double transduction was performed using both pTαa and pTαb 
containing retroviruses. To do this pTαb had to be cloned into a retroviral 
plasmid possessing a different reporter gene; human nerve growth factor 
receptor (NGFR) that can be detected by a PE conjugated antibody. Thus, 
pTαa expression was marked by GFP while pTαb expression was marked by 
NGFR (Figure 2.16). Using these constructs four different populations were 
evident after 10-day FTOC, which represent non-transduced cells (black), 
pTαa-expressing cells (green), pTαb-expressing cells (red) and cells 
expressing both pTαa and pTαb (blue) (Figure 2.16).  
Figure 2.16 
 
 
 
 
Figure 2.16 FACS profile of pTα
a 
and pTα
b
 double-transduced cells: pTα KO 
E14 thymocytes transduced with both pTα
a
 and pTα
b
 and cultured for 10 days were 
analysed for percentage of pTα
a 
(GFP
(+)
) and pTα
b
 (PE-NGFR
(+)
) and double-
transduced (GFP
(+)
PE
(+)
) cells. Numbers refer to percentage cells in each gate.   
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Similar to cells transduced with pTαa or pTαb alone, double-transduced cells 
exhibited a higher surface expression of TCRβ (MFI of 467) than non-
transduced cells (MFI of 248 units): consistent with formation of a preTCR 
(Figure 2.17A).  
Figure 2.17 
 
 
 
 
 
 
Figure 2.17 TCRβ surface expression and γδ cell development in pTα-
deficient thymocytes transduced with both pTα
a 
and pTα
b
: Dot plots showing 
E14 pTα KO thymocytes, after day-10 FTOC, that were non-transduced (black 
dots), transduced with pTα
a 
(green dots), or pTα
b 
(red dots), or both pTα
a 
and pTα
b 
(blue dots). (A) Cells are GFP
(+) 
TCRδ
(-) 
TCRβ
(lo)
 and the MFI for TCRβ is shown. 
(B) Live cells were analysed for TCRδ expression and the percentage of γδ cells is 
shown. 
A similar reduction in the percentage of γδ cells was also seen for double-
transduced cells when compared to those transduced with pTαa or pTαb 
alone (Figure 2.17B). Whereas ~18% of non-transduced cells were TCRδ(+), 
only ~4% of double-transduced cells, ~6% of pTαa-transduced cells and 
~3% of pTαb-transduced cells had become γδ cells (Figure 2.17B). This 
suggests that cells expressing both isoforms simultaneously were able to 
form signal-competent preTCRs resulting in development away from the γδ 
T cell lineage.  
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When the developmental characteristics of double-transduced thymocytes 
were assessed, it was apparent that they developed very similarly to cells 
expressing pTαa alone, and unlike those that expressed pTαb alone. Figure 
2.18 shows the percentages of ISP and TCRβ(hi) cells for two double-
transduction experiments after 10 or 13 day FTOC. Compared to cells 
expressing pTαb alone, a greater percentage of double-transduced cells 
were ISPs; ~20-25% compared to ~7-8% at day 10 and 13, respectively 
(Figure 2.18A). This was similar to the percentage of ISPs seen for pTαa-
alone which was ~24% at day 10 and ~35% at day 13. When TCRβ(hi) cells 
were analysed pTαb-alone promoted a 2.1-fold increase in the percentage 
of TCRβ(hi) cells, relative to that seen for the non-transduced population. 
However both pTαa-alone and double-transduced cells did not show a 
similar increase (Figure 2.18B). These data suggest that when pTαa and 
pTαb are expressed in the same cell, pTαa is dominant. 
Figure 2.18 
 
 
 
 
 
 
 
Figure 2.18 Double-transduced cells resemble those transduced with pTα
a
-
alone: Non-transduced, pTα
a
-only, pTα
b
-only
 
and double-transduced pTα KO 
thymocytes were analysed after day-10 or day-13 FTOC for percentage of ISPs (A) 
and TCRδ
(-) 
TCRβ
(hi)
 cells (B). TCRβ
(hi)
 cells are displayed relative to non-
transduced control.  
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Figure 2.19 
  
 
 
 
Figure 2.19 WT thymocytes transduced with pTα
a
 show reduced percentage 
of TCRβ
(hi)
 cells and a greater proportion of ISPs: C57BL/6 E14 thymocytes 
transduced with vector-only and pTα
a 
were analysed for the percentage of ISPs 
and TCRβ
(hi)
 cells, after 9 days in FTOC. Live cells were gated as shown. Numbers 
represent the percentage cells in each gate.  
 
To further asses the dominance of preTCRa, pTαa was transduced into WT 
E14 thymocytes that would express normal levels of the preTCR(s), and 
cultured in FTOC for 9 days (Figure 2.19). Compared to the vector control, 
expression of pTαa appears to reduce the percentage of TCRβ(hi) cells from 
~11% to ~5%. Furthermore, the percentage of ISPs is increased from ~8% 
in the vector control to ~20% for cells expressing pTαa (Figure 2.19). These 
results suggest that constitutive expression of pTαa in a WT background 
leads to pTαa acting in a dominant-negative manner. This also implies that 
the correct regulation of pTαa is necessary for optimal T cell development in 
the thymus.  
Our original hypothesis stated that preTCRa and preTCRb would promote 
the development of different lineages of αβ thymocytes. Thus, to determine 
whether the ISPs generated by pTαa expression and the TCRαβ(hi) mature 
cells that developed as a result of expression of pTαb, represented different 
T cell lineages; analysis of different T cell lineages was performed by 
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FACs. First, the ISPs that accumulated as a result of pTαa expression were 
characterised to determine whether these were true immature thymocytes 
en route to the DP stage, or indeed, whether they represented a mature 
CD8(+) population that had been positively selected by preTCRa signalling 
(Ito et al., 2002). In this report the authors showed that expression of a pTα 
transgene under control of the lck promoter on a TCRα-deficient 
background resulted in the development of peripheral CD8 T cells (Ito et 
al., 2002). These cells had low surface expression of TCRβ but appeared to 
be “mature” T cells as they expressed low levels of CD24 (heat stable 
antigen, HSA) and were able to produce IL-2 and upregulate CD69 upon 
stimulation with PMA and ionomycin (Ito et al., 2002). Therefore, it was 
possible the ISPs that developed in pTαa-expressing FTOCs were actually 
mature CD8 T cells with very low levels of TCRαβ. Positive selection 
induced by pTαa could occur in two ways; either CD8(+)TCR(lo) thymocytes 
had progressed through the DP stage and had been positively selected into 
the CD8 lineage, or constitutive expression of pTαa promoted development 
of CD8(+)TCR(lo) thymocytes bypassing the DP stage.  
CD69 is upregulated upon positive selection of DPs through TCRαβ 
(Anderson et al., 1994a). Therefore, CD8 T cells that had passed through 
the DP stage before being positively selected should express CD69 as well 
as TCRα. On the other hand, if preTCRa signalling positively selects CD8(+) 
T cells directly, bypassing the DP stage, these cells would be unlikely to 
upregulate CD69 or express a rearranged TCRα chain. However, both 
pathways should result in downregulation of HSA (Ito et al., 2002). To this 
end pTα KO CD8(+) TCRβ(lo) thymocytes transduced with vector, pTαa or 
pTαb were analysed after 13-15-day FTOC for CD69, HSA and TCRα 
expression.  
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 A higher surface expression of CD69 (average MFI of 959) was seen for 
ISPs transduced with vector compared to those expressing pTαa (average 
MFI of 738) or pTαb (average MFI of 787) (Figure 2.20). Thus, as the CD69 
levels on ISPs expressing pTαa were not higher than those expressing 
vector or pTαb, it was probable that these cells had not undergone positive 
selection through the TCR and had not passed through the DP stage.  
Figure 2.20 
  
 
 
 
Figure 2.20 Analysis of CD69 MFI in pTα KO ISP cells transduced with pTα
a 
or 
pTα
b
: Dot-plot shows ISP pTα KO thymocytes transduced with vector-only, pTα
a
,
 
or 
pTα
b 
that were analysed for CD69 expression, after 15-day FTOC. MFI for CD69 is 
shown. Each dot represents a single FTOC lobe. MFI is mean fluorescence 
intensity.   
 
HSA is expressed at high levels on immature thymocytes and is 
downregulated on mature thymocytes (Kishimoto and Sprent, 1997). Three 
populations of CD8(+) thymocytes were identified by TCRβ/HSA analysis of 
pTα KO thymocytes transduced with vector-only, pTαa or after 13-day 
FTOC; TCRβ(lo)HSA(hi); TCRβ(lo)HSA(lo); and TCRβ(hi)HSA(lo) (Figure 2.21). 
The “true ISP” population expresses low levels of TCRβ but high levels of 
HSA (TCRβ(lo)HSA(hi)). The “true CD8(+) SPs” are TCRβ(hi)HSA(lo), and the 
cells described by Ito et al are TCRβ(lo)HSA(lo) (Ito et al., 2002). For pTα KO 
cells transduced with vector-only ~37% of CD8(+) thymocytes were 
TCRβ(lo)HSA(hi), ~28% were TCRβ(lo)HSA(lo) and 27% were TCRβ(hi)HSA(lo) 
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(Figure 2.21). An increased proportion of CD8(+) cells transduced with pTαa 
TCRβ(lo)HSA(hi) (~45%), while ~26% were TCRβ(lo)HSA(lo) and ~22% were 
TCRβ(hi)HSA(lo) (Figure 2.21). Thus, although a readily detectable population 
of TCRβ(lo)HSA(lo)CD8(+) cells were present in pTαa-expressing cultures, this 
was not significantly higher than for vector-only cultures. Instead the 
presence of pTαa appears to expand the true ISP subset.  
Figure 2.21 
 
 
 
 
Figure 2.21 HSA and TCRβ analysis of CD8
(+) 
pTα KO cells transduced with 
pTα
a 
or pTα
b
: Dot-plots show CD8
(+) 
pTα KO thymocytes transduced with vector-
alone, pTα
a 
or pTα
b
 that were analysed for HSA and TCRβ expression, after 13-day 
FTOC. The percentage of GFP
(+)
CD8
(+)
 thymocytes that were TCRβ
(lo)
HSA
(hi) 
(circles), TCRβ
(lo)
HSA
(lo)
 (squares) and TCRβ
(hi)
HSA
(lo) 
(triangles) are shown.  TCR 
is T cell receptor, HSA is heat stable antigen. 
 
Figure 2.22 
 
 
 
 
Figure 2.22 Vα2 expression analysis of CD8
(+)
 pTα KO transduced 
thymocytes: Dot-plots showing CD8
(+) 
pTα KO thymocytes transduced with vector-
alone, pTα
a 
or pTα
b
 that were analysed for Vα2 expression, after 13-day FTOC. 
The percentages of TCRβ
(lo)
HSA
(hi) 
cells (circles), TCRβ
(lo)
HSA
(lo)
 cells (squares) 
and TCRβ
(hi)
HSA
(lo) 
cells (triangles), that were Vα2
(+) 
are shown. TCR is T cell 
receptor, HSA is heat stable antigen. 
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By contrast to that observed for vector-only, and pTαa cultures, only ~8% of 
pTαb-transduced CD8(+) T cells were TCRβ(lo)HSA(lo), while ~30% were true 
ISPs (TCRβ(lo)HSA(hi)) and the majority, ~50% were mature TCRβ(hi)HSA(lo) 
cells. To complete this analysis the three different CD8 populations 
described above were further assessed for expression of the Vα2 TCRα 
chain (Figure 2.22). 
Figure 2.23 
 
 
 
 
Figure 2.23 pTα
b 
promotes the development of mature CD8SP cells: Dot-plot 
shows the percentage of CD8SP pTα KO thymocytes transduced with vector-only, 
pTα
a 
or pTα
b
 from day-13 FTOCs. CD8SP cells are TCRδ(-) CD8
(+)
 TCR
(lo)
 HSA
(lo)
 
Vα2
(+)
. * p≥0.05, ** p≥0.01 and *** p≥ .001. 
 
These data show that ≤ 1% of all TCRβ(lo)HSA(hi) or TCRβ(lo)HSA(lo) CD8(+) 
cells from FTOCs of pTα KO thymocytes transduced with vector-only, pTαa 
or pTαb expressed Vα2, suggesting that these populations had not yet 
undergone TCRα rearrangements (Figure 2.22). This analysis also 
confirmed that the TCRβ(hi)HSA(lo) population of cells were mature CD8(+) T 
cells that had undergone TCRα rearrangements as well as positive via 
TCRαβ. Importantly, the proportion of TCRβ(hi)HSA(lo)CD8(+)Vα2(+) 
thymocytes from pTαb FTOCs was significantly higher at 4% of total GFP(+) 
cells, compared to 0.2% of vector-only FTOCs (p≤ 0.001) and 1.5% of pTαa 
FTOCs (p≤ 0.05 Figure 2.23). This confirmed the observation that pTαb has 
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a superior ability to promote development of mature SP thymocytes in 
FTOC compared to pTαa.   
IL-7Rα is thought to be upregulated on thymocytes downstream of preTCR 
signalling (Trigueros et al., 2003). Importantly, IL-7Rα expression is 
extinguished at the ISP stage which is absolutely necessary for the ISP to 
DP transition (Yu et al., 2004). Indeed, treatment of E15 C57BL/6 thymic 
lobes with IL-7 arrested thymocyte development at the ISP stage (Yu et al., 
2004). We therefore hypothesised that continued expression of pTαa may 
result in the accumulation of ISP thymocytes due to prolonged expression 
of IL-7Rα and the IL-7 receptor. To test this we analysed the surface 
expression of IL-7Rα after pTα-deficient E14 thymocytes transduced with 
vector-only, pTαa or pTαb were cultured in FTOC for 15 days. 
Figure 2.24 
 
 
 
 
 
 
 
Figure 2.24 thymocytes transduced with pTα
a 
express higher levels of IL-7Rα 
compared with those transduced with pTα
b
: Representative FACS plots 
showing pTα KO E14 thymocytes transduced with vector, pTα
a 
or pTα
b 
that were 
analysed for IL7-Rα (CD127) expression after 15-day FTOC. (A) Cells are TCRδ
(-) 
TCRβ
(lo)
 (green) or TCRβ
(hi)
 (blue). The green cells represented in (B) are TCRδ
(-) 
TCRβ
(lo)
CD8
(+)
, while the red cells in both (A) and (B) represent GFP
(-) 
TCRβ(
lo)
 DP 
cells as a negative control.   
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TCRβ(hi) cells from pTαa and pTαb FTOCs expressed lower levels of IL-7Rα 
compared with those transduced with vector alone (Figure 2.24). However, 
the immature thymocytes that developed as a result of preTCRa signalling 
expressed higher levels of IL-7Rα in comparison to those transduced with 
pTαb or vector (Figure 2.24A). This higher expression of IL-7Rα was 
reflected in the ISP population that developed as a result of preTCRa 
signalling (Figure 2.24B). Therefore, this preliminary result could suggest 
that IL-7 signalling may regulate the developmental phenotype seen for 
preTCRa.  
2.5 Differential expression of pTαa or pTαb does not influence 
regulatory T cell development. 
To further investigate whether preTCRa and preTCRb promoted the 
development of different lineages of T cells, development of regulatory T 
cells (T-regs) was assessed. Recently, thymic T-regs were reported to 
express high levels of pTαb but not pTαa and expression of pTαb was 
described to be essential for the regulatory function (Campese et al., 2009). 
pTα KO E14 thymocytes transduced with vector-only, pTαa or pTαb  were 
analysed for intracellular expression of Foxp3, a gene that marks the T-reg 
lineage, after 15 days in FTOC (Figure 2.25). When gated on mature 
CD4SP cells, ~2% of these were Foxp3(+) in vector-only FTOCs. Expression 
of pTαa appeared to make no difference to the percentage of Foxp3(+) in the 
4SP population, being 2% as well (Figure 2.2). Cultures that expressed 
pTαb-only had a lower representation of Foxp3(+) cells in the CD4SP pool, 
being ~0.6%. At this stage the significance of this finding is unclear but it 
suggests that there is not a major effect of pTαa or pTαb on T-reg 
development, and certainly would not support the observations made by 
Campese and co-workers for a role for pTαb in T-reg development.    
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Figure 2.25 
 
 
 
 
 
 
 
Figure 2.25 Regulatory T cell development is not influenced by expression of 
either pTα
a 
or pTα
b
: Representative FACS plots (from n=3 experiments) of CD4SP 
pTα KO thymocytes transduced with vector-alone, pTα
a 
or pTα
b 
that were analysed 
for expression of intracellular (i.c.) Foxp3, after 15-day FTOC. Cells were gated on 
GFP
(+)
 then analysed as described. Numbers represent percentages in each gate. 
 
2.6 Summary. 
In summary, the work presented in this chapter suggests that pTαa and 
pTαb drive qualitatively different T cell development; pTαa appears to 
promote development of immature ISP cells, with continued expression of 
pTαa detrimental to continued development. By contrast, pTαb promotes 
efficient development of mature cells. Evidence suggests that pTαa may 
promote sustained expression of the IL-7Rα chain which prevents normal 
developmental progression. Finally, preliminary experiments do not support 
the idea that pTαb is required for T-reg development.   
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Chapter 3  
Investigating oligomerization as a mechanism for signal 
initiation by the preTCR  
 
3.1 Introduction 
Signalling through the preTCR has been shown as weak when compared to 
the signal delivered by the γδ TCR. Indeed, this difference in signal strength 
has been proposed to determine αβ versus γδ lineage commitment at the 
DN stage of thymic ontogeny (Haks et al., 2005; Hayes et al., 2005). The 
preTCR is thought to signal ligand-independently (Haks et al., 2003; Irving 
et al., 1998). However, the mechanism by which this occurs is unclear. 
Among the possibilities are a low signalling threshold in DN thymocytes, 
which makes the cells very sensitive to signals through TCR complexes 
when compared to DP and SP cells (Haks et al., 2003). By contrast, a 
number of groups have suggested that ligand-independent signalling from 
the preTCR is due to intrinsic properties of the pTα chain (Borowski et al., 
2004; Yamasaki et al., 2006). Specifically, the currently accepted idea is 
that pTα promotes signalling by inducing oligomerization of preTCR 
complexes (Yamasaki et al., 2006). 
3.2 Oligomerization as a mechanism for ligand-independent signalling 
through the preTCR. 
In a recent report by Yamasaki and co-workers (Yamasaki et al., 2006) it 
was proposed that four charged amino acids in the extracellular Ig-loop of 
pTα (in this study only pTαa was considered) were shown to mediate 
oligomerization of pTα chains, and by extrapolation, preTCR complexes on 
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the surface of DN cells. This oligomerization was proposed as the 
mechanism by which signalling from the preTCR was initiated, presumably 
by clustering of intracellular signalling molecules. The four amino acids 
involved were identified as aspartic acid at position 22 (from the beginning 
of the extracellular domain - D22), arginine at position 24 (R24), arginine at 
position 102 (R102) and arginine at position 117 (R117) (Figure 3.1A). 
Mutation of any one of these residues to a non-charged amino acid, such 
as alanine was shown to abolish the oligomerization of the preTCR, as 
determined by the reduced ability of EPO-receptor-fused mutant pTα chains 
to drive proliferation of the IL-3-dependent BAF3 cell line.  
Figure 3.1 
 
 
 
 
 
Figure 3.1 Location of the “oligomerization residues” in pTα
a 
and pTα
b
. 
Schematic representation of pTα
a 
(A) and pTα
b 
(B) with exons coloured as blue for 
exon-1, red for exon-2, green for exon-3 and purple for exon-4. The location of the 
four amino acids (D22, R24, R102 and R117) implicated in pTα oligomerization are 
shown. “C” indicates cysteine residues that form disulphide bonds in the mature 
protein, “LP” indicates leader peptide, “TM” indicates transmembrane domain, and 
(P) indicates proposed phosphorylation sites. The positions of start and stop 
codons are shown.  
 
The authors also showed that mutant pTα chains could not drive 
development when expressed in pTα KO thymocytes in bone-marrow 
chimeras with RAG-2 KO irradiated recipients. However, in this study the 
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authors did not consider pTαb. pTαb lacks the extracellular Ig-loop of pTα 
and therefore three out of the four charged amino acid residues (Figure 
1.3B). Nonetheless, this receptor is functional as we have demonstrated in 
the previous chapter, being signalling-competent and able to rescue αβ T 
cell development in a pTα KO background. 
3.3 Generation of “mutant” pTα constructs that lack specific amino 
acid residues. 
To investigate the role of the charged amino acid residues in the 
extracellular Ig-loop of pTα, various “mutant” pTα constructs were 
generated. First, a construct with a single amino acid substitution was 
generated in which R24 in exon-2 of pTαa was mutated to the non-charged 
amino acid alanine (R24A Figure 3.2). This mutation, had been described 
in the Yamasaki report as lacking the capacity to promote oligomerization 
and to signal to drive β-selection (Yamasaki et al., 2006).  
Figure 3.2 
 
 
 
 
Figure 3.2 pTα
a 
R24A mutant. Schematic representation of pTα
a-
R24A mutant 
with exons coloured as blue for exon-1, red for exon-2, green for exon-3 and purple 
for exon-4. The single amino acid substitution at position 24 within the extracellular 
domain of pTα
a
 is shown. This mutation replaces arginine (R) with a non-charged 
amino acid alanine (A) and has been described to abolish the oligomerization 
capacity of pTα. The location of the other three amino acids (D22, R102 and R117) 
implicated in pTα oligomerization are shown. “C” indicates cysteine residues that 
form disulphide bonds in the mature protein, “LP” indicates leader peptide, “TM” 
indicates transmembrane domain, and (P) indicates proposed phosphorylation 
sites. The positions of start and stop codons are shown  
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Site directed mutagenesis (SDM) was employed to generate the R24A 
mutant. The protocol followed is shown in Figure 3.3; the pBlunt-pTαa 
plasmid was used as a template for the SDM PCR as it is smaller than pLZ- 
pTαa and therefore easier to manipulate. Forward and reverse primers were 
designed that were complimentary to the top and bottom strand of the DNA 
sequence of pTα. The primers were designed with the mutation at the 
centre of the sequence, with 10bp of homology either side. The (AGG) 
codon  to be mutated is situated 238bp from the start of the pTαa construct 
and was replaced by changing two bases; AG to GC, to code for alanine 
(GCG).  
 Figure 3.3 
 
 
 
 
 
 
 
 
Figure 3.3 Schematic of the method for Site Directed Mutagenesis. Amino acid 
substitutions were performed on pBlunt-pTα plasmids using homologous primers 
that contained the desired mutation. Parental plasmid was subsequently removed 
from the PCR reaction by Dpn1 digestion and the mutant plasmid transformed into 
E.coli for nick repair. Mutant clones were characterised by restriction digest and 
then sub-cloned into pLZ. The desired mutation is denoted by a red X. 
  
169 
 
pTαa in pBlunt
10ng 20ng H2ONo enz
In brief, a thermo-cycler was used to denature the plasmid, anneal the two 
primers and extend from the primers using a high-fidelity polymerase. The 
mutations were created in the daughter plasmid and the parent plasmid 
was digested away using Dpn1. Dpn1 digests methylated DNA specifically 
and therefore only digests the parent plasmid. Dpn1 digested PCR 
products for pTαa R24A are shown in Figure 3.4. Two different 
concentrations of parent plasmid were used for the PCR reaction; 10ng and 
20ng of DNA and a reaction was set up using parent plasmid but no 
polymerase (no enz) as a control (Figure 3.4). The mutant plasmid was 
then transformed into competent E.coli for nick repair and transformants 
were selected and characterised (Figure 3.5).  
Figure 3.4 
 
 
Figure 3.4 pTα
a
-R24A PCR: 10ng and 20ng of pBlunt-pTα
a 
plasmid was used as a 
template for pTα
a
-R24A PCR. PCR products were Dpn1 digested before gel 
electrophoresis. No enz stands for no enzyme.  
  
Changing the coding sequence from AGG to GCG inserted an Hha1 site at 
position 238 in the pTαa sequence. Therefore, mutant plasmids were 
identified by Hha1 digestion. Hha1 cuts the pBlunt sequence 26 times but 
only once in the WT pTαa sequence producing two large fragments of 
812bp and 620bp in length (Figure 3.5A). Insertion of the Hha1 site in the 
pTαa-R24A mutant construct cleaves the larger of the two fragments 
producing a 473bp and a 339bp fragment (Figure 3.5B). Figure 3.6 shows a 
Hha1 digest on six different pTαa-R24A clones; all six clones have the 
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mutation inserted resulting in the loss of the 812bp band seen in the parent, 
and gain of a 473bp and a 339bp band marked in red.  
Figure 3.5 
 
 
 
 
 
Figure 3.5 Hha1 restriction maps for pBlunt-pTα
a 
and pBlunt-pTα
a
-R24A 
plasmids. Hha1 restriction maps for (A) pBlunt-pTα
a 
and (B) pBlunt-pTα
a
-R24A 
plasmids are shown. The R24A mutation generates an Hha1 site within the pTα
a 
sequence which results in the loss of a 812bp Hha1 fragment present in the parent 
plasmid. This fragment is replaced by two fragments of 473bp and 339bp in length 
(shown in red) in pTα
a
-R24A.    
 
Figure 3.6 
 
 
 
 
 
Figure 3.6 Hha1 digests for pBlunt-pTα
a
-R24A clones. An agarose gel showing 
Hha1 restriction digests of six pBlunt-pTα
a
-R24A clones (lanes 1-6) and the pBlunt-
pTα
a
 parent plasmid (parent). The R24A mutation generates an Hha1 site within 
the pTα
a 
sequence which results in the loss of a 812bp Hha1 fragment present in 
the parent plasmid. This fragment is replaced by two fragments of 473bp and 
339bp in length (shown in red) in pTα
a
-R24A.    
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The pTαa R24A cassette was then sub-cloned out of the pBlunt backbone 
by BamH1 and Xho1 digestion and ligation into the pLZ plasmid (Figure 
3.3). The pLZ-pTαa-R24A transformants were then characterised by 
digestion with BamH1 and Xho1 for release of the pTαa R24A cassette, 
generating a 1032bp band (Figure 3.7).  
Figure 3.7 
 
 
 
 
Figure 3.7 BamH1 and Xho1 digests on pLZ-pTα
a
-R24A transformants. 
Agarose gel showing BamH1 and Xho1 double-digests on six pLZ-pTα
a
-R24A 
transformants (lanes 1-6) which resulted in the release of the pTα
a
-R24A cassette 
(1032bp in length). 
 
The pLZ-pTαa-R24A plasmid was transfected into the phoenix ecotropic 
packaging cell line, and virus harvested. pTαa-R24A virus used in parallel 
with WT-pTαa  and pTαb virus were used to transduce pTα-deficient E14 
thymocytes in FTOC, to determine whether the mutation perturbed the 
function of the preTCR as described by Yamasaki et al (Yamasaki et al., 
2006). After 8 days in FTOC thymocytes were analysed for preTCR 
expression by analysis of surface TCRβ on GFP(+)TCRδ(-) thymocytes 
(Figure 3.8). As described in the previous chapter, pTα-deficient 
thymocytes do not express a preTCR and therefore have low TCRβ surface 
expression (MFI of ~160). Expression of either pTαa or pTαb in pTα KO 
thymocytes increases the levels of TCRβ on the surface as a result of the 
172 
 
formation of the preTCR (MFI of 285 and 516 units, respectively). 
Importantly, pTαa-R24A expression also resulted in increased TCRβ 
surface levels (MFI of 514 in Figure 3.8). This shows that the R24A 
mutation does not abolish the ability of the pTαa chain to pair with TCRβ. In 
fact, pTαa-R24A preTCR surface levels were comparable to those of 
preTCRb and 1.8 fold higher than those of preTCRa, suggesting that 
disruption of the ability of the preTCR to oligomerize may lead to higher 
preTCR surface levels.  
Although the pTαa-R24A mutant was able to form a preTCR it may not have 
been signalling-competent. Thus, to investigate, the percentage of γδ cells 
generated in pTαa-R24A-expressing FTOCs was determined. As described 
in chapter 2 of the results, pTα-deficient mice have a large percentage γδ 
cells in the thymus due to the absence of the preTCR that drives αβ T cell 
development. Signalling through preTCRa and/or preTCRb promotes αβ T 
cell development resulting in a huge reduction of the percentage of γδ cells 
in the thymus. Results from three different experiments, two at FTOC day-8 
and one at FTOC day-15 are shown in Figure 3.9. The percentage of γδ 
cells in transduced (GFP(+)) thymocytes (hatched bars) in pTαa or pTαb 
FTOCs is ~10% which represents a large decrease compared to the vector-
only control (~40%) (Figure 3.9). Importantly, FTOCs transduced with pTαa-
R24A showed a similar reduction in the percentage of γδ cells to ~12.5%. 
These results show that the pTαa-R24A mutant was able to form a signal 
competent preTCR on the surface of pTα KO thymocytes in FTOC; 
promoting T cell development away from the γδ T cell lineage.  
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Figure 3.8 pTα
a
-R24A appears to form a preTCR with TCRβ. Representative 
histograms (from n=2 experiments) of E14 pTα KO thymocytes transduced with 
vector alone, pTα
a
, pTα
b 
or pTα
a
-R24A
 
and analysed after 8 days in FTOC. Cells 
are GFP
(+) 
TCRδ
(-)
 and gates shown exclude TCRβ
(hi)
 cells. MFI for TCRβ
(lo)
 cells is 
shown. 
 
Figure 3.9 
 
 
 
 
 
 
 
Figure 3.9 pTα
a
-R24A mutant forms a signal competent preTCR capable of 
reducing the percentage of γδ cells in FTOC. Bar graph shows Bar chart (from 
n=3 experiments) of pTα KO E14 thymocytes transduced with vector alone, pTα
a
, 
pTα
b
 or pTα
a
-R24A and cultured for 8-15 days in FTOC. Live cells were analysed 
for TCRδ and CD3ε. The percentage of TCRδ
(+)
 CD3ε
(+)
 cells are shown for non-
transduced thymocytes (black bars) and transduced thymocytes (hatched bars), ns 
is not significant, ** p≤ 0.01 *** p≤ 0.001.   
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3.4 Investigating the oligomerization requirements for signalling 
through pTαb. 
 Despite the ability of pTαb to signal in the absence of the extracellular 
domain of pTα, this isoform does possess one out of the four charged 
amino acid residues deemed necessary for oligomerization and therefore 
signalling through the preTCR (R117 Figure 3.10). In order to determine the 
role of this amino acid in signalling through preTCRb, a pTαb construct was 
generated in which the charged amino acid residue R117 was mutated to 
alanine (pTαb-R117A Figure 3.10). SDM to generate pTαb-R117A was 
performed following the same protocol as that described for pTαa-R24A. 
The R117 AGG codon at position 197 in the pTαb construct was mutated to 
alanine; GCG.  
 Figure 3.10 
 
 
 
Figure 3.10 pTα
b
-R117A mutant. Schematic representation of pTα
b
-R117A 
mutant with exons coloured as blue for exon-1, green for exon-3 and purple for 
exon-4. The single amino acid substitution at position 197 within the short 
extracellular domain of pTα
b
 is shown. This mutation replaces arginine (R) with a 
non-charged amino acid alanine (A) and has been described to abolish the 
oligomerization capacity of pTα. “C” indicates the cysteine residue that forms a 
disulphide bond with TCRβ, “LP” indicates leader peptide, “TM” indicates 
transmembrane domain, and (P) indicates proposed phosphorylation sites. The 
positions of start and stop codons are shown  
 
Figure 3.11A shows the amplified product from the pTαb-R117A PCR. The 
mutant plasmids were characterised by AccII digests. The pBlunt plasmid 
contains fifteen AccII sites but none are found in pTαb. Therefore, digesting 
the parent plasmid with AccII produces one large fragment of 1219bp 
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(Figure 3.11B). The pTαb-R117A mutation inserts an AccII site at position 
197 of the pTαb construct and therefore reduces the 1219bp fragment to 
two smaller fragments of 279 and 940bp in size (Figure 3.11C).  
Figure 3.11 
 
 
 
 
 
 
Figure 3.11 pTα
b
-R117A PCR and AccII restriction maps for pBlunt-pTα
b 
and 
pBlunt-pTα
b
-R117A. (A) 20ng of pBlunt-pTα
b 
plasmid was used as a template for 
pTα
b
-R117A PCR. PCR products were Dpn1 digested before gel electrophoresis. 
No enz stands for no enzyme. AccII restriction sites for (B) pBlunt-pTα
b 
and (C) 
pBlunt-pTα
b
-R117A are shown. The R117A mutation generates an AccII restriction 
site within pTα
b
 which results in the loss of a 1219bp AccII fragment present in the 
parent plasmid. This fragment is replaced by two fragments of 279bp and 940bp 
(shown in red) in pBlunt-pTα
b
-R117A.    
 
Figure 3.12 shows the AccII digests of five pTαb-R117A clones; only the 
first three contain the desired mutation, having lost the 1219bp fragment 
and replaced it with a 279bp and a 940bp fragment. pTαb-R117A was sub-
cloned by BamH1/Xho1 digestion into pLZ. Figure 3.13 shows the 
BamH1/Xho1 digestion of five pLZ-pTαb-R117A clones each with the 
correct pTαb-R117A band (712bp band). pLZ-pTαb-R117A pLZ was 
sequenced and then transfected into the phoenix ecotropic packaging cell 
line for production or retroviral vectors for expression in FTOC. The results 
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obtained from this construct will be described after the next section, which 
describes the generation of the final mutated version of pTαa. 
Figure 3.12 
 
 
 
 
 
 
Figure 3.12 AccII restriction digests for pBlunt-pTα
b
-R117A clones. An 
agarose gel showing AccII digests for five pBlunt-pTα
b
-R117A clones (lanes 1-5) 
and the parent pBlunt-pTα
b 
plasmid (parent). The R117A mutation generates an 
AccII restriction site within pTα
b
 which results in the loss of a 1219bp AccII 
fragment present in the parent plasmid. This fragment is replaced by two fragments 
of 279bp and 940bp (shown in red) in pBlunt-pTα
b
-R117A. Only clones 1-3 appear 
to have the desired mutation. 
 
Figure 3.13 
 
 
 
 
 
Figure 3.13 BamH1 and Xho1 digests of pLZ-pTα
b
-R117A clones. An Agarose 
gel showing the BamH1/Xho1 digests of five pLZ-pTα
b
-R117A clones (lanes 1-5) 
which releases the pTα
b
-R117A cassette (712bp). 
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3.5 Generation of a mutated pTαa construct that contains only the 
pTαb-associated R117 oligomerization residue. 
pTαb possesses only one of the four “oligomerization” residues present in 
pTαa. Thus, it could be argued that pTαa would have a superior ability to 
oligomerize than pTαb. Oligomerization has not only been proposed as a 
mechanism of preTCR signal initiation, but also has been suggested to 
induce rapid endocytosis and degradation of the preTCR. Thus the different 
surface levels of preTCRa and preTCRb that are described in chapter two, 
may be a result of the degree to which pTα can oligomerize. As surface 
levels of the preTCR may also influence preTCR signal strength, 
oligomerization may have a quantitative effect on developmental outcome. 
Thus, to test this hypothesis a second pTαa mutant was generated where 
D22, R24 and R102 were mutated to alanine to create a construct that 
mirrored pTαb in its capacity to oligomerize (Figure 3.14).  
Figure 3.14 
 
 
 
 
Figure 3.14 pTα
a 
DRRA mutant. Schematic representation of pTα
a
-DRRA mutant 
with exons coloured as blue for exon-1, red for exon-2, green for exon-3 and purple 
for exon-4. The three amino acid substitutions - D to A at position 22, R to A at 
position 24 and R to A at position 102, within the extracellular domain of pTα
a
 are 
shown. The location of the fourth amino acids (R117) implicated in pTα 
oligomerization is also shown. “C” indicates cysteine residues that form disulphide 
bonds in the mature protein, “LP” indicates leader peptide, “TM” indicates 
transmembrane domain, and (P) indicates proposed phosphorylation sites. The 
positions of start and stop codons are shown.  
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This construct, pTαa-DRRA, had to be generated by two SDM steps. The 
first step was to introduce the D22 and R24 mutations into pTαa by a single 
mutagenesis. This used primers that contained a single base change from 
A to C to change the aspartic acid at position 22 (GAT) to GCT (alanine) 
and two base changes to mutate the arginine at position 24 (AGG) to GCG 
(alanine). As with the previously described R24A construct pBlunt-pTαa 
plasmid was used as a template. Figure 3.15A shows the pTαa-D22R24A 
PCR, while Figure 3.15B shows analysis of the pBlunt-pTαa-D22R24A 
plasmids by Hha1 digest. As with pTαa-R24A the desired mutation was 
identified by loss of an 812bp fragment to give two fragments at 473bp and 
339bp. Figure 3.16B shows the Hha1 digests of six different clones each 
containing the D22R24A mutation. The pTαa-D22R24A mutant plasmid was 
then used as a template for the second SDM mutagenesis.  
Figure 3.15 
 
 
 
 
 
 
 
Figure 3.15 pTα
a
-D22R24A PCR and Hha1 digests of pBlunt-pTα
a
-D22R24A 
clones. (A) 10ng and 20ng of pTα
a
-pBlunt plasmid was used for the pTα
a
-
D22R24A PCR. PCR products were digested with Dpn1 and “no enz” refers to a 
control PCR reaction in which there was polymerase. (B) Hha1 digests of six 
pBlunt-pTα
a
-D22R24A clones (lanes 1-6) and pBlunt-pTα
a
 parent plasmid (parent). 
The R24A mutation generates an Hha1 site within the pTα
a 
sequence which results 
in loss of a 812bp fragment present in the parent plasmid. This fragment is 
replaced by two fragments of 473bp and 339bp (shown in red) in pTα
a
-D22R24A.    
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Ladder        + - H2O 
1kb
5kb
700bp
1.5kb
500bp
75bp
pTαa-DRRA 
(4.5kb)4kb
20kb
pBlunt-pTαa-
D22R24A (10ng)
R102 PCR:
The second mutagenesis step used primers that contained a CG to GC 
base change to mutate the arginine residue (CGG) at position 102 to 
alanine (GCG). Figure 3.16 shows the R102A PCR while transformants 
were characterised by AccII restriction digest. Figure 3.17 shows a 
restriction map of AccII sites in the parent and mutated constructs, showing 
cleavage of a 1548bp fragment to produce 994bp and 554bp fragments if 
mutagenesis was successful.  
Figure 3.16 
 
 
 
 
Figure 3.16 pTα
a
-R102 PCR. 10ng of pBlunt-pTα
a
-D22R24A plasmid was used as 
a template for the pTα
a
-R102 PCR to generate pTα
a
-DRRA (4.5kb). PCR products 
were digested with Dpn1. The (+) refers to the reaction with polymerase, while (-) is 
without.  
 
The AccII digest of five pTαa-DRRA clones is shown in Figure 3.18; all five 
have the desired mutation, having lost a 1548bp fragment present in the 
parent and gained the smaller 994bp and 554bp fragments. pTαa-DRRA 
was then sub-cloned into pLZ and tested by BamH1/Xho1 digests (Figure 
3.19). The pLZ-pTαa-DRRA plasmids were then sequenced and 
subsequently transfected into phoenix cells to generate virus for retroviral 
transduction of pTα KO E14 thymocytes in FTOC. 
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D22R24A:
pBlunt-pTαa-
D22R24A 
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592bp 581bp
(A)
(B)
Figure 3.17 
 
 
 
 
 
Figure 3.17 AccII restriction map for pBlunt-pTα
a
-D22R24A and pBlunt-pTα
a
-
DRRA plasmids. AccII restriction sites for (A) pBlunt-pTα
a
-D22R24A and (B) 
pBlunt-pTα
a
-DRRA are shown. The R102 mutation generates an AccII site which 
results in loss of a 1548bp fragment present in the parent plasmid (pBlunt-pTα
a
-
D22R24A). This fragment is replaced by two fragments of 554bp and 994bp in 
pBlunt-pTα
a
-DRRA (shown in red).   
 
 
Figure 3.18 
 
 
 
 
 
 
Figure 3.18: AccII digests of pBlunt-pTα
a
-DRRA plasmids. An agarose gel 
showing AccII digests for five pBlunt-pTα
a
-DRRA plasmids (lanes 1-5) and the 
parent plasmid AccII digests of pBlunt-pTα
a
-D22R24A (parent). The R102 mutation 
generates an AccII site which results in loss of a 1548bp fragment present in the 
parent plasmid. This fragment is replaced by two fragments of 554bp and 994bp in 
pBlunt-pTα
a
-DRRA (shown in red).   
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1kb
700bp
1.5kb
500bp
75bp
BamH1/Xho1 Digests:
5kb
20kb
Figure 3.19  
 
 
 
 
Figure 3.19 BamH1/Xho1 digests of pLZ-pTα
a
-DRRA clones. An Agarose gel 
showing the BamH1/Xho1 digests of six pLZ-pTα
b
-R117A clones (lanes 1-6) which 
releases the pTα
a
-DRRA cassette (1032bp). 
 
3.6 pTαb-R117A and pTαa-DRRA form signal competent preTCR 
complexes. 
FTOC experiments were set up with pTαb-R117A and pTαa-DRRA 
constructs transduced into pTα KO E14 thymocytes to compare the function 
of these mutant pTα alleles with pTαa and pTαb. First, the ability of the 
mutant pTα chains to form a preTCR was determined by analysis of surface 
TCRβ expression. As described previously, pTα KO DN cells have very low 
TCRβ surface levels. Expression of pTαa and pTαb increases the surface 
expression of TCRβ from an MFI of ~200 units seen for vector-only, to ~400 
units for preTCRa and ~500 units for preTCRb (Figure 3.20).  
Importantly, pTαb-R117A and pTαa-DRRA expression also resulted in a 
significant increase in TCRβ surface levels when compared to vector-only 
cells; to 590 units and 605 units, respectively (p≤ 0.001, Figure 3.20). In 
addition, these levels of TCRβ were similar to those seen with pTαb, but 
significantly higher than those of pTαa (p≤ 0.01, Figure 3.20). Thus, as seen 
with the pTαa-R24A allele, mutation of oligomerization residues in pTαa 
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promotes a higher surface expression of the preTCR (as judged by TCRβ 
surface expression).  
Figure 3.20 
 
 
 
 
 
Figure 3.20 pTα
a
-DRRA and pTα
b
-R117A promote surface expression of TCRβ 
comparable to that seen with pTα
b
. Bar chart showing (from n=5 experiments) 
E14 pTα KO thymocytes transduced with vector-only, pTα
a
, pTα
b
, pTα
a
-DRRA or 
pTα
b
-R117A that were analysed after 8-10-day FTOC, for
 
TCRβ expression. Cells 
are GFP
(+)
TCRδ
(-)
TCRβ
(lo)
 and the MFI for TCRβ is shown. MFI is mean 
fluorescence intensity. * p≤ 0.05 ** p≤ 0.01 *** p≤ 0.001   
 
The signalling capabilities of pTαb-R117A and pTαa-DRRA were determined 
by analysis of the percentage of γδ cells in FTOC. Figure 3.21 shows data 
from seven different FTOCs analysed from day-8 to day-15 for percentage 
of γδ cells. On average ~30-35% of pTα KO untransduced cells, shown in 
black, developed as γδ cells, although this number varied slightly from 
culture to culture (Figure 3.21). Approximately 40% of GFP(+) pLZ-
transduced cells developed as γδ cells. As described previously, expression 
of preTCRa or preTCRb reduced the percentage of γδ cells to ~10-12%. 
Expression of the mutant alleles of pTα, pTαb-R117A and pTαa-DRRA, also 
resulted in a significant reduction in γδ cell percentage to 9-11% (p≤ 0.001- 
Figure 3.21). Therefore, both pTαa-DRRA and pTαb-R117A formed 
signalling-competent preTCRs capable of rescuing αβ T cell development in 
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a pTα KO background, as shown by the reduction of γδ cells in FTOC. This 
provides strong evidence that oligomerization of the preTCR is not required 
for signal initiation at the β-selection checkpoint.  
Figure 3.21 
 
 
 
 
Figure 3.21 pTα
a
-DRRA and pTα
b
-R117A form signalling-competent preTCRs. 
Bar chart (from n=7 experiments) of pTα KO E14 thymocytes transduced with 
vector alone, pTα
a
, pTα
b
, pTα
a
-DRRA or pTα
b
-R117A and cultured for 8-15 days in 
FTOC. Live cells were analysed for TCRδ and CD3ε. The percentage of TCRδ
(+)
 
CD3ε
(+)
 cells are shown for untransduced thymocytes (black bars) and transduced 
thymocytes (hatched bars).* p≤ 0.05 and *** p≤ 0.001.   
  
3.7 pTαa-DRRA and pTαb-R117A promote qualitatively similar 
development to pTαb. 
The previous result clearly indicates that pTαa-DRRA and pTαb-R117A can 
form signalling competent preTCRs. To further investigate, the 
characteristics of αβ T cell development was assessed. Because the most 
striking difference between the phenotype of pTαa and pTαb was seen in the 
percentage of mature TCRβ(hi) cells and ISPs that developed in 15-day 
FTOC, analysis of pTαa-DRRA and pTαb-R117A was focused on these 
populations. As described in chapter two, pTαa expression in pTα KO 
thymocytes promoted the accumulation of ISPs resulting in a significantly 
higher percentage (~37%) to that seen in vector-only or pTαb-expressing 
cultures (both ~10% p≤ 0.001) (Figure 3.22). Importantly, the percentage of 
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ISP thymocytes that developed as a result of pTαa-DRRA expression was 
only ~16%, significantly lower than pTαa (p≤ 0.001) (Figure 3.22). Indeed, 
this percentage of ISPs was not significantly different to that promoted by 
pTαb (Figure 3.22). Thus, mutating the three “oligomerization” residues 
unique to pTαa (i.e. absent in pTαb) generates a pTα allele that behaves 
similarly to pTαb; it promotes increased surface expression of TCRβ and 
does not expand the ISP subset.  
pTαb-R117A expression also promoted development of few ISPs (~13.5% - 
Figure 3.23) that was not significantly different to pTαb but much reduced 
compared to pTαa (p≤ 0.001). However, both pTαa-DRRA and pTαb-R117A 
generated significantly increased numbers of mature TCRβ(hi) cells (Figure 
3.23). Expression of pTαa results in only ~15% of these cells (compared to 
~5% for vector only). By contrast, pTαb promoted development of ~40% 
TCRβ(hi) cells, while both pTαa-DRRA and pTαb-R117A generated ~37% 
TCRβ(hi) cells. Importantly, there was no significant difference between 
these figures and that seen for pTαb. 
Figure 3.22 
 
 
 
 
Figure 3.22 pTα
a
-DRRA and pTα
b
-R117A do not expand the ISP population.  
Bar chart (from n=6 experiments) of E14 pTα KO thymocytes transduced with 
vector alone, pTα
a
, pTα
b
, pTα
a
-DRRA or pTα
b
-R117A that were analysed for 
percentage of ISPs after 8-15 days in FTOC. Percentage of ISPs is shown for non-
transduced thymocytes (black bars) and transduced thymocytes (hatched bars). 
Cells are TCRδ
(-)
 TCRβ
(lo)
 CD8
(+)
. ns is not significant, * p≤ 0.05 and *** p≤ 0.001.   
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Figure 3.23 
 
 
 
 
 
Figure 3.23 pTα
a
-DRRA and pTα
b
-R117A promote development of mature 
TCRβ
(hi)
 cells. Bar chart (from n=6 experiments) of E14 pTα KO thymocytes 
transduced with vector alone, pTα
a
, pTα
b
, pTα
a
-DRRA or pTα
b
-R117A that were 
analysed for percentage of TCRβ
(hi)
 cells after 8-15 days in FTOC. Percentage of 
TCRβ
(hi)
 cells is shown for non-transduced thymocytes (black bars) and transduced 
thymocytes (hatched bars). Cells are TCRδ
(-)
 TCRβ
(hi)
, ns is not significant, * p≤ 
0.05 ** p≤ 0.01 and *** p≤ 0.001.   
 
3.8 Summary. 
To conclude, mutation of oligomerization residues in both pTαa and pTαb did 
not perturb their interaction with TCRβ as all pTα mutant alleles; pTαa-
R24A, pTαa-DRRA and pTαb-R117A were able to increase TCRβ on the 
surface of transduced thymocytes. Importantly, the preTCRs formed by the 
mutated pTα alleles were also able to signal and rescue αβ T cell 
development in pTα KO FTOCs as judged by a reduction in the percentage 
of γδ cells. Although removing the oligomerization residues did not affect 
preTCR signal initiation, it did affect the characteristics of the preTCRs that 
were formed from the mutant alleles. The oligomerization-deficient 
preTCRs were expressed at higher levels on the cell surface, similar to that 
seen for pTαb, and promoted very similar T cell development to pTαb. Thus, 
the ISP subset was not expanded (as seen for pTαa) and generation of 
mature TCRβ(hi) cells was favoured. Therefore, it appears that 
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oligomerization of the preTCR is not required for signalling per se. 
However, the ability to oligomerize appears to regulate the surface 
expression of the preTCR which in turn determines the functional outcome 
of preTCR signalling. Importantly, because pTαa-DRRA promotes 
development in a similar manner to pTαb, the ability to oligomerize is what 
distinguishes pTαa from pTαb.  
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Chapter 4 
Investigating the role of the preTCR in establishment of signalling 
thresholds in pre-selection DP thymocytes. 
 
4.1 Introduction.  
The results described in the previous chapters do not provide strong 
evidence to support our original hypothesis that pTαa and pTαb specified 
developments of different T cell lineages. Nonetheless, it was clear from 
the pTα KO FTOCs that sustained expression of pTαa was deleterious to 
the maturation of thymocytes beyond the ISP stage. By contrast, pTαb did 
not show this developmental restriction, allowing cells to progress through 
to the mature SP stage apparently unperturbed. Thus, it is possible that 
pTαb is required alongside pTαa for efficient development of αβ T cells. 
Because pTαb-expressing thymocytes were not blocked at the ISP to DP 
transition, signalling through preTCRb may promote progression to, and 
establishment of, the DP stage. Evidence from the expression analysis may 
support this hypothesis as transcripts for pTαb were found in greater 
abundance than those for pTαa within the DP population. Moreover, 
because a greater percentage of mature thymocytes developed as a result 
of pTαb expression, it is possible that this isoform also promotes the DP to 
SP transition. In this regard, the role of the preTCR and specifically 
preTCRb in the establishment of the DP stage and in positive selection was 
investigated.  
Positive selection of DP thymocytes is achieved through weak interactions 
of TCRαβ with self-peptide/MHC. It has been reported that pre-selected 
DPs are highly sensitive to signals through the TCR, and that this increased 
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sensitivity is required in order to select as broad a TCR repertoire as 
possible (Gallo et al., 2007). These authors identified a pool of “sensitive” 
pre-selected DPs by cross-linking CD3ε that resulted in rapid 
phosphorlyation of the ERK1/2 MAP kinases. Calcium signalling via 
calcineurin was described to be essential for setting up the sensitized state, 
as “ERK-sensitive” DP cells could not be detected in calcineurin-deficient 
mice. The mechanisms underlying calcium release and calcineurin 
activation were not described in this report. However, it was evident that 
prior prolonged inhibition of calcineurin activation by CSA resulted in 
abrogation of the DP cell sensitivity, whereas CSA administered alongside 
TCR stimulation had little effect (Gallo et al., 2007). Thus, it appears that 
signals prior to the establishment of the DP stage are required for 
sensitizing DP cells for efficient positive selection. 
4.2 The preTCR is required for efficient positive selection of DP cells; 
ERK sensitivity is absent from pTα-deficient thymocytes. 
We hypothesised that preTCR signalling was necessary for setting up the 
“ERK-sensitive” state of DP cells that allows efficient positive selection 
through the TCR. To test this hypothesis pTα KO CD69(lo) DP thymocytes 
were analysed for their ability to phosphorylate ERK1/2 after 1-10 minutes 
cross-linking by anti-CD3ε antibody. Figure 4.1 shows phosphor-ERK 
analysis of adult C57BL/6 CD69(lo)DP cells, adult pTα KO CD69(lo)DP cells 
and WT CD69(lo)DP cells in the presence of an inhibitor of ERK 
phosphorylation. Phospho-ERK was assessed for each of these conditions, 
before cross-linking of CD3ε (0 minutes), or after 1, 2, 5 and 10 minutes of 
activation through the TCR.  Cross-linking WT adult thymocytes revealed a 
population of cells that rapidly phosphorylated ERK1/2; ~21% after 1 
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minute and ~25% after 2 minutes. These represented the “ERK-sensitive” 
DP cells described by Gallo and co-workers (Gallo et al., 2007).  
Figure 4.1 
 
 
 
 
 
 
 
 
Figure 4.1 The “ERK-sensitive” DP population is absent in pTα KO mice. 
Representative FACS plots (from n=3 experiments) of CD69
(lo)
DP thymocytes from 
C57BL/6 (WT) and pTα KO adult mice that were analysed for intracellular ERK1/2 
phosphorylation at time-zero (0 min) and after 1, 2, 5 and 10 minutes cross-linking 
of anti-CD3ε. WT CD69
(lo)
DP cells were activated in the presence of an inhibitor of 
ERK-phosphorylation (UO126) as a negative control. Numbers represent 
percentages of cells within the gates. 
 
Phosphorylation of ERK was transient and was lost after 5 minutes of 
activation. In the presence of the phosphorylation inhibitor no increase in 
phospho-ERK was seen and the proportion of phospho-ERK(+) cells 
remained low (≤ 0.2%) at all time points. Importantly, the increase in 
phospho-ERK in DP cells was not observed for pTα KO CD69(lo)DP cells. 
Only ~8% were phospho-ERK(+) after 1 minute, a figure which decreased at 
2 minutes to ~5%. Similar to the WT DP cells the percentage of pTα KO 
190 
 
CD3ε
CD3ε
CD8α
C
D
4
WT:
pTαKO:
82.7%
16.7%
1.5%
9.6%
MFI:535
MFI: 735
phospho-ERK(+) DP cells returned to basal levels by 5 minutes. These data 
suggest that pTα KO DP cells have a markedly reduced “ERK sensitivity” 
as very few were able to phosphorylate ERK after brief stimulation through 
the TCR.  To ensure that the lack of ERK phosphorylation by pTα KO DP 
cells was not merely due to a lower level of CD3ε on the surface of the 
cells, C57BL/6 (WT) and pTα KO DP cells were analysed for surface CD3ε 
levels.  Figure 4.2 demonstrates that if anything there is a higher surface 
expression of CD3ε (MFI 735) in pTα KO DP cells compared to the 
equivalent WT population (MFI 535).  
Figure 4.2 
 
 
 
 
Figure 4.2: pTα KO DP cells express comparable surface levels of CD3ε 
compared to WT DP cells. Representative FACS plots of total thymocytes from 
C57BL/6 (WT) and pTα KO adult mice that were analysed for CD3ε expression on 
DP cells. MFI is mean fluorescence intensity.  
 
The results suggest that the preTCR plays a role in sensitising DP cells to 
subsequent signals through TCRαβ and that in the absence of the preTCR 
the “ERK-sensitive” CD69(lo)DP population was markedly reduced. 
Therefore we wanted to determine whether re-introduction of preTCR 
signalling by expression of either pTαa or pTαb in pTα KO thymocytes 
restored the “ERK-sensitive” DP state. To this end, E14 pTα KO 
thymocytes were transduced with pTαa and pTαb, and after 12-day FTOC 
were assayed for ERK-sensitivity by cross-linking CD3 and intracellular 
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analysis of phospho-ERK on DP cells as described above. Figure 4.3 
shows the results from this analysis. The first column represents adult WT 
DP cells after 0, 1, 1.5, 2 and 5 minutes of anti-CD3ε cross-linking; the 
second column shows adult pTα KO DP cells; the third shows the results 
for pTα KO DP cells transduced with pTαa and the fourth pTα KO cells 
transduced with pTαb. The FTOCs produced limited thymocyte numbers, so 
only two time points could be performed; time 0 and 1 minute cross-linking.  
Figure 4.3 
 
 
 
 
 
 
Figure 4.3 Expression of preTCR
a
 and preTCR
b 
in pTα KO DP thymocytes did 
not restore “ERK-sensitivity”: FACS plots show CD69
(lo)
DP cells from adult 
C57BL/6 or pTα KO mice and pTα KO DP thymocytes transduced with either pTα
a
 
or pTα
b
, after 11-day FTOC. CD69
(lo)
DP cells
 
were analysed for intracellular 
ERK1/2 phosphorylation after time zero, or 1, 1.5, 2 and 5 minutes activation by 
cross-linking with anti-CD3ε antibody. The numbers represent the percentage cells 
in each gate. 
  
Similar to previous results (Figure 4.1) after 1 minute activation a large 
proportion of WT DP cells have phosphorylated ERK (~36% compared to 
~6% at time 0). This percentage remained high after 1.5 and 2 minutes of 
cross-linking before reducing to basal levels after 5 minutes (Figure 4.3). 
pTα KO DP cells again displayed a reduced capacity to phosphorylate ERK 
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compared to WT DP cells. Surprisingly, DP thymocytes transduced with 
pTαa and pTαb did not show increased phosphorylated ERK, instead 
behaving in a similar manner to pTα KO thymocytes (Figure 4.3). 
Therefore, in this experiment it was not possible to restore the ERK-
sensitivity of pTα KO thymocytes to that of WT cells by expression of either 
preTCRa or preTCRb. Despite this result, it appears that preTCR-deficient 
DP thymocytes lack ERK sensitivity and are therefore unresponsive to 
weak signalling through the TCR suggesting that these cells will have 
altered signalling thresholds for positive and negative selection.  
4.3 Evidence that pTα KO thymocytes have an altered threshold for 
selection. 
The relative unresponsiveness of pTα KO DP cells to signals through the 
TCR would suggest that these cells may require strong signals for positive 
selection. In other words, the threshold for positive selection would be 
higher for pTα KO thymocytes (Figure 4.4). Therefore, we hypothesised 
that high-affinity TCR/MHC/peptide interactions which would normally 
delete WT DP thymocytes would positively select pTα KO DP thymocytes 
(Figure 4.4).  
Superantigens are pathogen products capable of activating subsets of T 
cells bearing specific TCRβ chains (Kappler et al., 1988; MacDonald et al., 
1988). This broad specificity is due to the fact that superantigens do not 
follow conventional antigen processing pathways in order to bind MHC. On 
the contrary, these proteins are able to attach to MHC-II alpha chains 
outside of the peptide binding pocket. Superantigens activate T cells by 
binding to specific TCRβ chain variable regions (Figure 4.5). Superantigen 
cross-linking of the TCR in peripheral tissues results in massive production 
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of cytokines (Figure 4.5a), a mechanism by which the superantigen-
producing microbe mediates its pathogenicity. 
Figure 4.4 
 
 
 
 
 
Figure 4.4: A schematic of the hypothesis: pTα KO thymocytes have a higher 
threshold for positive selection so that a high affinity interaction with MHC-self-
peptide which would negatively select WT thymocytes, results in positive selection 
of pTα KO cells.  
 
Many inbred mouse strains encode endogenous retroviral elements, 
specifically those of the mouse mammary tumour virus (MMTV) family, 
which express superantigens (Kappler et al., 1988; MacDonald et al., 
1988). When expressed in the thymus the high-affinity TCR-MHC 
interaction induced by the superantigen leads to the deletion of T cells 
bearing specific Vβ chains (Woodland et al., 1991) (Figure 4.5b). Therefore, 
superantigen expression provides a useful tool for analysing negative 
selection events in the mouse thymus. 
Here, we sought to determine whether superantigen-driven negative 
selection occurred normally in pTα KO thymocytes. However, the pTα KO 
mouse is bred on a C57BL/6 background that does not express the MHC-II 
I-Eα chain that presents MMTV superantigens. Therefore, T cells are not 
deleted by superantigens in C57BL/6 or pTα KO mice. In an attempt to 
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overcome this limitation mixed FTOCs were set-up using pTα KO mice, 
C57BL/6 mice and DBA/2 mice, that are Eα positive and encode seven 
MMTV endogenous proviruses; 1, 6, 7, 8, 11, 14 and 17, capable of 
deleting nine different TCRβ chains; Vβ3, 5, 6, 7, 8.1, 9, 11 and 12.  
Figure 4.5 
 
 
 
 
 
 
 
Figure 4.5 Depiction of the action of superantigens in the periphery and 
thymus. Superantigens bind MHC-II outside of the peptide binding pocket. 
Superantigens activate T cells by binding to specific TCRβ chain variable regions. 
In the periphery (A) this results in massive production of cytokines by the activated 
T cell (cytokine storm). In the thymus (B) superantigen activation of T cells leads to 
deletion (death) of thymocytes bearing superantigen-specific TCRβ chains. APC is 
antigen presenting cell and TEC is thymic epithelial cell. 
 
Figure 4.6 illustrates the experimental design; thymic lobes were collected 
from the DBA/2 E15 mice and depleted by 5-day 2-deoxy-guanosine 
treatment. C57BL/6 and pTα KO DN2/3 thymocytes were then sorted by 
FACS and used to repopulate the depleted DBA/2 lobes.  After 10-15-day 
FTOC CD4 thymocytes were analysed for Vβ-specific TCRβ expression 
(Figure 4.6). C57BL/6 E15 lobes were used as controls as negative 
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selection of thymocytes is not expected to occur in these lobes as they lack 
the Eα chain for superantigen presentation.  
Figure 4.6 
 
 
 
 
 
 
 
 
Figure 4.6 Experimental design for investigating the negative selection 
threshold of pTα KO thymocytes. An illustration of the mixed FTOC method is 
shown. DN2/3 thymocytes were isolated by FACS from C57BL/6 or pTα KO adult 
mice and used to repopulate depleted E15 thymic lobes from DBA/2 (Eα
(+)
) or 
C57BL/6 (Eα
(-)
) mice. After 10-15-day FTOC CD4 thymocytes were analysed for 
Vβ-specific TCRβ expression. 
 
The lack of T cells bearing Vβ5 and Vβ6 was evident in adult DBA/2 mouse 
thymus, as only 0.7% of TCRαβ(+)CD4(+) T cells were Vβ6(+) and only 0.8% 
were Vβ5(+). By contrast, in C57BL/6 mice, 6.9% were Vβ6(+) and 2.1% were 
Vβ5(+) (Figure 4.7).  
TCRαβ(+)CD4(+) thymocytes from C57BL/6 and pTα KO mice were analysed 
for Vβ5, Vβ6 and Vβ8 after 15 days FTOC in DBA/2 or C57BL/6 stroma. 
Unfortunately, the staining for Vβ5 and Vβ8 analysis was not of the quality 
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which allowed definitive conclusions to be drawn. However, the Vβ6 
analysis was more robust, although not entirely as expected. WT C57B/L6 
T cells were not deleted in C57B/L6 lobes consistent with the lack of 
superantigen presentation (Figure 4.8). However, they were also not 
deleted in DBA/2 lobes. We think this may be due to low MHC-II expression 
in depleted lobes, although direct evidence for this has not yet been 
obtained.  
Figure 4.7 
 
 
 
 
 
 
Figure 4.7 Thymocytes bearing Vβ6 and Vβ5 chains are deleted in the DBA/2 
thymus: CD4
(+)
TCRβ
(hi)
 thymocytes from adult C57BL/6 and DBA/2 mice were 
analysed for Vβ6 and Vβ5 expression. Numbers represent percentages in relevant 
quadrants.  
 
Importantly, however, we did see a significant difference in Vβ6 expression 
when pTα KO thymocytes were cultured in C57BL/6 lobes compared to 
DBA/2 lobes (Figure 4.9). In C57B/L6 lobes 4.2% of CD4(+)TCRβ(hi) cells 
were Vβ6(+) which increased to 13.1% in DBA/2 lobes. Thus, there is 
preliminary evidence to suggest that pTα KO thymocytes may respond 
differently to WT thymocytes upon interaction with high-affinity TCR-
stimulation.  
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Figure 4.8 
 
 
 
 
Figure 4.8 pTα KO thymocytes respond differently to WT thymocytes in 
DBA/2 stroma. Dot plot showing CD4SP thymocytes from C57BL/6 (black dots) 
and pTα KO (red dots) mice that were cultured for 15 days in C57BL/6 or DBA/2 
depleted E15 thymic lobes. CD4
(+)
TCRβ
(hi)
 cells were analysed for Vβ6 expression. 
The percentage of Vβ6
(+) 
cells is shown, * p≤ 0.05, ns is not significant.  
 
Collectively the results begin to suggest a role for the preTCR regulating 
the threshold for positive selection at the DP stage in thymic ontogeny. 
Admittedly, the project would benefit from a more extensive investigation 
into the negative selection thresholds of pTα KO thymocytes, but 
preliminary data would suggest that the T cell repertoire of the pTα KO 
mouse could be enriched for auto-reactive T cells. If proved correct, these 
results would implicate the preTCR in regulating the appropriate selection 
of a broad non-self-reactive TCR repertoire, with important consequences 
for autoimmune disease.  
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Chapter 5 
 pTαa and pTαb BAC transgenic mice 
 
5.1 Introduction  
The FTOC data of the previous chapter clearly demonstrate the differential 
effects of expression of pTαa and pTαb on T cell development. However, 
despite the usefulness of the FTOC system there are limitations. Perhaps 
the most important of these for this work is that the regulation of expression 
of pTαa and pTαb is under the control of a retroviral promoter (LTR) and thus 
not regulated by its own regulatory sequences. This is important, especially 
when considering pTαa as constitutive expression of pTαa into the DP stage, 
where, as the PCR data suggests, pTαa expression should be normally 
terminated, appears to be detrimental for continued T cell development. 
Thus, physiological regulation of pTαa expression at the DN-ISP stage, is 
critical for the appropriate developmental outcome of developing 
thymocytes.  A further limitation of FTOC is that only a relatively small 
number of thymocytes can be obtained from each thymic lobe. Unlike an 
adult mouse thymus which contains approximately 200 million thymocytes, 
FTOC produces nearer 200,000 cells. Rigorous analyses such as 
intracellular stains are much more difficult to perform on low numbers of 
cells. For example, when staining the pTαb-transduced thymocytes for 
Foxp3, very few T-regs were recovered, making the results less reliable. In 
order to overcome these limitations bacterial artificial chromosome (BAC) 
transgenic mice for pTαa and pTαb were generated. 
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pTα-deficient mice that express either pTαa or pTαb under the Lck promoter 
have been made (Gibbons et al., 2001). In this report, it was shown that 
both isoforms of pTα were able to function and rescued the αβ 
developmental block in the pTα KO mouse. However, the rescued mice did 
not have completely normal development and the different developmental 
capabilities of the two isoforms were not thoroughly analysed in this study. 
In addition, the pTαa and pTαb transgenes were expressed under the Lck 
promoter, so like our FTOC system, were not physiologically regulated. 
BAC transgenic mice are advantageous in this respect because a large 
section of genomic DNA containing the pTα gene can be used. Thus, pTα 
will be incorporated into the host genome along with its regulatory elements 
and so physiological timing of expression of pTαa and pTαb at the DN stage 
should be achieved. A further advantage of making BAC transgenics is that 
it makes it possible to perform analyses that are otherwise not possible 
when using the FTOC system. These include the analysis of the migration 
of T cells once they leave the thymus, and the identification of their function 
and location in the periphery.  
5.2 Recombineering to generate pTαa and pTαb BAC constructs.  
5.2.1 The pTαa and pTαb BAC constructs. 
BACs are large vector plasmids that carry up to 70kb of inserted DNA. 
Figure 5.1 shows the BAC constructs used for generating “pTαa-only” and 
“pTαb-only” transgenic mice. The “pTαa-only” construct consists of the 
complete coding sequence for pTα but with exons 1 and 2 fused to prevent 
any splicing events taking place that would remove exon-2 and produce 
pTαb. Thus, mice expressing this construct will only be able to express 
pTαa. The “pTαb-only” construct lacks exon-2, intron-1 and intron-2, 
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“pTαa – only” BAC construct:
“pTαb – only” BAC construct:
effectively fusing exons 1 and 3 so that only pTαb can be generated by mice 
expressing this construct.  
Figure 5.1 
 
 
 
 
Figure 5.1 Constructs for “pTα
a
- only” and “pTα
b
- only” BAC transgenic mice: 
Exon 1 and 2 are fused in the “pTα
a
- only” construct preventing removal of exon-2 
by differential splicing. Exon-2, intron-1 and intron-2 have been knocked out of the 
“pTα
b
- only” construct and exons 1 and 3 fused, so that pTα
b 
is exclusively 
expressed by this construct. 
 
The BMQ452P20 BAC, used for generating the constructs, was purchased 
from Ensembl organisation and consisted of 46KB of chromosomal DNA 
from chromosome 17 of C57BL/6 mice. This region included an 8.5kb 
region in the centre of the BAC that contained the pTα gene. The constructs 
were generated by a method called recombineering, which is a method of 
genetic engineering by use of bacterial homologous recombination 
(Warming et al., 2005).  
5.2.2 An overview of the Recombineering system. 
The BMQ452P20 BAC was electroporated into SW102 E.coli cells for 
recombineering (Warming et al., 2005). SW102 contain a defective λ 
prophage inserted into the bacterial genome. The phage genes, exo, bet, 
and gam, are transcribed from a temperature regulated promoter. The 
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promoter is inactive at 32°C but can be activated after 15 minutes heat 
shock at 42°C. This activation generates the recombination proteins; exo 
codes for a 5'-3' exonuclease that creates single-stranded overhangs on 
linear DNA that is introduced into the SW102 cells that is homologous to 
the site that is to be targeted; bet protects these overhangs and aids in the 
subsequent recombination process; and gam prevents degradation of the 
linear DNA (Warming et al., 2005). The linear DNA that is to be used to 
target the BAC (for example a PCR product or oligo) is introduced into 
heat-shocked electrocompetent SW102 bacteria using electroporation. The 
introduced DNA then undergoes homologous recombination with the BAC 
changing its sequence (Figure 5.2).  
Figure 5.2 
 
 
 
 
 
Figure 5.2 An illustration of the galk selection and counter-selection 
recombineering method. In the first step galk is introduced to the BAC, via linear 
DNA (a galk PCR product), by homologous recombination between homology 
regions (H1 and H2) in the BAC and galk cassette. galk
(+) 
SW102 bacteria are then 
selected for by culture on galactose containing medium.  galk is then replaced with 
a double-stranded DNA oligo that contains regions of homology (H3 and H4) with 
the BAC. This is achieved by counter selection using minimal medium containing 
2-deoxy-galactose (DOG) with glycerol as the sole carbon source. Thus the galk
(+) 
SW102 bacteria are selected against in this 2
nd
 step.   
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In addition to the phage genes, SW102 cells also contain a fully functional 
gal operon, except the galk gene is missing. The ability to grow on 
galactose minimal medium can be restored by adding galk in trans (i.e. by 
inserting a galk expression cassette into the BAC). Therefore, SW102 
clones that have undergone a recombination event to insert the galk 
cassette can be selected on galactose-containing medium.  Next, the galk 
cassette can be replaced by any DNA of choice by selection against galk 
using 2-deoxy-galactose. Thus, BAC sequences can be manipulated using 
homologous recombination with the galactose selection and counter-
selection process (Figure 5.2). 
5.3 Insertion of galk into the pTα-containing BAC. 
Figure 5.3 shows the recombineering strategy for generating the pTαa BAC 
constructs (see figure 5.8 for pTαb BAC strategy). The first targeting step 
was common for generation of both the pTαa and pTαb constructs. Two 
primers; P21 and P22, were used to amplify galk from a pGalk containing 
plasmid. P21 and P22 also contain 50bp homology to the intron sequence 
of pTα between exon-1 and exon-2 as well as 25bp homology to the 5’ and 
3’ end of the galk cassette. The resulting PCR product consists of the galk 
gene flanked by 50bp homology arms to the targeted site in the pTα gene. 
The galk PCR product was electroporated into SW102 cells containing the 
pTα BAC that had been heat-shocked to activate the recombineering 
machinery. The cells were grown on galactose-containing medium to select 
for those bacteria containing the BAC that had incorporated the galk 
sequence by homologous recombination. Transformants were analysed by 
restriction digest to confirm the presence of the galk sequence. The 
enzymes used for restriction digest characterisation were Hpa1, Xho1 and 
Xba1. Each of these enzymes was chosen because they cut in and around 
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the target site and because they cut the pTα BAC in fewer than 15 places 
(Figure 5.4).  
Figure 5.3 
 
 
 
 
 
 
 
Figure 5.3 Diagram of the recombineering method to generate the “pTα
a
- 
only” BAC construct: In the first step galk is inserted into a BAC containing the 
pTα gene, via a galk PCR product, by homologous recombination. The galk PCR 
product was generated using primers p21 and p22 that possess 50bp homology to 
the intron sequence between exons 1 and 2 of pTα (green and turquoise). The 
galk
(+)
 pTα BAC is selected for by the presence of galactose in the medium. galk is 
then replaced by a double stranded DNA oligo (p23+p24) that is homologous to 
75bp regions at the 3’ end of exon-1 (yellow) and the 5’ end of exon-2 (orange) of 
pTα. Thus, replacement of galk results in fusion of exons 1 and 2 to generate the 
pTα
a
 construct. The galk
(-)
 pTα BAC was selected for on 2-deoxy-galactose 
containing medium with glycerol as the only carbon source.  
 
A successful integration of galk could be readily detected by changes in the 
sizes of DNA fragments produced by these enzymes. Figure 5.4A shows 
the restriction maps for Hpa1, Xho1 and Xba1 for the pTα BAC sequence. 
Insertion of the galk cassette between exon-1 and 2 of pTα removes two 
Hpa1 sites generating one large fragment across the target site (19kb) in 
place of two smaller fragments present in the parent BAC (Figure 5.4B). 
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For the Xho1 and Xba1 digests, insertion of the galk cassette results in a 
decrease in size of about 2.8kb for each of the fragments traversing the 
target site; so that the 14.8kb Xho1 fragment is reduced to 11.9kb and the 
11.8kb Xba1 fragment is reduced to 9kb (Figure 5.4B).  
Figure 5.4 
 
 
 
 
 
 
 
Figure 5.4 Hpa1, Xho1 and Xba1 restriction digest maps for the pTα BAC and 
the galk
(+)
 pTα BAC. Restriction maps for Hpa1, Xho1 and Xba1 for the parent 
pTα BAC (A) and the galk
(+)
 pTα BAC (B) in which galk was inserted between 
exons 1 and 2 of pTα. Insertion of galk results in the loss of two Hpa1 sites 
resulting in the formation of a 19kb fragment in the galk(+) pTα BAC in place of two 
fragments of 9.1kb and 12.7kb present in the parent BAC. galk insertion results in 
the loss of ~2.8kb from the target region thus, reducing the size of an Xho1 
fragment from 14.8kb to 11.9kb, and a Xba1 fragment from 11.8kb to 9kb in the 
galk(+) pTα BAC. Boxes are drawn around the fragment sizes that are altered as a 
result of galk insertion. 
 
Figure 5.5 shows that galk(+) clones could be detected by Hpa1, Xho1 and 
Xba1 digests. The Xho1 digest revealed four potential galk(+) clones that 
had gained a ~11.9kb fragment in place of the 14.8kb fragment seen in the 
parent BAC (clones 1,3,8 and 11 Figure 5.5A). Three of the four potential 
galk(+) clones, when digested with Xba1, appeared to have gained a 9kb 
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fragment in place of the 11.8kb fragment present in the parent BAC (clones 
3, 8 and 11) (Figure 5.5B). From the Hpa1 digest it appears that all four 
clones had lost the 9.1kb and 12.7kb fragments, present in the parent BAC 
and gained a 19kb fragment in their place. The galk(+) BAC clones were 
sequenced and clone 11 was transformed into fresh SW102 cells for use in 
subsequent recombineering steps. 
Figure 5.5 
 
 
 
 
 
 
 
Figure 5.5: Restriction digest analysis of galk
(+)
 pTα BAC clones. (A) 15 galk
(+)
 
pTα BAC clones that had been positively selected on galactose containing medium 
were subjected to Xho1 digestion which revealed four potential galk
(+)
 pTα BAC 
clones that had lost a 14.8kb fragment present in the parent (BAC) and gained an 
11.9kb fragment. (B) the four galk
(+)
 pTα BAC clones identified in (A) were digested 
with Xba1. Clones 3,8 and 11 appear to have gained a 9kb fragment in place of an 
11.8kb fragment present in the parent BAC. (C) the four galk
(+)
 pTα BAC clones 
identified in (A) were digested with Hpa1 and all appeared to have gained a 19kb 
fragment in place of the 12.7kb and 9.1kb fragments present in the parent BAC. 
Clone 11 was used for subsequent targeting steps. Sizes of fragments are in 
kilobases (kb). 
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5.4. Generation of the pTαa BAC construct. 
The second recombineering step (see Figure 5.3) involved the deletion of 
intron-1 and fusion of exons 1 and 2. This was achieved by “replacement” 
of the galk sequence with a double-stranded oligonucleotide. For the pTαa 
BAC a double-stranded oligonucleotide was generated by annealing two 
100bp complimentary primers consisting of 50bp of homology to the 3’ end 
of exon-1 and 50bp of homology from the 5’ end of exon-2 (P23 and P24). 
The annealed P23 and P24 primers was electroporated into SW102 cells 
containing the galk(+) BAC. Homologous recombination by the bacteria 
resulted in the removal of the galk cassette and fusion of exon-1 with exon-
2, with the galk(-) transformants being selected on deoxy-galactose 
containing medium.  
Figure 5.6 
 
 
 
 
 
 
Figure 5.6 Generation of the pTα
a
-only BAC; Xba1 digests of galk
(-)
 clones. (A) 
A restriction map for Xba1 for the pTα
a
-only BAC in which exons 1 and 2 have 
been fused and intron-1 and galk removed. The loss of intron-1/galk results in a 
reduction in size of a Xba1 fragment from 9kb to 7.1kb. (B) Xba1 digests for 5 galk
(-
) 
clones (selected on media containing deoxy-galactose) and the galk
(+)
 parent BAC 
(from the first recombineering step). Three clones appear to have lost the 9kb 
fragment present in the parent and gained a 7.2kb fragment in its place (B, D and 
E). Boxes are drawn around the fragment sizes that characterise the recombination 
event (sizes are in kilobases).   
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The transformants were analysed by Xba1 digest. Figure 5.6A is an Xba1 
restriction map for the pTαa-only BAC. The fusion of exons 1 and 2 reduces 
the size of a 9kb fragment seen in the parent BAC (galk(+) pTα BAC, Figure 
5.4B) to 7kb in length. Figure 5.6B shows an Xba1 digest of five galk(-) 
transformants, three of which appear to have lost the 9kb fragment present 
in the parent BAC and gained a 7kb band (clones B, D and E in Figure 
5.6B).    
Figure 5.7 
 
 
 
 
 
 
Figure 5.7 Isolation of the pTα
a
-only fragment for generation of transgenic 
mice. (A) Spe1 restriction map for the pTα
a
-only BAC. Spe1 digestion produces a 
28.6kb fragment that includes the pTα
a
-only gene encompassed by 10kb and 15kb 
of sequence either side. (B) Gel electrophoresis of the pTα
a
-only gene Spe1 
fragment (26.8kb) that was isolated for pro-injection.  
 
Once putative pTαa BACs were identified by restriction digest they were 
sent for sequencing in the area of the mutated DNA. The pTαa BAC was 
then digested using Spe1 to generate a 28.6kb fragment with the pTαa-only 
gene in the centre. Spe1 was used because it cut 10kb upstream of the 
start site and 15kb downstream of exon-4 therefore ensuring that the 
regulatory elements for pTα transcription were included in the transgene 
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(Reizis and Leder, 1999) (Figure 5.7A). Following gel extraction and 
purification the fragment was resuspended in pro-injection buffer and used 
for pronuclear injection for generation of a pTαa-only transgenic mouse line 
(Figure 5.7).  
5.5 Generation of the pTαb BAC construct. 
The pTαb BAC construct was generated from the same galk(+) parent BAC 
as the pTαa construct (Figure 5.8). Deletion of exon-2, intron-1 and intron-2, 
and fusion of exons 1 and 3 was achieved by removal of the galk sequence 
using a double-stranded oligo generated by annealing complimentary 
100bp primers p31 and p32 (yellow and orange lines in Figure 5.8). 
Figure 5.8 
 
 
 
 
 
 
Figure 5.8 A diagram of the recombineering method to generate the “pTα
b
- 
only” BAC construct: In the first step galk is inserted into a BAC containing the 
pTα gene, via a galk PCR product, by homologous recombination. The galk PCR 
product was generated using primers p21 and p22 that possess 50bp homology to 
the intron sequence between exons 1 and 2 of pTα (green and turquoise). The 
galk
(+)
 pTα BAC is selected for by the presence of galactose in the medium. galk is 
then replaced by a double stranded DNA oligo (p31+p32) that is homologous to 
85bp regions at the 3’ end of exon-1 (yellow) and exon-3/intron-3 (orange) of pTα. 
Thus replacement of galk results in fusion of exons 1 and 3 to generate the pTα
b
 
construct. The galk
(-)
 pTα BAC was selected for on 2-deoxy-galactose containing 
medium with glycerol as the only carbon source.  
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P31 consisted of 85bp homology to the 3’ region of exon-1 and 15bp 
homology to the 5’ end of exon-3. P32 consisted of 15bp homology to the 3’ 
end of exon-1, all 45bp of exon-3 and 40bp of the 5’ end of intron-3. Once 
the primers were annealed and extended the oligo was then electroprated 
into SW102 cells containing the galk(+) BAC and homologous recombination 
removed the galk cassette by replacing the sequence with that of the oligo 
resulting in the fusion of exons 1 and 3. Once again galk(-) transformants 
were analysed for identification of the fusion event by Xba1 restriction 
digest (Figure 5.9A). Figure 5.9B shows Xba1 digests for six galk(-) 
transformants; two putative pTαb-only BAC clones were identified by the 
loss of the 9kb fragment present in the parent BAC and acquisition of a 
5.4kb band (clones A and B in figure 5.9B).  
Figure 5.9 
 
 
 
 
 
 
Figure 5.9 Generation of the pTα
b
-only BAC; Xba1 digests of galk
(-)
 clones. 
(A) A restriction map for Xba1 for the pTα
b
-only BAC in which exons 1 and 3 have 
been fused. Fusion of exons 1 and 3 results in a reduction in size of a Xba1 
fragment from 9kb to 5.4kb. (B) Xba1 digests for six galk
(-) 
clones (selected on 
media containing deoxy-galactose) and the galk
(+)
 parent BAC (from the first 
recombineering step). Two clones appear to have lost the 9kb fragment present in 
the parent and gained a 5.4kb fragment in its place (A and B). Boxes are drawn 
around the fragment sizes that characterise the recombination event (sizes are in 
kilobases).   
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The identified pTαb-only BAC was then sent for sequencing before being 
digested with Spe1 to produce a 25.4kb fragment for proinjection (Figure 
5.10A). The quality of the DNA was tested by running it out on an agarose 
gel (Figure 5.10B).   
Figure 5.10 
 
 
 
 
 
 
Figure 5.10 Isolation of the pTα
b
-only fragment for generation of transgenic 
mice. (A) Spe1 restriction map for the pTα
b
-only BAC. Spe1 digestion produces a 
25.4kb fragment that includes the pTα
b
-only gene encompassed by 10kb and 15kb 
of sequence either side. (B) Gel electrophoresis of the pTα
b
-only gene Spe1 
fragment (25.4kb) that was isolated for pro-injection.  
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5.6 Analysis of pTαa-only BAC transgenic founders.   
The pTαa-only transgenic construct was passed to the transgenic core 
facility at our institute for pronuclear injection into the male pronucleus of 
CD1 mouse fertilised eggs, as illustrated in Figure 5.11.  
Figure 5.11 
 
 
 
 
 
 
 
Figure 5.11 Generating a BAC transgenic mouse line: A schematic of the steps 
involved in generating the BAC transgenic founders. The BAC transgenic 
constructs were injected into the male pronucleus of CD1 mouse fertilised eggs. 
Once transferred to a pseudo-pregnant female the pronuclei fuse and the fertilised 
eggs begin to divide. The litter were genotyped for the presence of the transgene 
by PCR on genomic DNA. 
   
Once transferred into a pseudo-pregnant female the male pronucleus fuses 
with the female pronucleus and the fertilised eggs begin to divide. At 
weaning age the litter was ear-marked and the ear tissue used to extract 
genomic DNA for genotyping. The samples were genotyped using PCR on 
genomic DNA. Primers that amplified a 466bp non-coding sequence of the 
genome 9.5kb upstream of the pTα gene were used for a control PCR to 
confirm the presence and quality of the DNA (Figure 5.12A). PCR primers 
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that amplified a 450bp sequence traversing the exon-1 and 2 boundary 
were used to identify the pTαa transgene as this sequence would not be 
present in non-transgenic animals.  
Figure 5.12 
 
 
 
 
 
 
Figure 5.12 Genotyping pTα
a
-only BAC transgenic founders: 11 pTα
a
-only BAC 
transgenic founders were genotyped by PCR. (A) control PCR to confirm the 
presence and quality of the DNA using primers that amplified a 466bp non-coding 
sequence 9.5kb upstream of the pTα gene. 2ng of TCRδ KO genomic DNA was 
used for the positive control. (B) pTα
a
 transgene PCR using primers that amplify a 
450bp sequence traversing the exon-1 and 2 boundary unique to the transgene. 
For the positive control 2ng of TCRδ KO genomic DNA was spiked with the pTα
a
-
only Spe1 fragment. 
 
PCR on genomic DNA from eleven founder pups from the first pTαa 
transgene pro-injection identified only one transgene positive animal 
(sample number 4 in Figure 5.12B). This was the first pTαa transgenic 
founder. This animal was then paired with a pTα-/- x TCRδ-/- double 
knockout mouse (bred in our lab) in order to generate a “pTαa-only” 
transgenic mouse on a pTα-/- x TCRδ-/- background.  
Figure 5.13 shows the PCR analysis of a litter from a (“pTαa-only” 
transgenic founder x pTα-/-.TCRδ-/-) pairing.  There were 13 pups in this litter 
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Control PCR:
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and despite the fact that not all of the samples came up positive for the 
genomic DNA test, five of the animals (numbers 4, 6, 8, 9 and 10) were 
transgene positive.  
Figure 5.13 
 
 
Figure 5.13 Genotyping a “pTα
a
-only” transgenic founder X pTα
-/-
.TCRδ
-/-
 
litter. PCRs for 13 mice from a “pTα
a
-only” transgenic founder X pTα
-/-
.TCRδ
-/-
 
pairing are shown. A control PCR was performed to confirm the presence and 
quality of the DNA using primers that amplified a 466bp non-coding sequence 
9.5kb upstream of the pTα gene. 2ng of TCRδ KO genomic DNA was used as a 
positive control (+ve). The pTα
a
 transgene PCR was performed using primers that 
amplified a 450bp sequence traversing the exon-1 and 2 boundary unique to the 
transgene. For the positive control 2ng of TCRδ KO genomic DNA was spiked with 
a single copy of pTα
a
-only Spe1 fragment DNA. 
 
5.7 Initial analysis of pTαa-only mice on a “WT” background.  
To initially characterise the “pTαa-only” transgenic mice on a normal “WT” 
background, two transgene positive and two transgene negative animals 
were analysed. Figure 5.14 shows FACS analysis on thymocytes for two 
transgenic positive animals (8 and 9) compared to two transgene negative 
littermates (1 and 11). Effectively, these transgenic animals (on a WT 
background) are over expressing pTαa, so a dramatic phenotype was not 
expected. However, there did appear to be a subtle effect on mature 
TCRαβ(+) mature thymocytes in transgene positive animals. Thus, whereas 
normal littermates had 24.0% and 23.7% TCRαβ(hi) cells, this was reduced 
to 19.3% and 18.7% in transgene positive mice. This result is consistent 
with pTαa expression reducing the percentage of mature cells. However, the 
214 
 
TCRβ
TCRδ
TCRβ
CD8α
CD4
# 8 Transgene
positive
# 9 Transgene
positive 
# 11 Transgene
negative
# 1 Transgene
negative
0.3
99.5
0.2
99.7
0.4
99.5
0.2
99.6
76.2
75.2
69.6
72.5
80.5 19.3
81.0 18.7
75.7 24.0
75.9 23.7
Gated on live cells (A) (B) (C)
transgenic mice did not appear to have an overt increase in the ISP 
population.  
Figure 5.14 
 
 
 
 
 
 
 
Figure 5.14 FACS analysis of pTα
a
-only transgenic mice on a “WT” pTα
+/-
 
TCRδ
+/-
 background: FACS plots show thymocytes from two pTα
a
-transgene 
positive (8 and 9) and two pTα
a
-transgene negative littermates on a pTα
+/-
 TCRδ
+/-
 
background that were analysed for expression of TCRδ,
 
CD4, CD8α and TCRβ. (A) 
shows the percentage of TCRδ(+) cells, (B) shows the percentage of DP cells, and 
(C) shows the TCRβ expression profile for each of the mice that were analysed. 
Live cells are shown and the numbers represent percentages in each of the gates. 
 
5.8 Preliminary analysis of “pTαa-only” BAC transgenic mice on a  
pTα-/-TCRδ-/- background. 
After two generations of crossing pTαa-transgene-positive animals with pTα-
/- x TCRδ-/- mice, four mice were identified by PCR (as in Figure 5.13) and 
blood typing as being pTαa-transgene(+) pTα-/-. In addition to these, two 
littermates were identified as pTαa-transgene(+) pTα+/- and two as pTαa-
transgene(-) pTα(-/-). Flow cytometric analysis of the blood of these animals 
showed that γδ T cells were found in all of the mice that were analysed 
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(data not shown), suggesting that each of these mice had at least one 
intact TCRδ allele. Comparison of the ratio of CD4(+) and CD8(+) T cells in 
blood was helpful in determining the pTα gene status of the mice. pTα+/+ or 
pTα+/- (i.e. WT for pTα) mice appear to have a greater proportion of CD4(+) T 
cells in the blood compared with mice that lack the pTα gene (Figure 5.15). 
For example the CD4/CD8 ratio in the blood of pTα+/+ mice is higher at 4.2 
compared with that of the pTα-/- mice at 1.4 (Figure 5.15). Interestingly, the 
presence of the pTαa-transgene did not appear to significantly increase the 
CD4/CD8 ratio of a pTα-/- background (Figure 5.15).   
Figure 5.15 
 
 
 
 
Figure 5.15 Analysis of PBMC from pTα
a
-transgenic mice on different pTα 
backgrounds: Analysis of CD4 and CD8 T cell populations in the blood of pTα+/+, 
pTα-/-, pTα
a
-transgene
(+)
pTα
+/- 
and pTα
a
-transgene
(+)
pTα
-/- 
mice. Cells shown are 
B220
(-)
NK1.1
(-)
. Numbers indicate the percentages of cells in each gate.  
     
Analysis of the thymus of pTαa-transgene(+) pTα-/- mice revealed that pTαa 
transgene expression was able to largely rescue thymus size, as these 
mice (on average) had approximately 8.5x107 cells compared with 2x107 
cells observed for pTα-deficient animals (Figure 5.16). However, the rescue 
does not appear to be complete as the size of the pTαa-transgene(+) pTα-/- 
thymus was 2.3 fold less than the pTα+/+ thymus which consisted of 
approximately 2x108 cells (Figure 5.16).  The size of the pTαa-transgene(+) 
pTα+/- thymus, however, did resemble that of the WT at 1.9x108 cells.  
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Figure 5.16 pTα
a 
expression partially restores the thymus size of pTα-/- mice. 
Total cell counts from thymuses from pTα+/+, pTα-/-,pTα
a
-transgene
(+)
pTα
+/-
, pTα
a
-
transgene
(+)
pTα
-/- 
and pTα
a
-transgene
(-)
pTα
-/- 
(littermates).  Each dot represents an 
individual animal.  
 
5.9 The pTαa-transgene partially rescues αβ T cell development in a 
pTα-/- background. 
Consistent with the FTOC results and the increase in thymus size, pTαa 
expression largely rescued αβ T cell development in pTα-deficient animals, 
resulting in the reduction in the percentage of γδ cells in the thymus (Figure 
5.17A). Whereas, the percentage of γδ cells in the pTα-/- thymus was found 
to be ~13% (~7% for pTα-/- littermate), only ~1.2% of the pTαa-transgene(+) 
pTα-/- thymocytes were TCRδ(+). However, the percentage of γδ cells in the 
pTαa-transgene(+) pTα-/- thymus was approximately 5 fold greater than that 
observed for pTα+/+  and pTα+/- animals (Figure 5.17A), perhaps indicating 
that the rescue was not complete.  
The expression of the pTαa-transgene restored the proportion of DPs to 
approximately 60% in comparison with ~20% in pTα-deficient mice (Figure 
5.17B). Once again however, the restoration of αβ T cell development 
promoted by pTαa expression in pTα-deficient thymocytes does not appear 
to be complete, as the percentage of DPs in these mice was not equivalent 
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to that observed for pTα+/+ or pTα+/- animals, which had a larger proportion 
of DPs (79.4% and 73.6%, respectively) (Figure 5.17B). These results 
suggest that either the transgene is not expressed appropriately in these 
mice (despite expressing all the necessary pTα regulatory elements) or that 
pTαa alone is not sufficient to completely rescue T cell development in a 
pTα-deficient background.   
Figure 5.17 
 
 
 
 
 
Figure 5.17 pTα
a
-transgene expression partially rescues αβ T cell 
development in pTα
-/- 
mice. Representative FACS plots showing thymocytes from 
pTα+/+, pTα-/-,pTα
a
-transgene
(+)
pTα
+/-
, pTα
a
-transgene
(+)
pTα
-/- 
and pTα
a
-transgene
(-) 
pTα
-/- 
(littermates) were analysed for expression of TCRδ, CD3ε (A) and CD4 and 
CD8 (B). Numbers indicate percentages in each gate.   
 
5.10 Analysis of the DN compartment in pTαa-transgenic mice. 
To further investigate the nature of the incomplete rescue of αβ T cell 
development in these pTαa-transgenic mice, DN thymocytes, specifically 
DN3 and DN4, were analysed in more detail. In the thymus of pTα+/+ mice 
~37% of DN thymocytes were DN3 with ~40% being DN4 (Figure 5.18). In 
the absence of a preTCR, the majority of thymocytes are arrested at the 
DN3 stage. This can be seen in the pTα-deficient thymuses in which ~90% 
of DN thymocytes were DN3, with only ~5% DN4. In the presence of the 
pTαa-transgene in a pTα-deficient background the percentage of DN3s was 
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reduced to ~73% and the proportion of DN4s was increased slightly to 
~12% (Figure 5.18). This appears to be consistent with evidence from the 
percentages of both γδ and DP thymocytes, suggesting only a partial 
rescue of the pTα-/- phenotype. Progression of DN3 cells to the DN4 stage 
was not inhibited by the pTαa-transgene in pTα+/- thymocytes (Figure 5.18).  
Figure 5.18 
 
 
 
 
Figure 5.18 Analysis of DN thymocytes from pTα
a
-transgenic
 
mice. 
Representative FACS plots showing the percentages of DN3 and DN4 thymocytes 
from pTα
+/+
, pTα-/-, pTα
a
-transgene
(+)
pTα
+/-
, pTα
a
-transgene
(+)
pTα
-/- 
and pTα
a
-
transgene
(-)
pTα
(-/-) 
 (littermates) mice. Cells are TCRδ
(-)
B220
(-)
NK1.1
(-)
CD4
(-)
CD8
(-)
 
that were analysed for CD25 and CD44 expression. DN3 cells are CD44
(-)
CD25
(+)
 
and DN4 are CD44
(-)
CD25
(-)
. Numbers indicate percentages in each gate.  
  
5.11 pTαa-transgenic mice do not accumulate ISP cells. 
Expression of the pTαa-transgene restored development of a normal 
proportion of mature TCRβ(hi) cells in a pTα-deficient background. pTα-/- 
mice have only ~3.5% TCRβ(hi) cells, but this jumped to ~15% in the 
presence of the pTαa-transgene (Figure 5.19A). 
Importantly, when TCRβ(lo)CD8(+)CD4(-) ISP cells were assessed, there was 
no apparent accumulation of ISP cells in the thymuses of pTαa-transgene(+) 
pTα-/- animals (in comparison with pTα+/+ and pTα-/- mice) (Figure 5.19B). 
Indeed, a low percentage (~2.4%) was observed in all the mice analysed. 
These results suggest that the increased proportion of ISPs and fewer 
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TCRβ(hi) cells, observed for pTαa expression in FTOC may have been a 
direct result of prolonged constitutive expression of pTαa from the retroviral 
promoter. Thus, in the pTαa-transgenic mouse, in which the expression of 
pTαa is under control of endogenous regulatory elements, this phenotype is 
not observed.   
Figure 5.19 
 
 
 
 
 
Figure 5.19 ISP thymocyte development is not promoted by pTα
a 
transgene 
expression: Representative FACS plots showing thymocytes from pTα
+/+
, pTα-/-, 
pTα
a
-transgene
(+)
pTα
+/-
, pTα
a
-transgene
(+)
pTα
-/- 
and pTα
a
-transgene
(-)
pTα
(-/-) 
 
(littermates) mice that were analysed for TCRβ, CD4 and CD8. (A) TCRβ surface 
expression of TCRδ
(-)
 cells is shown. (B) TCRβ
(lo)
 thymocytes from (A) were 
analysed for expression of CD4 and CD8 to determine the percentage of ISPs. 
Numbers indicate percentages in each gate numbers in brackets represent 
percentages from the live gate.  
 
5.12 Analysis of phosphor-ERK levels in DP cells from pTαa-
transgenic mice. 
The restoration of a normal TCRβ(hi) population by expression of the pTαa-
transgene suggests that positive selection of DP cells is rescued in pTαa-
transgenic animals. To investigate further, DP thymocytes from pTαa-
transgene(+)pTα-/- mice were analysed for “ERK-sensitivity”. As described in 
the previous chapter, the preTCR may be required for regulating signalling 
thresholds for TCRαβ during positive selection. Cross-linking of WT DP 
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thymocytes with anti-CD3ε antibody resulted in rapid and transient 
phosphorylation of ERK1/2, while ERK1/2 phosphorylation was drastically 
reduced in pTα-deficient DPs (Figure 5.20). Cross-linking of TCRαβ in pTα-/- 
DP thymocytes expressing the pTαa-transgene resulted in ~30% phosphor-
ERK(+) cells after 1 minute. This was greater than that observed for WT 
controls (only 15-20% phosphor-ERK).  
Figure 5.20 
 
 
 
 
 
 
 
Figure 5.20 pTα
a
–transgene expression restores the “ERK-sensitivity” of 
pTα(-/-) DP thymocytes: Representative FACS plots of CD69
(lo)
DP thymocytes from 
pTα
+/+
, pTα-/-, pTα
a
-transgene
(+)
pTα
-/- 
mice that were analysed for intracellular 
ERK1/2 phosphorylation at time-zero (0 min) and after 1, and 2 minutes cross-
linking of anti-CD3ε. Numbers represent percentages of cells within the gates. 
 
Interestingly, the kinetics for WT cells, and pTα-/- cells expressing pTαa were 
very different to the phosphor-ERK kinetics of pTα-deficient DP cells. The 
latter display a more gradual and sustained increase in phosphor-ERK 
rather than a rapid transient burst. This may have important implications for 
both positive and negative selection in these cells, as will be discussed 
later. It should also be noted that this result is in contrast to the FTOC result 
in which retroviral expression of pTαa was not able to rescue the ERK-
sensitive state of CD69(lo) pTα-deficient DPs. Thus the precise timing and 
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regulation of pTαa may be very important in setting appropriate selection 
thresholds for TCRαβ signalling in pre-selection DP thymocytes. 
5.13 Summary. 
In summary, BAC-transgenic mice that express pTαa under pTα regulatory 
elements in the absence of pTαb have been generated. T cell development 
is largely rescued when these mice are crossed onto a pTα-/- background as 
the proportion of γδ cells is reduced and the percentage of DP cells 
increased. Furthermore, expression of pTαa restores development of 
mature TCRβ(hi) cells in the thymus, possibly as a result of restoration of 
positive selection thresholds for TCRαβ signalling in DP cells. Despite the 
apparent functionality of preTCRa, T cell development in the pTαa-
transgenic pTα-/- mice is not absolutely comparable to that of pTα+/+ mice. 
The size of the thymus is distinctly smaller and the percentage of DP cells 
marginally less than WT. Interestingly, a large percentage of pTαa-
transgenic pTα-/- thymocytes remain DN3 and do not appear to 
downregulate CD25, possibly explaining the differences in T cell 
development observed at later stages. However, very importantly, an 
accumulation of ISP cells is not observed in pTαa-transgenic pTα-/- mice. 
This suggests that termination of pTαa expression is vital for appropriate T 
cell development, and continued expression, as observed when pTαa is 
expressed from a retroviral promoter in FTOC, leads to a developmental 
block at the highly proliferative ISP stage. As proliferation is one of the pre-
requisites for oncogenesis, this conclusion has important implications for T 
cell leukaemia.   
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Conclusions and Discussions 
 
A functional ptcra gene is essential for adaptive immunity, as αβ T cell 
development is severely compromised in the absence of a preTCR  
(Fehling et al., 1995a). This and other observations initially suggested that 
the preTCR possessed unique qualities that “instructed” an αβ T cell fate in 
uncommitted DN progenitors (Borowski et al., 2004; Saint-Ruf et al., 2000). 
Nonetheless, both TCRγδ (Buer et al., 1997a) and a prematurely expressed 
transgenic TCRαβ  (Lacorazza et al., 2001b), were later shown to partly 
drive αβ T cell development in a preTCR-deficient background. By way of 
explanation, it emerged that a key component of fate determination was the 
strength of signal delivered by a TCR complex at the DN stage (Haks et al., 
2005; Hayes et al., 2005). Thus, the preTCR, that provides a weak signal 
due to its low surface expression, drives αβ T cell development, while 
TCRγδ, that generally signals more strongly, drives commitment to a γδ cell 
fate (Pennington et al., 2005). Although providing a compelling model for αβ 
lineage commitment at the DN stage, these studies did not focus on the DP 
products of preTCR-driven differentiation. Indeed, it was assumed that αβ -
committed DP cells were a homogenous pool of progenitors for subsequent 
selection events mediated through the αβTCR. More recently, this view has 
changed, with several studies suggesting heterogeneity in the DP 
population that may subsequently influence the type of T cell generated, be 
it conventional αβ  T cells, regulatory T cells (Pennington et al., 2006; van 
Santen et al., 2004), or T cells destined for the epithelial layers of the gut 
(Gangadharan et al., 2006).  
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The mechanism for generation of heterogeneity in the DP pool has been a 
principle focus of this thesis. We hypothesised that heterogeneity in post-β-
selection thymocytes arose from differential use of a preTCR formed with 
either pTαa, or the splice variant of pTα that lacks the extracellular Ig-loop, 
pTαb. We hypothesised that preTCRa and preTCRb signal differently to 
promote differential T cell developmental outcomes.  
To directly address our hypotheses we aimed to characterise expression of 
pTαa and pTαb in the thymus, on the population level and at the single cell 
level. In addition, our aim was to investigate the function of pTαa and pTαb 
when expressed in isolation in pTα-deficient thymocytes, and to generate 
BAC-transgenic mice where expression of pTαa and pTαb is controlled by 
endogenous regulatory elements.   
1.1 pTαa and pTαb expression in the thymus 
Semi-quantitative PCR for pTαa and pTαb revealed that both isoforms are 
expressed as early as DN2 cells, with expression appearing to peak in the 
DN3 and DN4 subsets, correlating with β-selection. Relative expression of 
pTαa and pTαb appears to decrease after the DN4 stage, as ISPs and DPs 
expressed lower levels of pTαa and pTαb RNA. Thus, pTαb appears to share 
the same expression pattern as pTαa in DN2, DN3, DN4 and ISP subsets, 
being similar to that already described for pTα (pTαa) (Saint-Ruf et al., 
1994). However, DP thymocytes appeared to express more pTαb than pTαa. 
This suggests that the regulation of splicing of the primary pTα transcript is 
biased in DP thymocytes to favour production of pTαb. 
Transcripts for pTαb were also found in greater abundance than those for 
pTαa in CD4 SP thymocytes, consistent with observations in TCRα KO mice 
from which pTαb was first identified (Barber et al., 1998). In this report it was 
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shown that TCRβ(+) CD4 peripheral T cells (“β”-only cells) from TCRα KO 
mice expressed pTαb but not pTαa (Barber et al., 1998). In a recent report 
peripheral Foxp3(+) T-regs were shown to express pTα, predominantly in 
the form of pTαb (Campese et al., 2009). Thus, the expression observed for 
pTαb in CD4 SPs may be a representation of pTαb expression in T-
regulatory cells, or perhaps “β-only” cells, in the thymus. It would be 
interesting to investigate this further, perhaps by analysing CD25(+) CD4SP 
cells, or looking in Foxp3-GFP transgenic mice (Fontenot et al., 2005).  
Thymic precursors of CD8αα(+)TCRαβ(+) intraepithelial lymphocytes of the 
gut have been identified within the DP subset. In addition to CD4 and 
CD8αβ, these cells express the CD8αα homodimer and are termed “triple 
positive” (TP).  In an adult thymus TPs constitute approximately 7% of the 
DP subset (Gangadharan et al., 2006). At embryonic day 17, however, 60% 
of DPs were found to express CD8αα. TP thymocytes can be distinguished 
from DPs by staining with fluorochrome-conjugated, thymic leukaemia (TL) 
tetramers. PCR analysis of CD4(+)CD8β(+)TL(+) (TP) and TL(-) (DP) 
thymocytes from E17 C57BL/6 mice, revealed that both TL(+) and TL(-) 
thymocytes appeared to express similar levels of pTαa and pTαb. This would 
suggest that unconventional and conventional T cell precursors in the 
thymus do not differentially use pTαa and pTαb. Thus, the heterogeneity 
observed in the TP population is not explained by the use of either preTCRa 
or preTCRb. This might suggest that TCRβ has a more prominent role at the 
β-selection checkpoint than is currently believed.  
Our initial hypothesis stated that differential use of a preTCR formed with 
either pTαa or pTαb by progenitor thymocytes would promote different T cell 
developmental outcomes. Thus, single cell PCR for pTαa and pTαb was set 
up to directly test whether individual DN3 and DN4 cells expressed either 
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pTαa or pTαb or both pTαa and pTαb. The assay has been optimised. 
However, due to time constraints, these experiments have not been 
completed, and therefore this question remains to be answered. 
Nevertheless, single cell PCR is a very useful tool and now that the 
technique has been established, will prove to be very beneficial for future 
research in the lab.  
1.2 preTCRa and preTCRb promote different T cell development.  
The alternatively-spliced isoform of pTα, pTαb, was initially identified as 
forming a signalling-competent preTCR complex in vitro (Barber et al., 
1998). Subsequently, pTαb was shown to largely rescue T cell development 
when expressed as a transgene from the p56lck promoter in pTα-deficient 
mice (Gibbons et al., 2001). However, only steady-state conditions were 
assessed in these animals, and variation in transgene copy number and 
integration site meant a direct comparison between preTCRb-driven and 
preTCRa-driven T cell development was unfeasible. Here, by using FTOC 
to carefully track T cell development over time, we reveal that early steps of 
thymocyte development mediated by preTCRa and preTCRb are not 
equivalent; preTCRa drives sustained expansion of the immature ISP 
subset, while preTCRb promotes the rapid development of TCRαβ(hi) SP 
cells.  
The observed difference in development promoted by preTCRa and 
preTCRb suggests that the two receptors produce qualitatively different 
signals. Both pTαa and pTαb, however, share an identical intracellular 
domain. Consistent with observations in vitro (Barber et al., 1998), our data 
demonstrate that surface expression of preTCRb is significantly greater 
than preTCRa in γδ(-), immature  thymocytes. Surface expression of TCRs 
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on DN thymocytes has been shown to positively correlate with signal 
strength (Hayes et al., 2005). As signal strength has profound effects on 
DN cell development (Haks et al., 2005; Hayes et al., 2005), it is possible 
that differential surface expression of preTCRa and preTCRb, and hence 
signalling capacity, underpins the differential developmental potential of 
pTαa- and pTαb-expressing DN cells.  
1.3 Differential surface expression distinguishes the function of 
preTCRa and preTCRb.  
Surface expression of the preTCR is known to be regulated by pTα 
(Carrasco et al., 2003; Panigada et al., 2002). Indeed, it was recently 
shown that four charged amino acids in the extracellular domain of full-
length pTα (i.e. pTαa) were necessary for pTα oligomerization and 
subsequent internalisation of the receptor (Yamasaki et al., 2006). 
Moreover, this study claimed that pTα oligomerization was essential for 
ligand-independent signalling from the preTCR and hence its function.  
Here, our data confirm that pTαb, which lacks three of these four “essential” 
amino acids (D22, R24, and R102), forms a preTCR in DN thymocytes that 
can signal to drive thymocyte development beyond the β-selection 
checkpoint. A pTαb R117A mutant, that lacks the remaining charged 
residue, can also drive thymocyte development in a manner 
indistinguishable to that of pTαb. Furthermore, a pTαa DRR mutant, in which 
the three charged amino acids unique to pTαa were mutated to alanine, 
induced increased TCRβ surface expression and a pattern of thymocyte 
development comparable to that seen for preTCRb.  
Thus, our results demonstrate that pTα oligomerization is not essential for 
preTCR signalling per se. Instead, oligomerization of pTαa limits preTCRa 
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surface expression in DN cells, driving prolonged expansion of the ISP 
subset toward the DP stage. By contrast, pTαb, which lacks three of the four 
amino acids required for pTαa oligomerization, permits preTCRb to be 
expressed at higher surface levels than preTCRa. This drives rapid 
development of DN cells through to mature TCRαβ(hi) SP cells. 
1.4 Ligand-independent signalling at the β-selection checkpoint. 
Our data demonstrate that regions of the pTα chain that mediate preTCR 
oligomerization are not required for signal initiation in DN thymocytes. 
These results have led us to consider alternative hypotheses for the 
mechanism of signal initiation at the β-selection checkpoint. Thus, we 
propose that ligand independent signalling is a property conferred to DN 
cells by the presence of unbound, readily available, “free” Lck at the cell 
surface. Lck is the most upstream signalling molecule in the TCR signal 
transduction pathway (Molina et al., 1992). Lck molecules are trafficked to 
the cell membrane soon after their synthesis (Bijlmakers et al., 1997; 
Bijlmakers and Marsh, 1999). In DP or SP cells, the majority of Lck 
molecules at the cell surface are bound to the cytoplasmic tails of the co-
receptor molecules CD4 and CD8 (Figure 1.1) (Van Laethem et al., 2007; 
Veillette et al., 1988). In order to signal, TCR complexes expressed at the 
surface of DP cells must interact with peptide/MHC in order to aggregate 
and recruit either CD4 or CD8 into the TCR complex, thus bringing Lck into 
close proximity of the intracellular domains of the various CD3 chains. Co-
receptor molecules, therefore, enforce MHC-specificity in the developing T 
cell repertoire (Van Laethem et al., 2007).  
DN cells by definition lack both CD4 and CD8. Thus a pool of “free” Lck is 
readily accessible to TCR complexes expressed at the cell membrane (Van 
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Laethem et al., 2007). Because of this ligand-independent TCR signalling in 
DN thymocytes may simply be a consequence of the pairing of 
appropriately matched TCR chains, which has the result of bringing 
together CD3ε containing cassettes in the presence of readily accessible 
“free” Lck. Indeed, early expression of a CD8 transgene effectively 
sequesters “free” Lck in DN thymocytes, limiting the availability of Lck for 
ligand-independent signalling and inhibiting their development to DP stage 
(Wack et al., 2000).  
Figure 1.1 
 
 
 
 
 
Figure 1.1 Availability of “free” Lck determines ligand independent signalling 
in thymocytes: DN thymocytes do not express co-receptors CD4 and CD8 
therefore all of the Lck expressed by these cells is available at the cell membrane 
to activate TCR complexes and initiate ligand independent signalling. The nature of 
the TCR is not important; αβ , γδ or preTCR, as long as 2 CD3 dimers are 
associated in the proximity of the “free” Lck. In DP thymocytes CD4 and CD8 co-
receptors bind with high affinity Lck; limiting the amount of “free” Lck available to 
interact with TCR complexes and prohibiting ligand independent signals.   
 
This view on the mechanism that underpins ligand-independent signalling 
allows us to suggest that the acquisition of CD4 and CD8 during DN-DP 
development marks the transition from a cell that is able to support ligand-
independent signalling to one that cannot. Thus in DP cells the association 
of two CD3ε containing molecules (i.e. CD3εγ or CD3εδ), mediated by 
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pairing of two TCR chains is not sufficient to induce TCR signalling as “free” 
Lck has been sequestered by CD4 and CD8 (Figure 1.1). 
This proposed mechanism would also neatly explain why cross-linking of 
CD3ε by monoclonal antibodies on RAG-deficient (DN) thymocytes (Shinkai 
and Alt, 1994), or dimerization of a huCD8-CD3ε fusion protein in RAG-
deficient thymocytes (Yamasaki et al., 2006), both efficiently promote 
progression past the β-selection checkpoint. Furthermore, it helps to explain 
the observation that ligand-independent signalling does not appear to be 
intrinsic to the receptor expressed at the surface of DN thymocytes; as the 
αβ TCR, γδTCR as well as several mutant forms of the preTCR are all able 
to drive β-selection (Gibbons et al., 2001; Haks et al., 2003; Haks et al., 
2005; Irving et al., 1998).  
1.5 Sustained expression of preTCRa but not preTCRb is detrimental to 
normal T cell development. 
Towards the end of this work, preliminary, characterisation of transduced 
thymocytes in FTOC suggested that preTCRa induced greater IL-7Rα 
expression on γδ(-) TCRβ(lo), immature thymocytes than preTCRb. This 
observation may help to explain the developmental phenotype promoted by 
preTCRa. IL-7 signalling promotes survival and proliferation of β-selected 
thymocytes (Trigueros et al., 2003). However, this preTCR-induced IL-7Rα 
upregulation appears to be transient as IL-7Rα expression is terminated at 
the ISP stage (Yu et al., 2004). IL-7 signalling inhibits expression of 
transcription factors TCF-1, LEF-1 and RORγt that are required for the ISP 
to DP transition in the thymus (Yu et al., 2004). Indeed, treatment of E15.5 
thymocytes with IL-7 interfered with DP and SP cell development resulting 
in an increase in the DN and ISP thymocyte populations (Yu et al., 2004). 
Thus, the effect of sustained IL-7 signalling around the β-selection 
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checkpoint resembles the phenotype observed for pTαa expression in 
FTOC, with accumulation of the ISP subset.  
Egr3 is also transiently upregulated following preTCR signalling and 
induces proliferation of post-β-selected thymocytes (Xi et al., 2006). 
Importantly, sustained Egr3 transgene expression in RAG KO mice also 
promotes the development and accumulation of ISP thymocytes (Carleton 
et al., 2002).  A similar phenotype was observed in mice that are deficient 
for the E-protein, HEB (Barndt et al., 1999).  preTCR signalling is known to 
upregulate the inhibitor of E-proteins, Id3, that allows subsequent 
thymocyte proliferation (Koltsova et al., 2007). Thus, it is possible that 
preTCRa promotes the inhibition of E-proteins via Egr3 and Id3 that, if pTαa 
expression is prolonged, promotes the continued proliferation of ISPs and 
prevents their differentiation to the DP stage. Importantly, the accumulation 
of the ISP subset is not observed in BAC transgenic pTαa-only mice that 
express pTαa under the pTα regulatory elements. Presumably this is 
because unlike in FTOC, pTαa is shut-off at an appropriate stage in these 
animals. These results emphasise the importance of transcriptional control 
of pTαa around the β-selection checkpoint, and suggests that a negative 
feedback mechanism, by which preTCR signals downregulate pTα 
transcription may be in operation (Saint-Ruf et al., 1994; Yashiro-Ohtani et 
al., 2009). Alternatively, splicing of the pTα transcript away from pTαa toward 
predominantly pTαb transcripts may attenuate the effects of preTCRa (see 
later). This would be an important area of further investigation along with 
the transcriptional relationship between pTα and TCF-1, LEF-1, Egr3, Id3, 
HEB and RORγt. 
pTα expression is regulated by Notch and transgenic mice expressing 
intracellular Notch3 under the control of the proximal Lck promoter develop 
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T cell lymphomas that express pTα (Bellavia et al., 2000). Deletion of pTα in 
Notch3 transgenic mice abrogates tumour development, indicating a role 
for pTα in T cell leukemogenesis (Bellavia et al., 2002). Furthermore, 
human T-acute lymphoblastic leukaemias (T-ALL) have been shown to 
express pTα (Bellavia et al., 2002). Thus, the ISPs that accumulate as a 
result of sustained preTCRa signalling could represent a subset of cells that 
are prone to oncogenesis, because of their continued proliferation and 
inhibited differentiation. These results suggest that constitutive expression 
of pTαa is detrimental to normal T cell development and may underlie a 
possible mechanism of tumourogenesis. Clearly these are areas that 
warrant further investigation. 
1.6 The function of pTαb. 
One of the major initial aims of this thesis was to ascribe a definitive role to 
the second isoform of pTα; pTαb. Unfortunately, this is one area of the work 
where questions remain unanswered. Nonetheless, much important 
information regarding pTαb has been discovered (see pervious discussion 
points), both for the protein itself, and for its relationship with pTαa. pTαa 
appears to be dominant to pTαb when expressed in the same cell. 
Dominance of pTαa over pTαb may be a direct result of the superior ability of 
pTαa to bind TCRβ and therefore promote low surface expression of the 
preTCR through receptor oligomerization and internalisation. This would 
imply that the function of preTCRb would only be effective in cells in which 
pTαb is expressed more abundantly than pTαa. Our expression data 
suggests that DP cells express more pTαb than pTαa and preTCRb 
signalling appears to promote the DP to SP transition very efficiently in 
FTOC. This would perhaps suggest a role for pTαb in either the 
establishment of the DP stage, or in the efficient transition of DP 
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thymocytes to the SP stage. Although a definitive answer is not presently at 
hand, the section below discusses this in more detail.  
1.7 The preTCR may particitpate in the establishment of TCR 
signalling thresholds in DP thymocytes. 
DP thymocytes undergo important selection events based on the strength 
and duration of signalling through their TCRs that determine their fate. 
High-affinity self-antigen-MHC interactions induce strong TCR signals in DP 
thymocytes, resulting in death by apoptosis (negative selection), while low-
affinity interactions between TCR and self-peptide-MHC direct 
differentiation to the SP stage (positive selection). It has been reported that 
prolonged signalling via calcineurin and NFAT induces an “ERK-sensitized” 
state in pre-selected DPs that allow them to differentiate in response to 
“weak” positively selecting signals (Gallo et al., 2007).  However, the origin 
of the signals that result in calcineurin and NFAT activation in pre-selected 
DPs was not addressed in this report. Our results show that this “ERK-
sensitized” population is absent in DP cells from pTα-deficient mice, 
implicating a role for the preTCR in regulating this sensitized threshold for 
TCR signalling in DPs. To our surprise, the “ERK-sensitized” state was not 
restored upon re-introduction of pTαa or pTαb into pTα-deficient thymocytes 
in FTOC. This is difficult to reconcile, especially considering the rapid 
development of TCRαβ(hi) SPs as a result of preTCRb expression. 
Nevertheless, “ERK-sensitized” DPs were evident in pTα-deficient mice that 
expressed the pTαa-BAC-transgene. Thus it appears that precise regulation 
of preTCR signalling is required for the establishment of this population of 
pre-selected DPs and again, is clearly an area that deserves further 
investigation.  
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Preliminary data from our initial attempts to delve deeper into the 
relationship between preTCR signalling and appropriate selection of 
TCRαβ-expressing DP cells, suggested that selection events in pTα-
deficient mice were not proceeding as normal. Indeed, Vβ6-expressing cells 
were over-represented in thymuses that displayed a Vβ-6 superantigen. 
Although difficult to interpret, at the very least it suggests that pTα-deficient 
DP cells perceive strong TCR signals differently than WT DP cells. This 
could imply that the threshold for positive selection is higher in pTα-deficient 
thymocytes and allows them to escape negative selection. Thus, the 
preTCR could be necessary for establishing low positive selection 
thresholds in DP thymocytes that allow their differentiation in response to 
“weak” TCR signals but not in response to “strong”, negatively selecting 
signals. In this regard, preTCR signalling may contribute to mechanisms 
that directly prevent the generation of self-reactive T cells in the thymus 
that would otherwise lead to potentially fatal autoimmune disease.    
1.8 Further observations on pTαa-only BAC transgenic mice. 
T cell development in pTαa-only BAC transgenic mice is not entirely as 
expected. Despite expressing pTαa from the pTα regulatory elements and 
promoter, the majority of DN thymocytes in pTαa-only BAC transgenic mice 
are at the DN3 stage. Furthermore, the size of the pTαa-only BAC 
transgenic thymus is substantially smaller than that of WT. This could 
suggest that the pTα BAC is not completely re-capitulating pTα expression 
in these animals. Alternatively, it could suggest that in the absence of pTαb 
T cell development across the β-selection checkpoint is not normal. This is 
an area for future investigation, as is the observation that the CD4/CD8 
ratio in the periphery of these transgenic animals is partially inverted 
towards CD8SPs. This may have roots in the problems with positive 
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selection as discussed earlier. Clearly these mice must be further 
characterised, with analysis of gut IELs being of particular interest. It would 
also be fascinating to compare the pTαa-only BAC transgenic mice with 
pTαb-only BAC transgenic mice that are presently being generated. It is 
hoped that the combination of data from these animals will help to shed 
insight into what appears to be a specific but subtle role for pTαb during T 
cell development.  
1.9 Summary. 
To summarise, the results presented in this thesis shed new insight on T 
cell development at the β-selection checkpoint. They reveal for the first time 
that distinct preTCRs, formed in DN cells when TCRβ pairs with either pTαa 
or pTαb, drive divergent T cell development. These results demonstrate that 
pTα oligomerization is not essential for initiation of preTCR signalling, 
demanding re-assessment of the mechanisms that underpin this ligand-
independent process. Instead, we propose that pTαa oligomerization 
establishes a lower set-point for preTCRa surface expression that regulates 
subsequent development. By contrast, pTαb, that lacks the ability to 
oligomerize, allows higher surface expression of preTCRb, driving distinct T 
cell development. Finally, these data strongly implicate the preTCR in a 
hitherto unrecognised role in setting sensitive ERK-mediated selection 
thresholds in pre-selected DP thymocytes that prevents the development of 
auto-reactive T cells and, therefore, autoimmune disease.  
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